Cayman公司成立于1980年,在过去20多年的发展过程中,始终保持着为科研工作者提供高质、优价研究产品的宗旨。该公司目前可以提供2,138 多种生化和免疫试剂,涉及肿瘤、氧化氮、神经学、凋亡、氧化性损伤、内分泌学等研究领域。非常有特色的检测试剂盒包括类花生酸类物质、游离的生物标志、环核苷、激素及氧化氮等。此外,还提供多种高质量试剂,如类花生酸类物质、氧化氮试剂及许多相关脂质、脂肪酸、酶和抗体等。Cayman非常愿意接受各地客户的要求,合成复杂和不稳定分子。
品牌商名称:Cayman Chemical
:(734) 971-3335
地址:1180 East Ellsworth Road Ann Arbor, Michigan 48108 USA
公司:http://www.caymanchem。。com/
世界*实验材料供应商Cayman正式授权上海起发为其中国代理,Cayman在一直是行业的*,一直为广大科研客户提供zui为的产品和服务,上海起发一直秉承为中国科研客户带来的产品,的服务, 签约Cayman就是为了给广大科研客户带来更加完善的产品和服务,您的满意将是我们zui大的收获
Cayman中国代理,Cayman上海代理,Cayman北京代理,Cayman广东代理,Cayman江苏代理 Cayman湖北代理, Cayman天津, Cayman黑龙江代理, Cayman内蒙古代理, Cayman吉林代理, Cayman福建代理, Cayman江苏代理, Cayman浙江代理, Cayman四川代理,
部分报价2
品牌 | 目录号 | 产品 | 规格 | 2015目录价 |
Cayman2015 | 10009222 | Sphingosine Kinase Inhibitor 2 | 25 mg | 2016 |
Cayman2015 | 10009222 | Sphingosine Kinase Inhibitor 2 | 5 mg | 448 |
Cayman2015 | 10009222 | Sphingosine Kinase Inhibitor 2 | 50 mg | 3584 |
Cayman2015 | 10009223 | Vilogenin (medaka) EIA Kit | 480 Well | 52960 |
Cayman2015 | 10009223 | Vilogenin (medaka) EIA Kit | 96 Well | 14120 |
Cayman2015 | 10009226 | (±)-SLV 319 | 1 mg | 350 |
Cayman2015 | 10009226 | (±)-SLV 319 | 10 mg | 2450 |
Cayman2015 | 10009226 | (±)-SLV 319 | 5 mg | 1316 |
Cayman2015 | 10009226 | (±)-SLV 319 | 50 mg | 9632 |
Cayman2015 | 10009227 | (R)-SLV 319 | 1 mg | 588 |
Cayman2015 | 10009227 | (R)-SLV 319 | 10 mg | 4704 |
Cayman2015 | 10009227 | (R)-SLV 319 | 5 mg | 2646 |
Cayman2015 | 10009227 | (R)-SLV 319 | 50 mg | 18816 |
Cayman2015 | 10009231 | HDAC1 (human recombinant) | 1 ea | 7420 |
Cayman2015 | 10009232 | HDAC3/NCOR2 (human recombinant) | 1 ea | 7100 |
Cayman2015 | 10009237 | Sphingosine Kinase 2 (human recombinant) | 1 ea | 5960 |
Cayman2015 | 10009239 | SREBP-2 Cell-Based Translocation Assay Kit | 96 Well | 3556 |
Cayman2015 | 10009266 | SREBP-2 Blocking Peptide | 1 ea | 1498 |
Cayman2015 | 10009268 | Transcription Factor HIF-1α Positive Control | 1 ea | 910 |
Cayman2015 | 10009269 | Transcription Factor HIF-1α Primary Antibody | 1 ea | 1092 |
Cayman2015 | 10009270 | Transcription Factor HIF-1α Competitor dsDNA | 1 ea | 686 |
Cayman2015 | 10009271 | Transcription Factor HIF-1α 96-Well Strip Plate | 1 ea | 896 |
Cayman2015 | 10009272 | Vilogenin (salmonid) Semi-Quantitative EIA Kit | 1 ea | 9140 |
Cayman2015 | 10009272 | Vilogenin (salmonid) Semi-Quantitative EIA Kit | 5 ea | 34280 |
Cayman2015 | 10009277 | Nuclear Extraction Kit | 1 ea | 2142 |
Cayman2015 | 10009278 | 8-iso-16-cyclohexyl-tetranor Prostaglandin E2 | 1 mg | 4480 |
Cayman2015 | 10009278 | 8-iso-16-cyclohexyl-tetranor Prostaglandin E2 | 100 μg | 560 |
Cayman2015 | 10009278 | 8-iso-16-cyclohexyl-tetranor Prostaglandin E2 | 500 μg | 2520 |
Cayman2015 | 10009279 | Transcription Factor Goat Anti-Mouse HRP Conjugate | 1 ea | 854 |
Cayman2015 | 10009280 | L-759,633 | 1 mg | 336 |
Cayman2015 | 10009280 | L-759,633 | 10 mg | 2688 |
Cayman2015 | 10009280 | L-759,633 | 25 mg | 5880 |
Cayman2015 | 10009280 | L-759,633 | 5 mg | 1512 |
Cayman2015 | 10009286 | 14(15)-EET-SI | 100 μg | 3276 |
Cayman2015 | 10009286 | 14(15)-EET-SI | 25 μg | 910 |
Cayman2015 | 10009286 | 14(15)-EET-SI | 50 μg | 1736 |
Cayman2015 | 10009291 | Cysteinyl Leukotriene Express EIA Kit | 480 Solid | 17584 |
Cayman2015 | 10009291 | Cysteinyl Leukotriene Express EIA Kit | 480 Well | 17584 |
Cayman2015 | 10009291 | Cysteinyl Leukotriene Express EIA Kit | 96 Solid | 4690 |
Cayman2015 | 10009291 | Cysteinyl Leukotriene Express EIA Kit | 96 Well | 4690 |
Cayman2015 | 10009292 | Leukotriene B4 Express EIA Kit | 480 Solid | 15400 |
Cayman2015 | 10009292 | Leukotriene B4 Express EIA Kit | 480 Well | 15400 |
Cayman2015 | 10009292 | Leukotriene B4 Express EIA Kit | 96 Solid | 4130 |
Cayman2015 | 10009292 | Leukotriene B4 Express EIA Kit | 96 Well | 4130 |
Cayman2015 | 10009301 | Nuclear Extraction Hypotonic Buffer (10X) | 1 ea | 350 |
Cayman2015 | 10009302 | Nuclear Extraction Dithiothreitol (1M) | 1 ea | 350 |
Cayman2015 | 10009303 | Nuclear Extraction Protease Inhibitor Cocktail (100X) | 1 ea | 770 |
Cayman2015 | 10009304 | Nuclear Extraction PBS (10X) | 1 ea | 350 |
Cayman2015 | 10009305 | Nuclear Extraction Phosphatase Inhibitors (50X) | 1 ea | 630 |
Cayman2015 | 10009306 | Nuclear Extraction Buffer (2X) | 1 ea | 350 |
Cayman2015 | 10009312 | SKF 96365 (hydrochloride) | 1 mg | 210 |
Cayman2015 | 10009312 | SKF 96365 (hydrochloride) | 10 mg | 1680 |
Cayman2015 | 10009312 | SKF 96365 (hydrochloride) | 5 mg | 952 |
Cayman2015 | 10009312 | SKF 96365 (hydrochloride) | 50 mg | 7350 |
Cayman2015 | 10009315 | 6-Aminonicotinamide | 1 g | 1120 |
Cayman2015 | 10009315 | 6-Aminonicotinamide | 100 mg | 140 |
Cayman2015 | 10009315 | 6-Aminonicotinamide | 250 mg | 336 |
Cayman2015 | 10009315 | 6-Aminonicotinamide | 500 mg | 630 |
Cayman2015 | 10009317 | PAC-1 | 100 mg | 4382 |
Cayman2015 | 10009317 | PAC-1 | 25 mg | 1218 |
Cayman2015 | 10009317 | PAC-1 | 250 mg | 9744 |
Cayman2015 | 10009317 | PAC-1 | 50 mg | 2310 |
Cayman2015 | 10009318 | LDH Diaphorase | 1 ea | 224 |
Cayman2015 | 10009318 | LDH Diaphorase | 5 ea | 840 |
Cayman2015 | 10009319 | LDH NAD+ (100X) | 1 ea | 224 |
Cayman2015 | 10009319 | LDH NAD+ (100X) | 5 ea | 840 |
Cayman2015 | 10009320 | LDH Lactic Acid (100X) | 1 ea | 154 |
Cayman2015 | 10009320 | LDH Lactic Acid (100X) | 5 ea | 574 |
Cayman2015 | 10009321 | LDH Standard | 1 ea | 154 |
Cayman2015 | 10009322 | Cell-Based Assay Buffer Tablet | 1 ea | 126 |
Cayman2015 | 10009322 | Cell-Based Assay Buffer Tablet | 2 ea | 224 |
Cayman2015 | 10009322 | Cell-Based Assay Buffer Tablet | 3 ea | 322 |
Cayman2015 | 10009322 | Cell-Based Assay Buffer Tablet | 4 ea | 378 |
Cayman2015 | 10009322 | Cell-Based Assay Buffer Tablet | 5 ea | 434 |
Cayman2015 | 10009323 | LCAT Polyclonal Antibody | 1 ea | 3206 |
Cayman2015 | 10009324 | LCAT Blocking Peptide | 1 ea | 1498 |
Cayman2015 | 10009325 | Malachite Green Phosphate Assay Kit | 1 ea | 1078 |
Cayman2015 | 10009328 | LDH INT (100X) | 1 ea | 224 |
Cayman2015 | 10009328 | LDH INT (100X) | 5 ea | 840 |
Cayman2015 | 10009330 | HAT Assay Buffer (5X) | 1 ea | 154 |
Cayman2015 | 10009331 | HAT Acetyl CoA | 1 ea | 294 |
Cayman2015 | 10009332 | Histone Acetyltransferase (pCAF) | 1 ea | 714 |
Cayman2015 | 10009333 | HAT Peptide | 1 ea | 854 |
Cayman2015 | 10009334 | HAT Stop Reagent | 1 ea | 154 |
Cayman2015 | 10009335 | HAT Developer | 1 ea | 714 |
Cayman2015 | 10009342 | AVP EIA Standard | 1 ea | 1218 |
Cayman2015 | 10009342 | AVP EIA Standard | 5 ea | 4564 |
Cayman2015 | 10009343 | AVP EIA Antiserum | 100 dtn | 840 |
Cayman2015 | 10009343 | AVP EIA Antiserum | 500 dtn | 3150 |
Cayman2015 | 10009344 | AVP AChE Tracer | 100 dtn | 2618 |
Cayman2015 | 10009344 | AVP AChE Tracer | 500 dtn | 9814 |
Cayman2015 | 10009348 | ω-3 Arachidonic Acid ethyl ester | 1 mg | 630 |
Cayman2015 | 10009348 | ω-3 Arachidonic Acid ethyl ester | 10 mg | 5670 |
Cayman2015 | 10009348 | ω-3 Arachidonic Acid ethyl ester | 5 mg | 2996 |
Cayman2015 | 10009349 | Cell Cycle Phase Determination Kit | 1 ea | 2772 |
Cayman2015 | 10009350 | Aldehyde Reactive Probe (trifluoroacetate salt) | 10 mg | 1246 |
Cayman2015 | 10009350 | Aldehyde Reactive Probe (trifluoroacetate salt) | 25 mg | 2968 |
Cayman2015 | 10009350 | Aldehyde Reactive Probe (trifluoroacetate salt) | 5 mg | 658 |
Cayman2015 | 10009350 | Aldehyde Reactive Probe (trifluoroacetate salt) | 50 mg | 5264 |
Cayman2015 | 10009365 | MTT Cell Proliferation Assay Kit | 2500 dtn | 4046 |
Cayman2015 | 10009365 | MTT Cell Proliferation Assay Kit | 500 dtn | 1078 |
Cayman2015 | 10009366 | Piceatannol | 10 mg | 1064 |
Cayman2015 | 10009366 | Piceatannol | 25 mg | 2352 |
Cayman2015 | 10009366 | Piceatannol | 5 mg | 588 |
Cayman2015 | 10009366 | Piceatannol | 50 mg | 3528 |
Cayman2015 | 10009368 | TP Receptor (human) Blocking Peptide | 1 ea | 1498 |
Cayman2015 | 10009370 | Dopamine β-hydroxylase (C-Term; human) Polyclonal Antibody | 1 ea | 6300 |
Cayman2015 | 10009371 | Dopamine β-hydroxylase (N-Term; human) Polyclonal Antibody | 1 ea | 6300 |
Cayman2015 | 10009372 | Dopamine Transporter (C-Term) Polyclonal Antibody | 1 ea | 6300 |
Cayman2015 | 10009373 | Dopamine Transporter (Extracellular Loop 2) Polyclonal Antibody | 1 ea | 6300 |
Cayman2015 | 10009374 | GSK3β (Phospho-Ser9) Polyclonal Antibody | 1 ea | 6500 |
Cayman2015 | 10009375 | 14(Z)-Eicosenoic Acid | 1 mg | 560 |
Cayman2015 | 10009375 | 14(Z)-Eicosenoic Acid | 10 mg | 4480 |
Cayman2015 | 10009375 | 14(Z)-Eicosenoic Acid | 25 mg | 9800 |
Cayman2015 | 10009375 | 14(Z)-Eicosenoic Acid | 5 mg | 2520 |
Cayman2015 | 10009377 | HDAC2 (human recombinant) | 1 ea | 7420 |
Cayman2015 | 10009379 | HDAC5 (human recombinant) | 1 ea | 7420 |
Cayman2015 | 10009381 | Adipolysis Assay Kit | 1 ea | 3556 |
Cayman2015 | 10009396 | Tryptophan Hydroxylase Polyclonal Antibody | 1 ea | 6300 |
Cayman2015 | 10009397 | Tryptophan Hydroxylase (Phospho-Ser58) Polyclonal Antibody | 1 ea | 6300 |
Cayman2015 | 10009398 | Tryptophan Hydroxylase (Phospho-Ser260) Polyclonal Antibody | 1 ea | 6500 |
Cayman2015 | 10009399 | Glycine Receptor Polyclonal Antibody | 1 ea | 6300 |
Cayman2015 | 10009400 | Gap-43 (Phospho-Ser41) Polyclonal Antibody | 1 ea | 6500 |
Cayman2015 | 10009410 | ATF2 (Phospho-Ser490,498) Polyclonal Antibody | 1 ea | 6500 |
Cayman2015 | 10009411 | Ribosomal S6 Kinase 2 Polyclonal Antibody | 1 ea | 6500 |
Cayman2015 | 10009413 | Tyrosine Hydroxylase (Phospho-Ser31) Polyclonal Antibody | 1 ea | 6500 |
Cayman2015 | 10009414 | Tyrosine Hydroxylase (Phospho-Ser40) Polyclonal Antibody | 1 ea | 6500 |
Cayman2015 | 10009419 | Nitric Oxide Cell-Based Assay Kit | 96 Well | 3500 |
Cayman2015 | 10009431 | 1-Stearoyl-2-Arachidonoyl PC-d8 | 1 mg | 8428 |
Cayman2015 | 10009431 | 1-Stearoyl-2-Arachidonoyl PC-d8 | 100 μg | 1148 |
Cayman2015 | 10009431 | 1-Stearoyl-2-Arachidonoyl PC-d8 | 50 μg | 602 |
Cayman2015 | 10009431 | 1-Stearoyl-2-Arachidonoyl PC-d8 | 500 μg | 4816 |
Cayman2015 | 10009434 | Leukotriene B4 Express EIA Monoclonal Antibody | 100 dtn | 630 |
Cayman2015 | 10009434 | Leukotriene B4 Express EIA Monoclonal Antibody | 500 dtn | 2380 |
Cayman2015 | 10009435 | Leukotriene B4 Express AChE Tracer | 100 dtn | 2450 |
Cayman2015 | 10009435 | Leukotriene B4 Express AChE Tracer | 500 dtn | 9170 |
Cayman2015 | 10009436 | Leukotriene B4 Express Standard | 1 ea | 406 |
Cayman2015 | 10009437 | Kifunensine | 1 mg | 1232 |
Cayman2015 | 10009437 | Kifunensine | 10 mg | 8008 |
Cayman2015 | 10009437 | Kifunensine | 5 mg | 5236 |
Cayman2015 | 10009437 | Kifunensine | 50 mg | 24640 |
Cayman2015 | 10009445 | Glucoraphanin | 1 mg | 350 |
Cayman2015 | 10009445 | Glucoraphanin | 10 mg | 2786 |
Cayman2015 | 10009445 | Glucoraphanin | 5 mg | 1582 |
Cayman2015 | 10009458 | JTE-013 | 1 mg | 266 |
Cayman2015 | 10009458 | JTE-013 | 10 mg | 2128 |
Cayman2015 | 10009458 | JTE-013 | 5 mg | 1204 |
Cayman2015 | 10009458 | JTE-013 | 50 mg | 9310 |
Cayman2015 | 10009465 | HDAC6 (human recombinant) | 1 ea | 7420 |
Cayman2015 | 10009466 | HDAC9 (human recombinant) | 1 ea | 7420 |
Cayman2015 | 10009473 | 1,2-Dipalmitoyl-sn-glycero-3-PC | 100 mg | 896 |
Cayman2015 | 10009473 | 1,2-Dipalmitoyl-sn-glycero-3-PC | 25 mg | 280 |
Cayman2015 | 10009473 | 1,2-Dipalmitoyl-sn-glycero-3-PC | 250 mg | 1680 |
Cayman2015 | 10009473 | 1,2-Dipalmitoyl-sn-glycero-3-PC | 50 mg | 504 |
Cayman2015 | 10009488 | TF CREB (Phospho-Ser133) Competitor dsDNA | 1 ea | 686 |
Cayman2015 | 10009489 | TF CREB (Phospho-Ser133) 96-Well Strip Plate | 1 ea | 896 |
Cayman2015 | 10009501 | 20-hydroxy N-Arachidonoyl Taurine | 100 μg | 5992 |
Cayman2015 | 10009501 | 20-hydroxy N-Arachidonoyl Taurine | 25 μg | 1666 |
Cayman2015 | 10009501 | 20-hydroxy N-Arachidonoyl Taurine | 50 μg | 3164 |
Cayman2015 | 10009501 | 20-hydroxy N-Arachidonoyl Taurine | 500 μg | 26656 |
Cayman2015 | 10009504 | Raf-1 (Phospho-Ser301) Polyclonal Antibody | 1 ea | 6500 |
Cayman2015 | 10009505 | Raf-1 (Phospho-Ser642) Polyclonal Antibody | 1 ea | 6500 |
Cayman2015 | 10009506 | PSD95 Polyclonal Antibody | 1 ea | 6500 |
Cayman2015 | 10009517 | MEK1 (Phospho-Thr386) Polyclonal Antibody | 1 ea | 6500 |
Cayman2015 | 10009518 | MEK1 (Phospho-Thr292) Polyclonal Antibody | 1 ea | 6500 |
Cayman2015 | 10009523 | CAY10429-d3 | 1 mg | 3472 |
Cayman2015 | 10009523 | CAY10429-d3 | 100 μg | 434 |
Cayman2015 | 10009523 | CAY10429-d3 | 5 mg | 15190 |
Cayman2015 | 10009523 | CAY10429-d3 | 500 μg | 1960 |
Cayman2015 | 10009524 | ChREBP DBD (human recombinant) | 10 μg | 1918 |
Cayman2015 | 10009524 | ChREBP DBD (human recombinant) | 25 μg | 4536 |
Cayman2015 | 10009524 | ChREBP DBD (human recombinant) | 5 μg | 1008 |
Cayman2015 | 10009531 | PtdIns-(3,4,5)-P3-biotin (sodium salt) | 10 μg | 1806 |
Cayman2015 | 10009531 | PtdIns-(3,4,5)-P3-biotin (sodium salt) | 100 μg | 11746 |
Cayman2015 | 10009531 | PtdIns-(3,4,5)-P3-biotin (sodium salt) | 25 μg | 4284 |
Cayman2015 | 10009531 | PtdIns-(3,4,5)-P3-biotin (sodium salt) | 50 μg | 7406 |
Cayman2015 | 10009532 | 8(9)-EET-d11 | 10 μg | 1372 |
Cayman2015 | 10009532 | 8(9)-EET-d11 | 25 μg | 3262 |
Cayman2015 | 10009532 | 8(9)-EET-d11 | 50 μg | 6174 |
Cayman2015 | 10009536 | CAY10512 | 10 mg | 462 |
Cayman2015 | 10009536 | CAY10512 | 100 mg | 3696 |
Cayman2015 | 10009536 | CAY10512 | 50 mg | 2086 |
Cayman2015 | 10009536 | CAY10512 | 500 mg | 16170 |
Cayman2015 | 10009542 | Anhydrotetracycline (hydrochloride) | 10 mg | 350 |
Cayman2015 | 10009542 | Anhydrotetracycline (hydrochloride) | 100 mg | 1932 |
Cayman2015 | 10009542 | Anhydrotetracycline (hydrochloride) | 25 mg | 742 |
Cayman2015 | 10009542 | Anhydrotetracycline (hydrochloride) | 50 mg | 1232 |
Cayman2015 | 10009547 | FABP1 (human recombinant) | 100 μg | 3976 |
Cayman2015 | 10009547 | FABP1 (human recombinant) | 25 μg | 1106 |
Cayman2015 | 10009547 | FABP1 (human recombinant) | 50 μg | 2100 |
Cayman2015 | 10009548 | FABP2 (human recombinant) | 100 μg | 3976 |
Cayman2015 | 10009548 | FABP2 (human recombinant) | 25 μg | 1106 |
Cayman2015 | 10009548 | FABP2 (human recombinant) | 50 μg | 2100 |
Cayman2015 | 10009549 | FABP4 (human recombinant) | 100 μg | 3976 |
Cayman2015 | 10009549 | FABP4 (human recombinant) | 25 μg | 1106 |
Cayman2015 | 10009549 | FABP4 (human recombinant) | 50 μg | 2100 |
Cayman2015 | 10009551 | FABP7 (human recombinant) | 100 μg | 3976 |
Cayman2015 | 10009551 | FABP7 (human recombinant) | 25 μg | 1106 |
Cayman2015 | 10009551 | FABP7 (human recombinant) | 50 μg | 2100 |
Cayman2015 | 10009557 | SC-1 | 1 mg | 630 |
Cayman2015 | 10009557 | SC-1 | 10 mg | 3150 |
Cayman2015 | 10009557 | SC-1 | 25 mg | 6930 |
Cayman2015 | 10009557 | SC-1 | 5 mg | 1736 |
Cayman2015 | 10009563 | sPLA2 (human recombinant Type V) | 10 μg | 1876 |
Cayman2015 | 10009563 | sPLA2 (human recombinant Type V) | 25 μg | 4452 |
Cayman2015 | 10009563 | sPLA2 (human recombinant Type V) | 50 μg | 8442 |
Cayman2015 | 10009569 | (R)-Roscovitine | 1 mg | 448 |
Cayman2015 | 10009569 | (R)-Roscovitine | 10 mg | 3332 |
Cayman2015 | 10009569 | (R)-Roscovitine | 5 mg | 1904 |
Cayman2015 | 10009569 | (R)-Roscovitine | 500 μg | 238 |
Cayman2015 | 10009570 | SecinH3 | 1 mg | 546 |
Cayman2015 | 10009570 | SecinH3 | 10 mg | 2730 |
Cayman2015 | 10009570 | SecinH3 | 25 mg | 5460 |
Cayman2015 | 10009570 | SecinH3 | 5 mg | 1638 |
Cayman2015 | 10009581 | PCSK9 (mouse) Blocking Peptide | 1 ea | 1498 |
Cayman2015 | 10009582 | Glucose Colorimetric Assay Kit | 192 Well | 2450 |
Cayman2015 | 10009591 | MTT Reagent | 1 ea | 504 |
Cayman2015 | 10009591 | MTT Reagent | 5 ea | 1890 |
Cayman2015 | 10009594 | Pyocyanin | 10 mg | 1806 |
Cayman2015 | 10009594 | Pyocyanin | 100 mg | 10276 |
Cayman2015 | 10009594 | Pyocyanin | 5 mg | 952 |
Cayman2015 | 10009594 | Pyocyanin | 50 mg | 6090 |
Cayman2015 | 10009598 | 6,7-dihydroxy Bergamottin | 1 mg | 210 |
Cayman2015 | 10009598 | 6,7-dihydroxy Bergamottin | 10 mg | 1680 |
Cayman2015 | 10009598 | 6,7-dihydroxy Bergamottin | 25 mg | 3682 |
Cayman2015 | 10009598 | 6,7-dihydroxy Bergamottin | 5 mg | 952 |
Cayman2015 | 10009599 | Calcipotriol (hydrate) | 10 mg | 784 |
Cayman2015 | 10009599 | Calcipotriol (hydrate) | 100 mg | 6272 |
Cayman2015 | 10009599 | Calcipotriol (hydrate) | 50 mg | 3528 |
Cayman2015 | 10009599 | Calcipotriol (hydrate) | 500 mg | 27440 |
Cayman2015 | 10009624 | COX-2 (human) Western Ready Control | 1 ea | 714 |
Cayman2015 | 10009628 | 5(S),6(R)-11-trans DiHETE | 100 μg | 4340 |
Cayman2015 | 10009628 | 5(S),6(R)-11-trans DiHETE | 25 μg | 1204 |
Cayman2015 | 10009628 | 5(S),6(R)-11-trans DiHETE | 50 μg | 2282 |
Cayman2015 | 10009634 | Purmorphamine | 1 mg | 308 |
Cayman2015 | 10009634 | Purmorphamine | 10 mg | 2464 |
Cayman2015 | 10009634 | Purmorphamine | 25 mg | 5390 |
Cayman2015 | 10009634 | Purmorphamine | 5 mg | 1386 |
Cayman2015 | 10009638 | 5-Lipoxygenase (human recombinant) Western Ready Control | 1 ea | 784 |
Cayman2015 | 10009642 | SOTS-1 (technical grade) | 1 mg | 378 |
Cayman2015 | 10009642 | SOTS-1 (technical grade) | 10 mg | 2744 |
Cayman2015 | 10009642 | SOTS-1 (technical grade) | 5 mg | 1568 |
Cayman2015 | 10009642 | SOTS-1 (technical grade) | 500 μg | 196 |
Cayman2015 | 10009644 | BAY-43-9006 | 1 mg | 350 |
Cayman2015 | 10009644 | BAY-43-9006 | 10 mg | 1050 |
Cayman2015 | 10009644 | BAY-43-9006 | 5 mg | 700 |
Cayman2015 | 10009644 | BAY-43-9006 | 50 mg | 3332 |
Cayman2015 | 10009645 | Maslinic Acid | 1 mg | 294 |
Cayman2015 | 10009645 | Maslinic Acid | 10 mg | 2352 |
Cayman2015 | 10009645 | Maslinic Acid | 25 mg | 5152 |
Cayman2015 | 10009645 | Maslinic Acid | 5 mg | 1330 |
Cayman2015 | 10009650 | (+)-AS 115 | 1 mg | 5264 |
Cayman2015 | 10009650 | (+)-AS 115 | 100 μg | 658 |
Cayman2015 | 10009650 | (+)-AS 115 | 500 μg | 2968 |
Cayman2015 | 10009651 | 2-thio-Acetyl MAGE | 1 mg | 434 |
Cayman2015 | 10009651 | 2-thio-Acetyl MAGE | 10 mg | 3472 |
Cayman2015 | 10009651 | 2-thio-Acetyl MAGE | 25 mg | 7602 |
Cayman2015 | 10009651 | 2-thio-Acetyl MAGE | 5 mg | 1960 |
Cayman2015 | 10009652 | HDAC4 (human recombinant) | 1 ea | 7420 |
Cayman2015 | 10009658 | Cayman Practice EIA Kit | 96 Well | 784 |
Cayman2015 | 10009660 | CYPMPO | 1 mg | 714 |
Cayman2015 | 10009660 | CYPMPO | 10 mg | 5712 |
Cayman2015 | 10009660 | CYPMPO | 5 mg | 3220 |
Cayman2015 | 10009661 | N-Octadecyl-N'-propyl-sulfamide | 10 mg | 1624 |
Cayman2015 | 10009661 | N-Octadecyl-N'-propyl-sulfamide | 25 mg | 3850 |
Cayman2015 | 10009661 | N-Octadecyl-N'-propyl-sulfamide | 5 mg | 854 |
Cayman2015 | 10009661 | N-Octadecyl-N'-propyl-sulfamide | 50 mg | 6832 |
Cayman2015 | 10009729 | Ricinoleic Acid methyl ester | 1 mg | 686 |
Cayman2015 | 10009729 | Ricinoleic Acid methyl ester | 10 mg | 5488 |
Cayman2015 | 10009729 | Ricinoleic Acid methyl ester | 5 mg | 3094 |
Cayman2015 | 10009733 | 5(Z),8(Z),14(Z)-Eicosatrienoic Acid | 1 mg | 5012 |
Cayman2015 | 10009733 | 5(Z),8(Z),14(Z)-Eicosatrienoic Acid | 100 μg | 770 |
Cayman2015 | 10009733 | 5(Z),8(Z),14(Z)-Eicosatrienoic Acid | 500 μg | 2702 |
Cayman2015 | 10009734 | Prostaglandin E Synthase-1 (microsomal) Western Ready Control | 1 ea | 714 |
Cayman2015 | 10009746 | PTEN (human recombinant) | 100 μg | 7714 |
Cayman2015 | 10009746 | PTEN (human recombinant) | 25 μg | 2142 |
Cayman2015 | 10009746 | PTEN (human recombinant) | 50 μg | 4074 |
Cayman2015 | 10009759 | NMDA Receptor NR2B Subunit (Phospho-Tyr1252) Polyclonal Antibody | 1 ea | 6500 |
Cayman2015 | 10009760 | NMDA Receptor NR2B Subunit (Phospho-Tyr1336) Polyclonal Antibody | 1 ea | 6500 |
Cayman2015 | 10009761 | NMDA Receptor NR2B Subunit (Phospho-Tyr1472) Polyclonal Antibody | 1 ea | 6500 |
Cayman2015 | 10009762 | Progesterone Receptor (Phospho-Ser190) Monoclonal Antibody | 1 ea | 6500 |
Cayman2015 | 10009763 | Progesterone Receptor (Phospho-Ser294) Monoclonal Antibody | 1 ea | 6500 |
Cayman2015 | 10009768 | LY293111 | 1 mg | 2282 |
Cayman2015 | 10009768 | LY293111 | 10 mg | 16856 |
Cayman2015 | 10009768 | LY293111 | 5 mg | 9632 |
Cayman2015 | 10009768 | LY293111 | 500 μg | 1204 |
Cayman2015 | 10009779 | Cholesterol Cell-Based Detection Assay Kit | 192 Well | 3300 |
Cayman2015 | 10009785 | Dynamin (Phospho-Ser774) Polyclonal Antibody | 1 ea | 6500 |
Cayman2015 | 10009786 | Dynamin (Phospho-Ser778) Polyclonal Antibody | 1 ea | 6500 |
Cayman2015 | 10009796 | CAY10602 | 10 mg | 616 |
Cayman2015 | 10009796 | CAY10602 | 100 mg | 4508 |
Cayman2015 | 10009796 | CAY10602 | 5 mg | 322 |
Cayman2015 | 10009796 | CAY10602 | 50 mg | 2576 |
Cayman2015 | 10009797 | CAY10591 | 1 mg | 714 |
Cayman2015 | 10009797 | CAY10591 | 10 mg | 5712 |
Cayman2015 | 10009797 | CAY10591 | 25 mg | 12502 |
Cayman2015 | 10009797 | CAY10591 | 5 mg | 3220 |
Cayman2015 | 10009798 | EX-527 | 1 mg | 350 |
Cayman2015 | 10009798 | EX-527 | 10 mg | 1050 |
Cayman2015 | 10009798 | EX-527 | 25 mg | 2282 |
Cayman2015 | 10009798 | EX-527 | 5 mg | 644 |
Cayman2015 | 10009799 | 17(S)-HDoHE | 100 μg | 4634 |
Cayman2015 | 10009799 | 17(S)-HDoHE | 25 μg | 1288 |
Cayman2015 | 10009799 | 17(S)-HDoHE | 250 μg | 10304 |
Cayman2015 | 10009799 | 17(S)-HDoHE | 50 μg | 2450 |
Cayman2015 | 10009804 | 3-PT-PtdIns-(3,4,5)-P3 (1,2-dioctanoyl) (sodium salt) | 100 μg | 2422 |
Cayman2015 | 10009804 | 3-PT-PtdIns-(3,4,5)-P3 (1,2-dioctanoyl) (sodium salt) | 25 μg | 672 |
Cayman2015 | 10009804 | 3-PT-PtdIns-(3,4,5)-P3 (1,2-dioctanoyl) (sodium salt) | 250 μg | 5376 |
Cayman2015 | 10009804 | 3-PT-PtdIns-(3,4,5)-P3 (1,2-dioctanoyl) (sodium salt) | 50 μg | 1274 |
Cayman2015 | 10009813 | thio-Miltefosine | 1 mg | 364 |
Cayman2015 | 10009813 | thio-Miltefosine | 10 mg | 2912 |
Cayman2015 | 10009813 | thio-Miltefosine | 25 mg | 6370 |
Cayman2015 | 10009813 | thio-Miltefosine | 5 mg | 1638 |
Cayman2015 | 10009815 | PtdIns-(4,5)-P2 Binding Protein | 100 μg | 4634 |
Cayman2015 | 10009815 | PtdIns-(4,5)-P2 Binding Protein | 25 μg | 1288 |
Cayman2015 | 10009815 | PtdIns-(4,5)-P2 Binding Protein | 50 μg | 2450 |
Cayman2015 | 10009816 | (+)-Nutlin-3 | 1 mg | 826 |
Cayman2015 | 10009816 | (+)-Nutlin-3 | 10 mg | 3724 |
Cayman2015 | 10009816 | (+)-Nutlin-3 | 25 mg | 8260 |
Cayman2015 | 10009816 | (+)-Nutlin-3 | 5 mg | 2072 |
Cayman2015 | 10009817 | PtdIns-(3,4,5)-P3 Binding Protein | 100 μg | 4634 |
Cayman2015 | 10009817 | PtdIns-(3,4,5)-P3 Binding Protein | 25 μg | 1288 |
Cayman2015 | 10009817 | PtdIns-(3,4,5)-P3 Binding Protein | 50 μg | 2450 |
Cayman2015 | 10009818 | NF-κB (p50) (human recombinant) | 10 μg | 1918 |
Cayman2015 | 10009818 | NF-κB (p50) (human recombinant) | 25 μg | 4536 |
Cayman2015 | 10009818 | NF-κB (p50) (human recombinant) | 5 μg | 1008 |
Cayman2015 | 10009831 | Protein Carbonyl Homogenization Buffer (10X) | 1 ea | 224 |
Cayman2015 | 10009832 | (±)12,13-DiHOME | 100 μg | 1260 |
Cayman2015 | 10009832 | (±)12,13-DiHOME | 25 μg | 350 |
Cayman2015 | 10009832 | (±)12,13-DiHOME | 50 μg | 672 |
Cayman2015 | 10009832 | (±)12,13-DiHOME | 500 μg | 5600 |
Cayman2015 | 10009835 | MK 0524 | 1 mg | 770 |
Cayman2015 | 10009835 | MK 0524 | 10 mg | 2618 |
Cayman2015 | 10009835 | MK 0524 | 25 mg | 5782 |
Cayman2015 | 10009835 | MK 0524 | 5 mg | 1736 |
Cayman2015 | 10009846 | CREB (Phospho-Ser133) Transcription Factor Assay Kit | 96 Well | 5740 |
Cayman2015 | 10009848 | TF CREB (Phospho-Ser133) Primary Antibody | 1 ea | 1092 |
Cayman2015 | 10009849 | TF CREB (Phospho-Ser133) Positive Control | 1 ea | 910 |
Cayman2015 | 10009851 | D-myo-Inositol-1,3,4,5,6-pentaphosphate (ammonium salt) | 1 mg | 5488 |
Cayman2015 | 10009851 | D-myo-Inositol-1,3,4,5,6-pentaphosphate (ammonium salt) | 100 μg | 686 |
Cayman2015 | 10009851 | D-myo-Inositol-1,3,4,5,6-pentaphosphate (ammonium salt) | 500 μg | 3094 |
Cayman2015 | 10009853 | CFSE Cell Division Assay Kit | 100 test | 2030 |
Cayman2015 | 10009856 | 7-AAD Cell Viability Assay Kit | 1 ea | 2142 |
Cayman2015 | 10009864 | 1-Stearoyl-2-Arachidonoyl PC | 1 mg | 126 |
Cayman2015 | 10009864 | 1-Stearoyl-2-Arachidonoyl PC | 10 mg | 1008 |
Cayman2015 | 10009864 | 1-Stearoyl-2-Arachidonoyl PC | 25 mg | 2212 |
Cayman2015 | 10009864 | 1-Stearoyl-2-Arachidonoyl PC | 5 mg | 574 |
Cayman2015 | 10009866 | Cell-Based Assay Wash Buffer | 1 ea | 154 |
Cayman2015 | 10009867 | Cholesterol Detection Filipin III | 1 ea | 2100 |
Cayman2015 | 10009868 | Cholesterol Detection Assay Buffer | 1 ea | 154 |
Cayman2015 | 10009869 | Cell-Based Assay U-18666A | 1 ea | 714 |
Cayman2015 | 10009870 | CD36 Monoclonal FITC Antibody (Clone JC63.1) | 1 ea | 3416 |
Cayman2015 | 10009871 | Palmitoleic Acid | 1 g | 2128 |
Cayman2015 | 10009871 | Palmitoleic Acid | 100 mg | 266 |
Cayman2015 | 10009871 | Palmitoleic Acid | 5 g | 9310 |
Cayman2015 | 10009871 | Palmitoleic Acid | 500 mg | 1204 |
Cayman2015 | 10009872 | 1-Stearoyl-2-Arachidonoyl-sn-Glycerol-d8 | 1 mg | 5040 |
Cayman2015 | 10009872 | 1-Stearoyl-2-Arachidonoyl-sn-Glycerol-d8 | 100 μg | 630 |
Cayman2015 | 10009872 | 1-Stearoyl-2-Arachidonoyl-sn-Glycerol-d8 | 500 μg | 2842 |
Cayman2015 | 10009874 | 1,2-Dioctanoyl PC | 10 mg | 294 |
Cayman2015 | 10009874 | 1,2-Dioctanoyl PC | 25 mg | 700 |
Cayman2015 | 10009874 | 1,2-Dioctanoyl PC | 5 mg | 154 |
Cayman2015 | 10009874 | 1,2-Dioctanoyl PC | 50 mg | 1232 |
Cayman2015 | 10009875 | 16-phenoxy Prostaglandin F2α ethyl amide | 1 mg | 1036 |
Cayman2015 | 10009875 | 16-phenoxy Prostaglandin F2α ethyl amide | 10 mg | 7644 |
Cayman2015 | 10009875 | 16-phenoxy Prostaglandin F2α ethyl amide | 5 mg | 4368 |
Cayman2015 | 10009879 | 1,2-Didecanoyl PC | 10 mg | 294 |
Cayman2015 | 10009879 | 1,2-Didecanoyl PC | 25 mg | 700 |
Cayman2015 | 10009879 | 1,2-Didecanoyl PC | 5 mg | 154 |
Cayman2015 | 10009879 | 1,2-Didecanoyl PC | 50 mg | 1232 |
Cayman2015 | 10009880 | GW 590735 | 1 mg | 602 |
Cayman2015 | 10009880 | GW 590735 | 10 mg | 4816 |
Cayman2015 | 10009880 | GW 590735 | 25 mg | 10542 |
Cayman2015 | 10009880 | GW 590735 | 5 mg | 2716 |
Cayman2015 | 10009893 | CD36 Monoclonal Antibody (Clone JC63.1) (azide free) | 1 ea | 1848 |
Cayman2015 | 10009893 | CD36 Monoclonal Antibody (Clone JC63.1) (azide free) | 5 ea | 8316 |
Cayman2015 | 10009897 | (-)-11-nor-9-carboxy-Δ9-THC (exempt preparation) | 1 mg | 1274 |
Cayman2015 | 10009897 | (-)-11-nor-9-carboxy-Δ9-THC (exempt preparation) | 5 mg | 5922 |
Cayman2015 | 10009897 | (-)-11-nor-9-carboxy-Δ9-THC (exempt preparation) | 500 μg | 910 |
Cayman2015 | 10009898 | (-)-11-nor-9-carboxy-Δ9-THC-d3 (exempt preparation) | 1 mg | 5488 |
Cayman2015 | 10009898 | (-)-11-nor-9-carboxy-Δ9-THC-d3 (exempt preparation) | 100 μg | 686 |
Cayman2015 | 10009898 | (-)-11-nor-9-carboxy-Δ9-THC-d3 (exempt preparation) | 500 μg | 3094 |
Cayman2015 | 10009899 | Cell-Based Assay Fixative | 1 ea | 434 |
Cayman2015 | 10009900 | SREBP-2 Cell-Based Assay Primary Antibody | 1 ea | 1428 |
Cayman2015 | 10009906 | Cell-Based Assay Blocking Solution | 1 ea | 364 |
Cayman2015 | 10009907 | DyLightTM 550-Conjugated Goat Anti-Rabbit Secondary Antibody | 1 ea | 854 |
Cayman2015 | 10009908 | JC-1 Assay Reagent | 1 ea | 2282 |
Cayman2015 | 10009911 | Tangeritin | 1 mg | 140 |
Cayman2015 | 10009911 | Tangeritin | 100 mg | 8400 |
Cayman2015 | 10009911 | Tangeritin | 5 mg | 630 |
Cayman2015 | 10009911 | Tangeritin | 50 mg | 4900 |
Cayman2015 | 10009926 | Phosphatidylcholine Colorimetric Assay Kit | 96 Well | 3556 |
Cayman2015 | 10009928 | Sphingomyelin Colorimetric Assay Kit | 96 Well | 3556 |
Cayman2015 | 10009929 | SAHA | 1 g | 2128 |
Cayman2015 | 10009929 | SAHA | 100 mg | 266 |
Cayman2015 | 10009929 | SAHA | 250 mg | 630 |
Cayman2015 | 10009929 | SAHA | 500 mg | 1204 |
Cayman2015 | 10009931 | 24(S)-hydroxy Cholesterol | 1 mg | 770 |
Cayman2015 | 10009931 | 24(S)-hydroxy Cholesterol | 10 mg | 6930 |
Cayman2015 | 10009931 | 24(S)-hydroxy Cholesterol | 5 mg | 3654 |
Cayman2015 | 10009948 | Adipolysis Assay IBMX Solution (1,000X) | 1 ea | 574 |
Cayman2015 | 10009949 | Adipolysis Assay Insulin Solution (1,000X) | 1 ea | 574 |
Cayman2015 | 10009950 | Adipolysis Assay Dexamethasone Solution (1,000X) | 1 ea | 574 |
Cayman2015 | 10009951 | Adipolysis Assay Isoproterenol Solution | 1 ea | 574 |
Cayman2015 | 10009952 | Glycerol Standard Solution | 1 ea | 854 |
Cayman2015 | 10009953 | Free Glycerol Assay Reagent (10X) | 1 ea | 504 |
Cayman2015 | 10009957 | Propidium Iodide Reagent | 1 ea | 1148 |
Cayman2015 | 10009959 | RNase A Solution | 1 ea | 1148 |
Cayman2015 | 10009960 | Cell Cycle Phase Determination Fixative | 1 ea | 434 |
Cayman2015 | 10009962 | 2-(14,15-Epoxyeicosatrienoyl) Glycerol | 100 μg | 9730 |
Cayman2015 | 10009962 | 2-(14,15-Epoxyeicosatrienoyl) Glycerol | 25 μg | 2702 |
Cayman2015 | 10009962 | 2-(14,15-Epoxyeicosatrienoyl) Glycerol | 50 μg | 5138 |
Cayman2015 | 10009964 | In Vitro Angiogenesis Assay Kit | 1 ea | 3416 |
Cayman2015 | 10009984 | 5(6)-EET-d11 | 10 μg | 1372 |
Cayman2015 | 10009984 | 5(6)-EET-d11 | 25 μg | 3262 |
Cayman2015 | 10009984 | 5(6)-EET-d11 | 50 μg | 6174 |
Cayman2015 | 10009986 | Dimethoxycurcumin | 1 mg | 308 |
Cayman2015 | 10009986 | Dimethoxycurcumin | 10 mg | 1848 |
Cayman2015 | 10009986 | Dimethoxycurcumin | 5 mg | 1232 |
Cayman2015 | 10009992 | Zeaxanthin | 1 mg | 3164 |
Cayman2015 | 10009992 | Zeaxanthin | 500 μg | 1666 |
Cayman2015 | 10009993 | (±)9,10-DiHOME-d4 | 100 μg | 3780 |
Cayman2015 | 10009993 | (±)9,10-DiHOME-d4 | 25 μg | 1050 |
Cayman2015 | 10009993 | (±)9,10-DiHOME-d4 | 50 μg | 2002 |
Cayman2015 | 10009993 | (±)9,10-DiHOME-d4 | 500 μg | 16800 |
Cayman2015 | 10009994 | (±)12,13-DiHOME-d4 | 100 μg | 3780 |
Cayman2015 | 10009994 | (±)12,13-DiHOME-d4 | 25 μg | 1050 |
Cayman2015 | 10009994 | (±)12,13-DiHOME-d4 | 250 μg | 8400 |
Cayman2015 | 10009994 | (±)12,13-DiHOME-d4 | 50 μg | 2002 |
Cayman2015 | 10009995 | 9(10)-EpOME-d4 | 100 μg | 4536 |
Cayman2015 | 10009995 | 9(10)-EpOME-d4 | 25 μg | 1260 |
Cayman2015 | 10009995 | 9(10)-EpOME-d4 | 250 μg | 10080 |
Cayman2015 | 10009995 | 9(10)-EpOME-d4 | 50 μg | 2394 |
Cayman2015 | 10009996 | 12(13)-EpOME-d4 | 100 μg | 4536 |
Cayman2015 | 10009996 | 12(13)-EpOME-d4 | 25 μg | 1260 |
Cayman2015 | 10009996 | 12(13)-EpOME-d4 | 250 μg | 10080 |
Cayman2015 | 10009996 | 12(13)-EpOME-d4 | 50 μg | 2394 |
Cayman2015 | 10009998 | (±)8,9-DHET-d11 | 100 μg | 7462 |
Cayman2015 | 10009998 | (±)8,9-DHET-d11 | 25 μg | 2072 |
Cayman2015 | 10009998 | (±)8,9-DHET-d11 | 250 μg | 16576 |
Cayman2015 | 10009998 | (±)8,9-DHET-d11 | 50 μg | 3934 |
Cayman2015 | 10009999 | 5(Z),11(Z),14(Z)-Eicosatrienoic Acid | 1 mg | 5012 |
Cayman2015 | 10009999 | 5(Z),11(Z),14(Z)-Eicosatrienoic Acid | 100 μg | 770 |
Cayman2015 | 10009999 | 5(Z),11(Z),14(Z)-Eicosatrienoic Acid | 500 μg | 2702 |
Cayman2015 | 10010 | Prostaglandin A1 | 1 mg | 490 |
Cayman2015 | 10010 | Prostaglandin A1 | 10 mg | 2800 |
Cayman2015 | 10010 | Prostaglandin A1 | 5 mg | 1596 |
Cayman2015 | 10010 | Prostaglandin A1 | 50 mg | 11032 |
Cayman2015 | 10010001 | Δ6-Testosterone Enanthate | 10 mg | 1372 |
Cayman2015 | 10010001 | Δ6-Testosterone Enanthate | 25 mg | 3080 |
Cayman2015 | 10010001 | Δ6-Testosterone Enanthate | 5 mg | 798 |
Cayman2015 | 10010002 | 6-keto Testosterone Enanthate | 1 mg | 490 |
Cayman2015 | 10010002 | 6-keto Testosterone Enanthate | 10 mg | 3906 |
Cayman2015 | 10010002 | 6-keto Testosterone Enanthate | 5 mg | 2170 |
Cayman2015 | 10010003 | 6α-Testosterone Enanthate | 1 mg | 2604 |
Cayman2015 | 10010003 | 6α-Testosterone Enanthate | 5 mg | 10976 |
Cayman2015 | 10010003 | 6α-Testosterone Enanthate | 500 μg | 1372 |
Cayman2015 | 10010004 | 6β-Testosterone Enanthate | 1 mg | 2604 |
Cayman2015 | 10010004 | 6β-Testosterone Enanthate | 5 mg | 10976 |
Cayman2015 | 10010004 | 6β-Testosterone Enanthate | 500 μg | 1372 |
Cayman2015 | 10010005 | Cysteinyl Leukotriene Column Elution Solvent | 250 mL | 1470 |
Cayman2015 | 10010005 | Cysteinyl Leukotriene Column Elution Solvent | 50 mL | 392 |
Cayman2015 | 10010013 | Glutathione S-Transferase Polyclonal Antibody | 1 ea | 2142 |
Cayman2015 | 10010016 | (+)-Cloprostenol isopropyl ester | 1 mg | 812 |
Cayman2015 | 10010016 | (+)-Cloprostenol isopropyl ester | 10 mg | 6496 |
Cayman2015 | 10010016 | (+)-Cloprostenol isopropyl ester | 5 mg | 3654 |
Cayman2015 | 10010019 | FABP2 Polyclonal Antibody | 1 ea | 3206 |
Cayman2015 | 10010020 | FABP2 Blocking Peptide | 1 ea | 1498 |
Cayman2015 | 10010024 | LY223982 | 1 mg | 294 |
Cayman2015 | 10010024 | LY223982 | 10 mg | 2352 |
Cayman2015 | 10010024 | LY223982 | 25 mg | 5152 |
Cayman2015 | 10010024 | LY223982 | 5 mg | 1330 |
Cayman2015 | 10010032 | CAY10570 | 1 mg | 616 |
Cayman2015 | 10010032 | CAY10570 | 10 mg | 4508 |
Cayman2015 | 10010032 | CAY10570 | 5 mg | 2576 |
Cayman2015 | 10010032 | CAY10570 | 500 μg | 322 |
Cayman2015 | 10010043 | CAY10561 | 1 mg | 532 |
Cayman2015 | 10010043 | CAY10561 | 10 mg | 3920 |
Cayman2015 | 10010043 | CAY10561 | 5 mg | 2240 |
Cayman2015 | 10010043 | CAY10561 | 500 μg | 280 |
Cayman2015 | 10010061 | 17-trifluoromethylphenyl trinor Prostaglandin F2α ethyl amide | 1 mg | 826 |
Cayman2015 | 10010061 | 17-trifluoromethylphenyl trinor Prostaglandin F2α ethyl amide | 10 mg | 6608 |
Cayman2015 | 10010061 | 17-trifluoromethylphenyl trinor Prostaglandin F2α ethyl amide | 5 mg | 3724 |
Cayman2015 | 10010061 | 17-trifluoromethylphenyl trinor Prostaglandin F2α ethyl amide | 50 mg | 28910 |
Cayman2015 | 10010062 | 17-trifluoromethylphenyl trinor Prostaglandin F2α isopropyl ester | 1 mg | 630 |
Cayman2015 | 10010062 | 17-trifluoromethylphenyl trinor Prostaglandin F2α isopropyl ester | 10 mg | 5040 |
Cayman2015 | 10010062 | 17-trifluoromethylphenyl trinor Prostaglandin F2α isopropyl ester | 5 mg | 2842 |
Cayman2015 | 10010063 | 15(S)-15-methyl Prostaglandin F2α isopropyl ester | 1 mg | 546 |
Cayman2015 | 10010063 | 15(S)-15-methyl Prostaglandin F2α isopropyl ester | 10 mg | 4368 |
Cayman2015 | 10010063 | 15(S)-15-methyl Prostaglandin F2α isopropyl ester | 5 mg | 2464 |
Cayman2015 | 10010064 | 15(S)-15-methyl Prostaglandin F2α ethyl amide | 1 mg | 980 |
Cayman2015 | 10010064 | 15(S)-15-methyl Prostaglandin F2α ethyl amide | 10 mg | 7840 |
Cayman2015 | 10010064 | 15(S)-15-methyl Prostaglandin F2α ethyl amide | 5 mg | 4410 |
Cayman2015 | 10010066 | PC Buffer (10X) | 1 ea | 154 |
Cayman2015 | 10010067 | PC Color Detector | 1 ea | 364 |
Cayman2015 | 10010068 | PC Enzyme Mixture | 1 ea | 364 |
Cayman2015 | 10010069 | PC-Specific Phospholipase D | 1 ea | 1428 |
Cayman2015 | 10010070 | Phosphatidylcholine Standard | 1 ea | 574 |
Cayman2015 | 10010071 | PC Detergent Solution | 1 ea | 154 |
Cayman2015 | 10010072 | SM Buffer (10X) | 1 ea | 154 |
Cayman2015 | 10010073 | SM Color Detector | 1 ea | 294 |
Cayman2015 | 10010074 | SM Enzyme Mixture | 1 ea | 364 |
Cayman2015 | 10010075 | SM Alkaline Phosphatase | 1 ea | 294 |
Cayman2015 | 10010076 | Sphingomyelinase | 1 ea | 1428 |
Cayman2015 | 10010077 | Sphingomyelin Standard | 1 ea | 434 |
Cayman2015 | 10010078 | SM Detergent Solution | 1 ea | 154 |
Cayman2015 | 10010088 | CAY10526 | 1 mg | 630 |
Cayman2015 | 10010088 | CAY10526 | 10 mg | 5040 |
Cayman2015 | 10010088 | CAY10526 | 5 mg | 2842 |
Cayman2015 | 10010093 | 1-Oleoyl Lysophosphatidic Acid | 1 mg | 210 |
Cayman2015 | 10010093 | 1-Oleoyl Lysophosphatidic Acid | 10 mg | 1680 |
Cayman2015 | 10010093 | 1-Oleoyl Lysophosphatidic Acid | 25 mg | 3682 |
Cayman2015 | 10010093 | 1-Oleoyl Lysophosphatidic Acid | 5 mg | 952 |
Cayman2015 | 10010094 | 1-Palmitoyl Lysophosphatidic Acid | 1 mg | 434 |
Cayman2015 | 10010094 | 1-Palmitoyl Lysophosphatidic Acid | 10 mg | 3472 |
Cayman2015 | 10010094 | 1-Palmitoyl Lysophosphatidic Acid | 25 mg | 7602 |
Cayman2015 | 10010094 | 1-Palmitoyl Lysophosphatidic Acid | 5 mg | 1960 |
Cayman2015 | 10010096 | COX-2 (mouse) Polyclonal FITC Antibody | 1 ea | 3920 |
Cayman2015 | 10010098 | Glucose Assay Standard | 1 ea | 532 |
Cayman2015 | 10010100 | Glucose Colorimetric Enzyme Mixture | 1 ea | 392 |
Cayman2015 | 10010101 | 11-cis Vaccenyl Acetate | 10 mg | 476 |
Cayman2015 | 10010101 | 11-cis Vaccenyl Acetate | 100 mg | 3528 |
Cayman2015 | 10010101 | 11-cis Vaccenyl Acetate | 5 mg | 252 |
Cayman2015 | 10010101 | 11-cis Vaccenyl Acetate | 50 mg | 2016 |
Cayman2015 | 10010102 | 16-phenoxy tetranor Prostaglandin F2α methyl ester | 1 mg | 1176 |
Cayman2015 | 10010102 | 16-phenoxy tetranor Prostaglandin F2α methyl ester | 5 mg | 4928 |
Cayman2015 | 10010102 | 16-phenoxy tetranor Prostaglandin F2α methyl ester | 500 μg | 616 |
Cayman2015 | 10010103 | 16-phenoxy tetranor Prostaglandin F2α isopropyl ester | 1 mg | 1148 |
Cayman2015 | 10010103 | 16-phenoxy tetranor Prostaglandin F2α isopropyl ester | 10 mg | 8302 |
Cayman2015 | 10010103 | 16-phenoxy tetranor Prostaglandin F2α isopropyl ester | 5 mg | 4816 |
Cayman2015 | 10010103 | 16-phenoxy tetranor Prostaglandin F2α isopropyl ester | 500 μg | 602 |
Cayman2015 | 10010109 | 8-DY547-cGMP | 100 μg | 3248 |
Cayman2015 | 10010109 | 8-DY547-cGMP | 50 μg | 1708 |
Cayman2015 | 10010110 | 17-phenyl trinor Prostaglandin F2α methyl ester | 1 mg | 826 |
Cayman2015 | 10010110 | 17-phenyl trinor Prostaglandin F2α methyl ester | 10 mg | 6608 |
Cayman2015 | 10010110 | 17-phenyl trinor Prostaglandin F2α methyl ester | 5 mg | 3724 |
Cayman2015 | 10010111 | 17-trifluoromethylphenyl trinor Prostaglandin F2α methyl ester | 1 mg | 644 |
Cayman2015 | 10010111 | 17-trifluoromethylphenyl trinor Prostaglandin F2α methyl ester | 10 mg | 5152 |
Cayman2015 | 10010111 | 17-trifluoromethylphenyl trinor Prostaglandin F2α methyl ester | 5 mg | 2898 |
Cayman2015 | 10010112 | Ptd(S)Ins-(3,4)-P2 (1,2-dipalmitoyl) (sodium salt) | 1 mg | 6720 |
Cayman2015 | 10010112 | Ptd(S)Ins-(3,4)-P2 (1,2-dipalmitoyl) (sodium salt) | 100 μg | 840 |
Cayman2015 | 10010112 | Ptd(S)Ins-(3,4)-P2 (1,2-dipalmitoyl) (sodium salt) | 500 μg | 3780 |
Cayman2015 | 10010115 | (+)-Cloprostenol methyl ester | 1 mg | 812 |
Cayman2015 | 10010115 | (+)-Cloprostenol methyl ester | 10 mg | 6496 |
Cayman2015 | 10010115 | (+)-Cloprostenol methyl ester | 5 mg | 3654 |
Cayman2015 | 10010116 | CB-25 | 1 mg | 350 |
Cayman2015 | 10010116 | CB-25 | 10 mg | 2632 |
Cayman2015 | 10010116 | CB-25 | 5 mg | 1372 |
Cayman2015 | 10010117 | CB-52 | 1 mg | 350 |
Cayman2015 | 10010117 | CB-52 | 10 mg | 2800 |
Cayman2015 | 10010117 | CB-52 | 5 mg | 1582 |
Cayman2015 | 10010117 | CB-52 | 50 mg | 12250 |
Cayman2015 | 10010118 | AM1241 | 1 mg | 350 |
Cayman2015 | 10010118 | AM1241 | 10 mg | 1582 |
Cayman2015 | 10010118 | AM1241 | 25 mg | 3500 |
Cayman2015 | 10010118 | AM1241 | 5 mg | 882 |
Cayman2015 | 10010123 | Prostaglandin D2-d9 | 100 μg | 3220 |
Cayman2015 | 10010123 | Prostaglandin D2-d9 | 25 μg | 896 |
Cayman2015 | 10010123 | Prostaglandin D2-d9 | 50 μg | 1708 |
Cayman2015 | 10010129 | AG-041R | 1 mg | 504 |
Cayman2015 | 10010129 | AG-041R | 10 mg | 4032 |
Cayman2015 | 10010129 | AG-041R | 5 mg | 2268 |
Cayman2015 | 10010129 | AG-041R | 50 mg | 17640 |
Cayman2015 | 10010132 | 15-deoxy-Δ12,14-Prostaglandin J2-2-glycerol ester | 1 mg | 4368 |
Cayman2015 | 10010132 | 15-deoxy-Δ12,14-Prostaglandin J2-2-glycerol ester | 100 μg | 546 |
Cayman2015 | 10010132 | 15-deoxy-Δ12,14-Prostaglandin J2-2-glycerol ester | 500 μg | 2464 |
Cayman2015 | 10010146 | Soluble Epoxide Hydrolase Polyclonal Antibody | 1 ea | 2926 |
Cayman2015 | 10010147 | Soluble Epoxide Hydrolase Blocking Peptide | 1 ea | 1498 |
Cayman2015 | 10010151 | Fluprostenol methyl ester | 1 mg | 784 |
Cayman2015 | 10010151 | Fluprostenol methyl ester | 10 mg | 6272 |
Cayman2015 | 10010151 | Fluprostenol methyl ester | 5 mg | 3528 |
Cayman2015 | 10010164 | 1-Octadecyl Lysophosphatidic Acid | 1 mg | 476 |
Cayman2015 | 10010164 | 1-Octadecyl Lysophosphatidic Acid | 10 mg | 3528 |
Cayman2015 | 10010164 | 1-Octadecyl Lysophosphatidic Acid | 5 mg | 2016 |
Cayman2015 | 10010164 | 1-Octadecyl Lysophosphatidic Acid | 500 μg | 252 |
Cayman2015 | 10010172 | (R)-Equol | 1 mg | 182 |
Cayman2015 | 10010172 | (R)-Equol | 10 mg | 1456 |
Cayman2015 | 10010172 | (R)-Equol | 25 mg | 3192 |
Cayman2015 | 10010172 | (R)-Equol | 5 mg | 826 |
Cayman2015 | 10010173 | (S)-Equol | 1 mg | 224 |
Cayman2015 | 10010173 | (S)-Equol | 10 mg | 1792 |
Cayman2015 | 10010173 | (S)-Equol | 25 mg | 3920 |
Cayman2015 | 10010173 | (S)-Equol | 5 mg | 1008 |
Cayman2015 | 10010175 | AS-604850 | 1 mg | 280 |
Cayman2015 | 10010175 | AS-604850 | 10 mg | 2240 |
Cayman2015 | 10010175 | AS-604850 | 25 mg | 4900 |
Cayman2015 | 10010175 | AS-604850 | 5 mg | 1260 |
Cayman2015 | 10010177 | PI3-Kinase α Inhibitor 2 | 1 mg | 560 |
Cayman2015 | 10010177 | PI3-Kinase α Inhibitor 2 | 10 mg | 4116 |
Cayman2015 | 10010177 | PI3-Kinase α Inhibitor 2 | 5 mg | 2352 |
Cayman2015 | 10010177 | PI3-Kinase α Inhibitor 2 | 500 μg | 294 |
Cayman2015 | 10010180 | cis-12-Octadecenoic Acid methyl ester | 10 mg | 882 |
Cayman2015 | 10010180 | cis-12-Octadecenoic Acid methyl ester | 5 mg | 462 |
Cayman2015 | 10010180 | cis-12-Octadecenoic Acid methyl ester | 50 mg | 3696 |
Cayman2015 | 10010181 | Ptd(S)Ins-(3,4)-P2 (1,2-dioctanoyl) (sodium salt) | 1 mg | 6720 |
Cayman2015 | 10010181 | Ptd(S)Ins-(3,4)-P2 (1,2-dioctanoyl) (sodium salt) | 100 μg | 840 |
Cayman2015 | 10010181 | Ptd(S)Ins-(3,4)-P2 (1,2-dioctanoyl) (sodium salt) | 500 μg | 3780 |
Cayman2015 | 10010183 | Fatty Acid Amide Hydrolase (human recombinant) | 100 U | 6146 |
Cayman2015 | 10010183 | Fatty Acid Amide Hydrolase (human recombinant) | 25 U | 1708 |
Cayman2015 | 10010183 | Fatty Acid Amide Hydrolase (human recombinant) | 50 U | 3248 |
Cayman2015 | 10010188 | 1-Hexadecyl Lysophosphatidic Acid | 1 mg | 434 |
Cayman2015 | 10010188 | 1-Hexadecyl Lysophosphatidic Acid | 10 mg | 3472 |
Cayman2015 | 10010188 | 1-Hexadecyl Lysophosphatidic Acid | 25 mg | 7602 |
Cayman2015 | 10010188 | 1-Hexadecyl Lysophosphatidic Acid | 5 mg | 1960 |
Cayman2015 | 10010199 | WST-8 Cell Proliferation Assay Kit | 480 Well | 1372 |
Cayman2015 | 10010199 | WST-8 Cell Proliferation Assay Kit | 4800 Well | 8400 |
Cayman2015 | 10010199 | WST-8 Cell Proliferation Assay Kit | 96 Well | 700 |
Cayman2015 | 10010200 | XTT Cell Proliferation Assay Kit | 480 Well | 1372 |
Cayman2015 | 10010200 | XTT Cell Proliferation Assay Kit | 4800 Well | 8400 |
Cayman2015 | 10010200 | XTT Cell Proliferation Assay Kit | 96 Well | 700 |
Cayman2015 | 10010206 | FABP4 Inhibitor | 1 mg | 490 |
Cayman2015 | 10010206 | FABP4 Inhibitor | 10 mg | 1722 |
Cayman2015 | 10010206 | FABP4 Inhibitor | 25 mg | 3682 |
Cayman2015 | 10010206 | FABP4 Inhibitor | 5 mg | 980 |
Cayman2015 | 10010208 | Active Caspase-3 Substrate N-Ac-DEVD-N'-MC-R110 | 1 ea | 1078 |
Cayman2015 | 10010209 | Active Caspase-3 Standard | 1 ea | 714 |
Cayman2015 | 10010210 | Caspase-3 Inhibitor N-Ac-Asp-Glu-Val-Asp-CHO | 1 ea | 714 |
Cayman2015 | 10010212 | Caspase-3 Dithiothreitol (1M) | 1 ea | 154 |
Cayman2015 | 10010213 | Caspase-3 Assay Buffer | 1 ea | 154 |
Cayman2015 | 10010215 | Cell-Based Assay Lysis Buffer | 1 ea | 154 |
Cayman2015 | 10010219 | 1,8-ANS | 10000 mg | 406 |
Cayman2015 | 10010219 | 1,8-ANS | 100000 mg | 2940 |
Cayman2015 | 10010219 | 1,8-ANS | 5000 mg | 210 |
Cayman2015 | 10010219 | 1,8-ANS | 50000 mg | 1680 |
Cayman2015 | 10010228 | Lyso-PAF C-18 -d4 | 1 mg | 2352 |
Cayman2015 | 10010228 | Lyso-PAF C-18 -d4 | 100 μg | 294 |
Cayman2015 | 10010228 | Lyso-PAF C-18 -d4 | 500 μg | 1330 |
Cayman2015 | 10010229 | PAF C-18-d4 | 1 mg | 2128 |
Cayman2015 | 10010229 | PAF C-18-d4 | 100 μg | 266 |
Cayman2015 | 10010229 | PAF C-18-d4 | 500 μg | 1204 |
Cayman2015 | 10010231 | FABP4 Inhibitor/Ligand Screening Assay Kit | 1 ea | 3556 |
Cayman2015 | 10010233 | CAY10567 | 1 g | 2240 |
Cayman2015 | 10010233 | CAY10567 | 100 mg | 294 |
Cayman2015 | 10010233 | CAY10567 | 250 mg | 700 |
Cayman2015 | 10010233 | CAY10567 | 500 mg | 1330 |
Cayman2015 | 10010236 | ML-9 | 10 mg | 630 |
Cayman2015 | 10010236 | ML-9 | 100 mg | 3780 |
Cayman2015 | 10010236 | ML-9 | 250 mg | 7084 |
Cayman2015 | 10010236 | ML-9 | 50 mg | 2520 |
Cayman2015 | 10010237 | Triciribine | 1 mg | 1638 |
Cayman2015 | 10010237 | Triciribine | 10 mg | 13104 |
Cayman2015 | 10010237 | Triciribine | 5 mg | 7378 |
Cayman2015 | 10010238 | Erbstatin Analog | 1 mg | 126 |
Cayman2015 | 10010238 | Erbstatin Analog | 10 mg | 1008 |
Cayman2015 | 10010238 | Erbstatin Analog | 5 mg | 574 |
Cayman2015 | 10010238 | Erbstatin Analog | 50 mg | 4410 |
Cayman2015 | 10010239 | Kenpaullone | 1 mg | 546 |
Cayman2015 | 10010239 | Kenpaullone | 10 mg | 2072 |
Cayman2015 | 10010239 | Kenpaullone | 25 mg | 4508 |
Cayman2015 | 10010239 | Kenpaullone | 5 mg | 1372 |
Cayman2015 | 10010240 | Olomoucine | 1 mg | 280 |
Cayman2015 | 10010240 | Olomoucine | 10 mg | 1568 |
Cayman2015 | 10010240 | Olomoucine | 25 mg | 3430 |
Cayman2015 | 10010240 | Olomoucine | 5 mg | 882 |
Cayman2015 | 10010241 | AICAR | 10 mg | 210 |
Cayman2015 | 10010241 | AICAR | 100 mg | 1568 |
Cayman2015 | 10010241 | AICAR | 5 mg | 112 |
Cayman2015 | 10010241 | AICAR | 50 mg | 896 |
Cayman2015 | 10010242 | AG-494 | 10 mg | 714 |
Cayman2015 | 10010242 | AG-494 | 25 mg | 1708 |
Cayman2015 | 10010242 | AG-494 | 5 mg | 378 |
Cayman2015 | 10010242 | AG-494 | 50 mg | 3024 |
Cayman2015 | 10010243 | AG-825 | 1 mg | 350 |
Cayman2015 | 10010243 | AG-825 | 10 mg | 1582 |
Cayman2015 | 10010243 | AG-825 | 5 mg | 1232 |
Cayman2015 | 10010243 | AG-825 | 50 mg | 6132 |
Cayman2015 | 10010244 | AG-1478 | 1 mg | 238 |
Cayman2015 | 10010244 | AG-1478 | 10 mg | 1904 |
Cayman2015 | 10010244 | AG-1478 | 25 mg | 4172 |
Cayman2015 | 10010244 | AG-1478 | 5 mg | 1078 |
Cayman2015 | 10010245 | U-83836E | 10 mg | 168 |
Cayman2015 | 10010245 | U-83836E | 100 mg | 1344 |
Cayman2015 | 10010245 | U-83836E | 25 mg | 406 |
Cayman2015 | 10010245 | U-83836E | 50 mg | 756 |
Cayman2015 | 10010246 | SB 216763 | 10 mg | 1568 |
Cayman2015 | 10010246 | SB 216763 | 100 mg | 11564 |
Cayman2015 | 10010246 | SB 216763 | 5 mg | 826 |
Cayman2015 | 10010246 | SB 216763 | 50 mg | 6608 |
Cayman2015 | 10010247 | SB 415286 | 1 mg | 560 |
Cayman2015 | 10010247 | SB 415286 | 10 mg | 4116 |
Cayman2015 | 10010247 | SB 415286 | 5 mg | 2352 |
Cayman2015 | 10010247 | SB 415286 | 500 μg | 294 |
Cayman2015 | 10010248 | AG-17 | 10 mg | 560 |
Cayman2015 | 10010248 | AG-17 | 25 mg | 1330 |
Cayman2015 | 10010248 | AG-17 | 5 mg | 294 |
Cayman2015 | 10010248 | AG-17 | 50 mg | 2352 |
Cayman2015 | 10010249 | H-8 (hydrochloride) | 10 mg | 1050 |
Cayman2015 | 10010249 | H-8 (hydrochloride) | 25 mg | 2352 |
Cayman2015 | 10010249 | H-8 (hydrochloride) | 5 mg | 532 |
Cayman2015 | 10010249 | H-8 (hydrochloride) | 50 mg | 4172 |
Cayman2015 | 10010250 | Cellular Retinol Binding Protein 7 Polyclonal Antibody | 1 ea | 2842 |
Cayman2015 | 10010251 | Cellular Retinol Binding Protein 7 Blocking Peptide | 1 ea | 1498 |
Cayman2015 | 10010252 | Methyl-L-NIO (hydrochloride) | 10 mg | 1358 |
Cayman2015 | 10010252 | Methyl-L-NIO (hydrochloride) | 25 mg | 3220 |
Cayman2015 | 10010252 | Methyl-L-NIO (hydrochloride) | 5 mg | 714 |
Cayman2015 | 10010252 | Methyl-L-NIO (hydrochloride) | 50 mg | 5712 |
Cayman2015 | 10010254 | Pentosidine | 1 mg | 2730 |
Cayman2015 | 10010254 | Pentosidine | 10 mg | 21840 |
Cayman2015 | 10010254 | Pentosidine | 5 mg | 12292 |
Cayman2015 | 10010255 | 5-(galactosylhydroxy)-L-Lysine | 1 mg | 546 |
Cayman2015 | 10010255 | 5-(galactosylhydroxy)-L-Lysine | 10 mg | 4368 |
Cayman2015 | 10010255 | 5-(galactosylhydroxy)-L-Lysine | 5 mg | 2464 |
Cayman2015 | 10010255 | 5-(galactosylhydroxy)-L-Lysine | 50 mg | 19110 |
Cayman2015 | 10010260 | Rofecoxib | 100 mg | 1540 |
Cayman2015 | 10010260 | Rofecoxib | 250 mg | 3626 |
Cayman2015 | 10010260 | Rofecoxib | 50 mg | 966 |
Cayman2015 | 10010260 | Rofecoxib | 500 mg | 5796 |
Cayman2015 | 10010263 | RIPA Buffer Concentrate | 1 ea | 364 |
Cayman2015 | 10010265 | LFM-A13 | 10 mg | 1470 |
Cayman2015 | 10010265 | LFM-A13 | 100 mg | 10780 |
Cayman2015 | 10010265 | LFM-A13 | 5 mg | 770 |
Cayman2015 | 10010265 | LFM-A13 | 50 mg | 6160 |
Cayman2015 | 10010266 | BAY-11-7082 | 10 mg | 1036 |
Cayman2015 | 10010266 | BAY-11-7082 | 25 mg | 2464 |
Cayman2015 | 10010266 | BAY-11-7082 | 5 mg | 546 |
Cayman2015 | 10010266 | BAY-11-7082 | 50 mg | 4368 |
Cayman2015 | 10010267 | SC-514 | 10 mg | 882 |
Cayman2015 | 10010267 | SC-514 | 25 mg | 2086 |
Cayman2015 | 10010267 | SC-514 | 5 mg | 490 |
Cayman2015 | 10010267 | SC-514 | 50 mg | 3682 |
Cayman2015 | 10010275 | Apigenin | 100 mg | 2422 |
Cayman2015 | 10010275 | Apigenin | 25 mg | 672 |
Cayman2015 | 10010275 | Apigenin | 50 mg | 1274 |
Cayman2015 | 10010275 | Apigenin | 500 mg | 10752 |
Cayman2015 | 10010279 | Palmitate (calcium salt) | 1 g | 784 |
Cayman2015 | 10010279 | Palmitate (calcium salt) | 100 mg | 98 |
Cayman2015 | 10010279 | Palmitate (calcium salt) | 5 g | 3430 |
Cayman2015 | 10010279 | Palmitate (calcium salt) | 500 mg | 448 |
Cayman2015 | 10010290 | 1-Palmitoyl Lysophosphatidic Acid (sodium salt) | 1 mg | 434 |
Cayman2015 | 10010290 | 1-Palmitoyl Lysophosphatidic Acid (sodium salt) | 10 mg | 3472 |
Cayman2015 | 10010290 | 1-Palmitoyl Lysophosphatidic Acid (sodium salt) | 25 mg | 7602 |
Cayman2015 | 10010290 | 1-Palmitoyl Lysophosphatidic Acid (sodium salt) | 5 mg | 1960 |
Cayman2015 | 10010291 | 1-Octadecyl Lysophosphatidic Acid (sodium salt) | 1 mg | 462 |
Cayman2015 | 10010291 | 1-Octadecyl Lysophosphatidic Acid (sodium salt) | 10 mg | 3696 |
Cayman2015 | 10010291 | 1-Octadecyl Lysophosphatidic Acid (sodium salt) | 25 mg | 8092 |
Cayman2015 | 10010291 | 1-Octadecyl Lysophosphatidic Acid (sodium salt) | 5 mg | 2086 |
Cayman2015 | 10010292 | 1-Hexadecyl Lysophosphatidic Acid (sodium salt) | 1 mg | 448 |
Cayman2015 | 10010292 | 1-Hexadecyl Lysophosphatidic Acid (sodium salt) | 10 mg | 3332 |
Cayman2015 | 10010292 | 1-Hexadecyl Lysophosphatidic Acid (sodium salt) | 5 mg | 1904 |
Cayman2015 | 10010292 | 1-Hexadecyl Lysophosphatidic Acid (sodium salt) | 500 μg | 238 |
Cayman2015 | 10010293 | Palmitoyl 3-carbacyclic Phosphatidic Acid | 1 mg | 1624 |
Cayman2015 | 10010293 | Palmitoyl 3-carbacyclic Phosphatidic Acid | 10 mg | 11956 |
Cayman2015 | 10010293 | Palmitoyl 3-carbacyclic Phosphatidic Acid | 5 mg | 6832 |
Cayman2015 | 10010293 | Palmitoyl 3-carbacyclic Phosphatidic Acid | 500 μg | 854 |
Cayman2015 | 10010298 | Palmitoleoyl 3-carbacyclic Phosphatidic Acid | 1 mg | 1624 |
Cayman2015 | 10010298 | Palmitoleoyl 3-carbacyclic Phosphatidic Acid | 10 mg | 11956 |
Cayman2015 | 10010298 | Palmitoleoyl 3-carbacyclic Phosphatidic Acid | 5 mg | 6832 |
Cayman2015 | 10010298 | Palmitoleoyl 3-carbacyclic Phosphatidic Acid | 500 μg | 854 |
Cayman2015 | 10010299 | Oleoyl 3-carbacyclic Phosphatidic Acid | 1 mg | 1624 |
Cayman2015 | 10010299 | Oleoyl 3-carbacyclic Phosphatidic Acid | 10 mg | 11956 |
Cayman2015 | 10010299 | Oleoyl 3-carbacyclic Phosphatidic Acid | 5 mg | 6832 |
Cayman2015 | 10010299 | Oleoyl 3-carbacyclic Phosphatidic Acid | 500 μg | 854 |
Cayman2015 | 10010300 | AG-18 | 10 mg | 714 |
Cayman2015 | 10010300 | AG-18 | 25 mg | 1708 |
Cayman2015 | 10010300 | AG-18 | 5 mg | 378 |
Cayman2015 | 10010300 | AG-18 | 50 mg | 3024 |
Cayman2015 | 10010301 | CAY10554 | 10 mg | 1358 |
Cayman2015 | 10010301 | CAY10554 | 25 mg | 3220 |
Cayman2015 | 10010301 | CAY10554 | 5 mg | 714 |
Cayman2015 | 10010301 | CAY10554 | 50 mg | 5712 |
Cayman2015 | 10010302 | DRB | 10 mg | 336 |
Cayman2015 | 10010302 | DRB | 100 mg | 2688 |
Cayman2015 | 10010302 | DRB | 250 mg | 5880 |
Cayman2015 | 10010302 | DRB | 50 mg | 1512 |
Cayman2015 | 10010303 | Triglyceride Colorimetric Assay Kit | 96 Well | 2772 |
Cayman2015 | 10010309 | RG-13022 | 10 mg | 1218 |
Cayman2015 | 10010309 | RG-13022 | 5 mg | 644 |
Cayman2015 | 10010309 | RG-13022 | 50 mg | 5152 |
Cayman2015 | 10010310 | RG-14620 | 10 mg | 1218 |
Cayman2015 | 10010310 | RG-14620 | 5 mg | 644 |
Cayman2015 | 10010310 | RG-14620 | 50 mg | 5152 |
Cayman2015 | 10010311 | AG-490 | 10 mg | 714 |
Cayman2015 | 10010311 | AG-490 | 25 mg | 1708 |
Cayman2015 | 10010311 | AG-490 | 5 mg | 378 |
Cayman2015 | 10010311 | AG-490 | 50 mg | 3024 |
Cayman2015 | 10010312 | AG-82 | 10 mg | 560 |
Cayman2015 | 10010312 | AG-82 | 25 mg | 1330 |
Cayman2015 | 10010312 | AG-82 | 5 mg | 294 |
Cayman2015 | 10010312 | AG-82 | 50 mg | 2352 |
Cayman2015 | 10010313 | AG-99 | 10 mg | 714 |
Cayman2015 | 10010313 | AG-99 | 25 mg | 1708 |
Cayman2015 | 10010313 | AG-99 | 5 mg | 378 |
Cayman2015 | 10010313 | AG-99 | 50 mg | 3024 |
Cayman2015 | 10010314 | AG-213 | 10 mg | 1204 |
Cayman2015 | 10010314 | AG-213 | 25 mg | 2842 |
Cayman2015 | 10010314 | AG-213 | 5 mg | 630 |
Cayman2015 | 10010314 | AG-213 | 50 mg | 5040 |
Cayman2015 | 10010315 | AG-183 | 10 mg | 854 |
Cayman2015 | 10010315 | AG-183 | 25 mg | 2016 |
Cayman2015 | 10010315 | AG-183 | 5 mg | 448 |
Cayman2015 | 10010315 | AG-183 | 50 mg | 3584 |
Cayman2015 | 10010317 | FABP Assay Buffer (10X) | 1 ea | 294 |
Cayman2015 | 10010318 | FABP4 (human recombinant) Assay Reagent (5X) | 1 ea | 1428 |
Cayman2015 | 10010322 | Normal Rabbit IgG-FITC | 1 ea | 1428 |
Cayman2015 | 10010324 | Harmine | 1000 mg | 1050 |
Cayman2015 | 10010324 | Harmine | 250 mg | 350 |
Cayman2015 | 10010324 | Harmine | 500 mg | 630 |
Cayman2015 | 10010329 | Lavendustin C | 1 mg | 280 |
Cayman2015 | 10010329 | Lavendustin C | 10 mg | 2240 |
Cayman2015 | 10010329 | Lavendustin C | 5 mg | 1260 |
Cayman2015 | 10010329 | Lavendustin C | 50 mg | 9800 |
Cayman2015 | 10010332 | AMP-Deoxynojirimycin | 1 mg | 910 |
Cayman2015 | 10010332 | AMP-Deoxynojirimycin | 10 mg | 6664 |
Cayman2015 | 10010332 | AMP-Deoxynojirimycin | 5 mg | 3808 |
Cayman2015 | 10010332 | AMP-Deoxynojirimycin | 500 μg | 476 |
Cayman2015 | 10010333 | Misoprostol (free acid)-d5 | 1 mg | 3892 |
Cayman2015 | 10010333 | Misoprostol (free acid)-d5 | 100 μg | 1260 |
Cayman2015 | 10010333 | Misoprostol (free acid)-d5 | 50 μg | 812 |
Cayman2015 | 10010334 | Fluvastatin | 10 mg | 406 |
Cayman2015 | 10010334 | Fluvastatin | 100 mg | 2646 |
Cayman2015 | 10010334 | Fluvastatin | 25 mg | 910 |
Cayman2015 | 10010334 | Fluvastatin | 50 mg | 1526 |
Cayman2015 | 10010337 | Fluvastatin (sodium salt) | 10 mg | 280 |
Cayman2015 | 10010337 | Fluvastatin (sodium salt) | 100 mg | 1652 |
Cayman2015 | 10010337 | Fluvastatin (sodium salt) | 25 mg | 616 |
Cayman2015 | 10010337 | Fluvastatin (sodium salt) | 50 mg | 924 |
Cayman2015 | 10010338 | Lovastatin | 10 mg | 420 |
Cayman2015 | 10010338 | Lovastatin | 5 mg | 280 |
Cayman2015 | 10010338 | Lovastatin | 50 mg | 980 |
Cayman2015 | 10010339 | Lovastatin Hydroxy Acid (sodium salt) | 1 mg | 406 |
Cayman2015 | 10010339 | Lovastatin Hydroxy Acid (sodium salt) | 10 mg | 1512 |
Cayman2015 | 10010339 | Lovastatin Hydroxy Acid (sodium salt) | 25 mg | 3500 |
Cayman2015 | 10010339 | Lovastatin Hydroxy Acid (sodium salt) | 5 mg | 1120 |
Cayman2015 | 10010340 | Mevastatin | 10 mg | 504 |
Cayman2015 | 10010340 | Mevastatin | 25 mg | 770 |
Cayman2015 | 10010340 | Mevastatin | 5 mg | 280 |
Cayman2015 | 10010340 | Mevastatin | 50 mg | 896 |
Cayman2015 | 10010342 | Pravastatin | 10 mg | 406 |
Cayman2015 | 10010342 | Pravastatin | 100 mg | 2646 |
Cayman2015 | 10010342 | Pravastatin | 25 mg | 910 |
Cayman2015 | 10010342 | Pravastatin | 50 mg | 1526 |
Cayman2015 | 10010343 | Pravastatin (sodium salt) | 10 mg | 504 |
Cayman2015 | 10010343 | Pravastatin (sodium salt) | 25 mg | 770 |
Cayman2015 | 10010343 | Pravastatin (sodium salt) | 5 mg | 280 |
Cayman2015 | 10010343 | Pravastatin (sodium salt) | 50 mg | 896 |
Cayman2015 | 10010344 | Simvastatin | 100 mg | 1512 |
Cayman2015 | 10010344 | Simvastatin | 25 mg | 630 |
Cayman2015 | 10010344 | Simvastatin | 5 mg | 350 |
Cayman2015 | 10010344 | Simvastatin | 50 mg | 952 |
Cayman2015 | 10010345 | Simvastatin (sodium salt) | 1 mg | 392 |
Cayman2015 | 10010345 | Simvastatin (sodium salt) | 10 mg | 3136 |
Cayman2015 | 10010345 | Simvastatin (sodium salt) | 25 mg | 6860 |
Cayman2015 | 10010345 | Simvastatin (sodium salt) | 5 mg | 1764 |
Cayman2015 | 10010350 | CCG-1423 | 10 mg | 798 |
Cayman2015 | 10010350 | CCG-1423 | 25 mg | 1890 |
Cayman2015 | 10010350 | CCG-1423 | 5 mg | 420 |
Cayman2015 | 10010350 | CCG-1423 | 50 mg | 3360 |
Cayman2015 | 10010351 | 17-phenyl trinor Prostaglandin F2α methyl amide | 1 mg | 630 |
Cayman2015 | 10010351 | 17-phenyl trinor Prostaglandin F2α methyl amide | 10 mg | 4102 |
Cayman2015 | 10010351 | 17-phenyl trinor Prostaglandin F2α methyl amide | 5 mg | 2842 |
Cayman2015 | 10010351 | 17-phenyl trinor Prostaglandin F2α methyl amide | 50 mg | 10234 |
Cayman2015 | 10010353 | XTT Reagent (powder) | 1 ea | 574 |
Cayman2015 | 10010353 | XTT Reagent (powder) | 5 ea | 2156 |
Cayman2015 | 10010355 | CJ-023423 | 1 mg | 770 |
Cayman2015 | 10010355 | CJ-023423 | 10 mg | 6160 |
Cayman2015 | 10010355 | CJ-023423 | 25 mg | 13482 |
Cayman2015 | 10010355 | CJ-023423 | 5 mg | 3472 |
Cayman2015 | 10010357 | WST-8 Reagent (powder) | 1 ea | 574 |
Cayman2015 | 10010357 | WST-8 Reagent (powder) | 5 ea | 2156 |
Cayman2015 | 10010364 | FABP5 (human recombinant) | 100 μg | 3976 |
Cayman2015 | 10010364 | FABP5 (human recombinant) | 25 μg | 1106 |
Cayman2015 | 10010364 | FABP5 (human recombinant) | 50 μg | 2100 |
Cayman2015 | 10010367 | ZM 336372 | 1 mg | 350 |
Cayman2015 | 10010367 | ZM 336372 | 10 mg | 1470 |
Cayman2015 | 10010367 | ZM 336372 | 25 mg | 3234 |
Cayman2015 | 10010367 | ZM 336372 | 5 mg | 826 |
Cayman2015 | 10010368 | GW 5074 | 1 mg | 406 |
Cayman2015 | 10010368 | GW 5074 | 10 mg | 2030 |
Cayman2015 | 10010368 | GW 5074 | 25 mg | 4564 |
Cayman2015 | 10010368 | GW 5074 | 5 mg | 1316 |
Cayman2015 | 10010372 | GW 842166X | 1 mg | 238 |
Cayman2015 | 10010372 | GW 842166X | 10 mg | 1918 |
Cayman2015 | 10010372 | GW 842166X | 25 mg | 3654 |
Cayman2015 | 10010372 | GW 842166X | 5 mg | 1078 |
Cayman2015 | 10010375 | 5-Iodotubercidin | 1 mg | 1092 |
Cayman2015 | 10010375 | 5-Iodotubercidin | 100 μg | 182 |
Cayman2015 | 10010375 | 5-Iodotubercidin | 250 μg | 406 |
Cayman2015 | 10010375 | 5-Iodotubercidin | 5 mg | 3640 |
Cayman2015 | 10010376 | FABP Assay Detection Reagent (5X) | 1 ea | 714 |
Cayman2015 | 10010377 | Arachidonic Acid Control | 1 ea | 1428 |
Cayman2015 | 10010380 | ent-8-iso-15(S)-Prostaglandin F2α | 100 μg | 4942 |
Cayman2015 | 10010380 | ent-8-iso-15(S)-Prostaglandin F2α | 25 μg | 1372 |
Cayman2015 | 10010380 | ent-8-iso-15(S)-Prostaglandin F2α | 50 μg | 2604 |
Cayman2015 | 10010383 | PtdIns-(3,4,5)-P3-fluorescein (ammonium salt) | 10 μg | 966 |
Cayman2015 | 10010383 | PtdIns-(3,4,5)-P3-fluorescein (ammonium salt) | 100 μg | 7728 |
Cayman2015 | 10010383 | PtdIns-(3,4,5)-P3-fluorescein (ammonium salt) | 25 μg | 2296 |
Cayman2015 | 10010383 | PtdIns-(3,4,5)-P3-fluorescein (ammonium salt) | 50 μg | 4354 |
Cayman2015 | 10010388 | PtdIns-(4,5)-P2-fluorescein (ammonium salt) | 10 μg | 966 |
Cayman2015 | 10010388 | PtdIns-(4,5)-P2-fluorescein (ammonium salt) | 100 μg | 7728 |
Cayman2015 | 10010388 | PtdIns-(4,5)-P2-fluorescein (ammonium salt) | 25 μg | 2296 |
Cayman2015 | 10010388 | PtdIns-(4,5)-P2-fluorescein (ammonium salt) | 50 μg | 4354 |
Cayman2015 | 10010396 | CAY10535 | 1 mg | 504 |
Cayman2015 | 10010396 | CAY10535 | 10 mg | 4032 |
Cayman2015 | 10010396 | CAY10535 | 5 mg | 2268 |
Cayman2015 | 10010396 | CAY10535 | 50 mg | 17640 |
Cayman2015 | 10010398 | CB-13 | 10 mg | 1148 |
Cayman2015 | 10010398 | CB-13 | 25 mg | 2716 |
Cayman2015 | 10010398 | CB-13 | 5 mg | 602 |
Cayman2015 | 10010398 | CB-13 | 50 mg | 4816 |
Cayman2015 | 10010399 | SB 202190 | 10 mg | 350 |
Cayman2015 | 10010399 | SB 202190 | 25 mg | 672 |
Cayman2015 | 10010400 | CAY10571 | 10 mg | 980 |
Cayman2015 | 10010400 | CAY10571 | 25 mg | 2338 |
Cayman2015 | 10010400 | CAY10571 | 5 mg | 518 |
Cayman2015 | 10010401 | SIRT1 Direct Fluorescent Screening Assay Kit | 96 Well | 4200 |
Cayman2015 | 10010405 | 15-keto-17-phenyl trinor Prostaglandin F2α ethyl amide | 1 mg | 770 |
Cayman2015 | 10010405 | 15-keto-17-phenyl trinor Prostaglandin F2α ethyl amide | 10 mg | 6160 |
Cayman2015 | 10010405 | 15-keto-17-phenyl trinor Prostaglandin F2α ethyl amide | 25 mg | 13482 |
Cayman2015 | 10010405 | 15-keto-17-phenyl trinor Prostaglandin F2α ethyl amide | 5 mg | 3472 |
Cayman2015 | 10010406 | Fluprostenol methyl amide | 1 mg | 784 |
Cayman2015 | 10010406 | Fluprostenol methyl amide | 10 mg | 6272 |
Cayman2015 | 10010406 | Fluprostenol methyl amide | 5 mg | 3528 |
Cayman2015 | 10010410 | GW 848687X | 1 mg | 1918 |
Cayman2015 | 10010410 | GW 848687X | 5 mg | 8064 |
Cayman2015 | 10010410 | GW 848687X | 500 μg | 1008 |
Cayman2015 | 10010411 | NS-304 | 1 mg | 504 |
Cayman2015 | 10010411 | NS-304 | 10 mg | 4032 |
Cayman2015 | 10010411 | NS-304 | 5 mg | 2268 |
Cayman2015 | 10010411 | NS-304 | 50 mg | 17640 |
Cayman2015 | 10010412 | MRE-269 | 1 mg | 504 |
Cayman2015 | 10010412 | MRE-269 | 10 mg | 4032 |
Cayman2015 | 10010412 | MRE-269 | 5 mg | 2268 |
Cayman2015 | 10010412 | MRE-269 | 50 mg | 17640 |
Cayman2015 | 10010421 | Zaprinast | 10 mg | 294 |
Cayman2015 | 10010421 | Zaprinast | 100 mg | 2352 |
Cayman2015 | 10010421 | Zaprinast | 250 mg | 5152 |
Cayman2015 | 10010421 | Zaprinast | 50 mg | 1330 |
Cayman2015 | 10010422 | Nilotinib | 10 mg | 406 |
Cayman2015 | 10010422 | Nilotinib | 25 mg | 826 |
Cayman2015 | 10010422 | Nilotinib | 5 mg | 266 |
Cayman2015 | 10010422 | Nilotinib | 50 mg | 1344 |
Cayman2015 | 10010425 | 13,14-dihydro-15-keto Prostaglandin D1 | 1 mg | 1414 |
Cayman2015 | 10010425 | 13,14-dihydro-15-keto Prostaglandin D1 | 10 mg | 11312 |
Cayman2015 | 10010425 | 13,14-dihydro-15-keto Prostaglandin D1 | 5 mg | 6370 |
Cayman2015 | 10010428 | CJ-42794 | 10 mg | 546 |
Cayman2015 | 10010428 | CJ-42794 | 100 mg | 4368 |
Cayman2015 | 10010428 | CJ-42794 | 250 mg | 8190 |
Cayman2015 | 10010428 | CJ-42794 | 50 mg | 2464 |
Cayman2015 | 10010460 | 17-chlorophenyl trinor Prostaglandin F2α ethyl amide | 1 mg | 980 |
Cayman2015 | 10010460 | 17-chlorophenyl trinor Prostaglandin F2α ethyl amide | 10 mg | 7840 |
Cayman2015 | 10010460 | 17-chlorophenyl trinor Prostaglandin F2α ethyl amide | 5 mg | 4410 |
Cayman2015 | 10010466 | SP 600125 | 10 mg | 742 |
Cayman2015 | 10010466 | SP 600125 | 25 mg | 1232 |
Cayman2015 | 10010466 | SP 600125 | 5 mg | 490 |
Cayman2015 | 10010466 | SP 600125 | 50 mg | 2212 |
Cayman2015 | 10010468 | 15-Lipoxygenase Inhibitor 1 | 1 mg | 672 |
Cayman2015 | 10010468 | 15-Lipoxygenase Inhibitor 1 | 10 mg | 4900 |
Cayman2015 | 10010468 | 15-Lipoxygenase Inhibitor 1 | 5 mg | 2800 |
Cayman2015 | 10010468 | 15-Lipoxygenase Inhibitor 1 | 500 μg | 350 |
Cayman2015 | 10010469 | 10-Acetyl-3,7-dihydroxyphenoxazine | 1 mg | 154 |
Cayman2015 | 10010469 | 10-Acetyl-3,7-dihydroxyphenoxazine | 10 mg | 1232 |
Cayman2015 | 10010469 | 10-Acetyl-3,7-dihydroxyphenoxazine | 25 mg | 2702 |
Cayman2015 | 10010469 | 10-Acetyl-3,7-dihydroxyphenoxazine | 5 mg | 700 |
Cayman2015 | 10010470 | AL 8810 ethyl amide | 1 mg | 854 |
Cayman2015 | 10010470 | AL 8810 ethyl amide | 10 mg | 6832 |
Cayman2015 | 10010470 | AL 8810 ethyl amide | 5 mg | 3850 |
Cayman2015 | 10010484 | 5(Z),14(Z)-Eicosadienoic Acid | 1 mg | 7616 |
Cayman2015 | 10010484 | 5(Z),14(Z)-Eicosadienoic Acid | 100 μg | 952 |
Cayman2015 | 10010484 | 5(Z),14(Z)-Eicosadienoic Acid | 500 μg | 4284 |
Cayman2015 | 10010486 | 14,15-EE-8(Z)-E | 100 μg | 1918 |
Cayman2015 | 10010486 | 14,15-EE-8(Z)-E | 25 μg | 532 |
Cayman2015 | 10010486 | 14,15-EE-8(Z)-E | 50 μg | 1008 |
Cayman2015 | 10010486 | 14,15-EE-8(Z)-E | 500 μg | 8512 |
Cayman2015 | 10010494 | 2-PCPA (hydrochloride) | 10 mg | 140 |
Cayman2015 | 10010494 | 2-PCPA (hydrochloride) | 100 mg | 560 |
Cayman2015 | 10010494 | 2-PCPA (hydrochloride) | 250 mg | 882 |
Cayman2015 | 10010494 | 2-PCPA (hydrochloride) | 50 mg | 350 |
Cayman2015 | 10010495 | (+)-Cloprostenol methyl amide | 1 mg | 784 |
Cayman2015 | 10010495 | (+)-Cloprostenol methyl amide | 10 mg | 6272 |
Cayman2015 | 10010495 | (+)-Cloprostenol methyl amide | 5 mg | 3528 |
Cayman2015 | 10010497 | Manumycin A | 1 mg | 1120 |
Cayman2015 | 10010497 | Manumycin A | 5 mg | 5040 |
Cayman2015 | 10010499 | Prostaglandin A2-biotin | 1 mg | 3248 |
Cayman2015 | 10010499 | Prostaglandin A2-biotin | 100 μg | 406 |
Cayman2015 | 10010499 | Prostaglandin A2-biotin | 500 μg | 1834 |
Cayman2015 | 10010500 | 8-iso Prostaglandin A2-biotin | 100 μg | 1274 |
Cayman2015 | 10010500 | 8-iso Prostaglandin A2-biotin | 50 μg | 672 |
Cayman2015 | 10010500 | 8-iso Prostaglandin A2-biotin | 500 μg | 5376 |
Cayman2015 | 10010501 | Farnesyl Thiosalicylic Acid | 10 mg | 812 |
Cayman2015 | 10010501 | Farnesyl Thiosalicylic Acid | 25 mg | 1904 |
Cayman2015 | 10010501 | Farnesyl Thiosalicylic Acid | 5 mg | 448 |
Cayman2015 | 10010501 | Farnesyl Thiosalicylic Acid | 50 mg | 3584 |
Cayman2015 | 10010502 | CAY10562 | 10 mg | 672 |
Cayman2015 | 10010502 | CAY10562 | 100 mg | 4900 |
Cayman2015 | 10010502 | CAY10562 | 25 mg | 1582 |
Cayman2015 | 10010502 | CAY10562 | 5 mg | 350 |
Cayman2015 | 10010509 | Triglyceride Standard | 1 ea | 434 |
Cayman2015 | 10010511 | Triglyceride Enzyme Mixture (15X) | 1 ea | 2450 |
Cayman2015 | 10010516 | TMP-153 | 100 mg | 3276 |
Cayman2015 | 10010516 | TMP-153 | 25 mg | 910 |
Cayman2015 | 10010516 | TMP-153 | 50 mg | 1736 |
Cayman2015 | 10010517 | BIBB 515 | 1 mg | 126 |
Cayman2015 | 10010517 | BIBB 515 | 10 mg | 1008 |
Cayman2015 | 10010517 | BIBB 515 | 25 mg | 2212 |
Cayman2015 | 10010517 | BIBB 515 | 5 mg | 574 |
Cayman2015 | 10010518 | PD 146176 | 10 mg | 1008 |
Cayman2015 | 10010518 | PD 146176 | 25 mg | 2394 |
Cayman2015 | 10010518 | PD 146176 | 5 mg | 532 |
Cayman2015 | 10010518 | PD 146176 | 50 mg | 4256 |
Cayman2015 | 10010519 | Vialinin A | 1 mg | 644 |
Cayman2015 | 10010519 | Vialinin A | 10 mg | 5152 |
Cayman2015 | 10010519 | Vialinin A | 25 mg | 11270 |
Cayman2015 | 10010519 | Vialinin A | 5 mg | 2898 |
Cayman2015 | 10010521 | Palmitoyl thio-PC | 1 mg | 1288 |
Cayman2015 | 10010521 | Palmitoyl thio-PC | 10 mg | 10304 |
Cayman2015 | 10010521 | Palmitoyl thio-PC | 5 mg | 5796 |
Cayman2015 | 10010522 | U-46619 Glycine methyl ester | 1 mg | 6860 |
Cayman2015 | 10010522 | U-46619 Glycine methyl ester | 100 μg | 938 |
Cayman2015 | 10010522 | U-46619 Glycine methyl ester | 50 μg | 490 |
Cayman2015 | 10010522 | U-46619 Glycine methyl ester | 500 μg | 3920 |
Cayman2015 | 10010526 | CAY10563 | 10 mg | 672 |
Cayman2015 | 10010526 | CAY10563 | 100 mg | 4900 |
Cayman2015 | 10010526 | CAY10563 | 25 mg | 1582 |
Cayman2015 | 10010526 | CAY10563 | 5 mg | 350 |
Cayman2015 | 10010527 | CAY10564 | 10 mg | 672 |
Cayman2015 | 10010527 | CAY10564 | 100 mg | 4900 |
Cayman2015 | 10010527 | CAY10564 | 25 mg | 1582 |
Cayman2015 | 10010527 | CAY10564 | 5 mg | 350 |
Cayman2015 | 10010528 | CAY10565 | 10 mg | 672 |
Cayman2015 | 10010528 | CAY10565 | 100 mg | 4900 |
Cayman2015 | 10010528 | CAY10565 | 25 mg | 1582 |
Cayman2015 | 10010528 | CAY10565 | 5 mg | 350 |
Cayman2015 | 10010530 | CD4 Monoclonal FITC Antibody (Clone RIV7) | 1 ea | 3346 |
Cayman2015 | 10010537 | Transcription Factor NF-κB (human p65) Combo Positive Control | 1 ea | 462 |
Cayman2015 | 10010541 | L-threo-Sphingosine C-18 | 10 mg | 2660 |
Cayman2015 | 10010541 | L-threo-Sphingosine C-18 | 100 mg | 19600 |
Cayman2015 | 10010541 | L-threo-Sphingosine C-18 | 5 mg | 1400 |
Cayman2015 | 10010541 | L-threo-Sphingosine C-18 | 50 mg | 11200 |
Cayman2015 | 10010547 | O-Arachidonoyl Glycidol | 10 mg | 1750 |
Cayman2015 | 10010547 | O-Arachidonoyl Glycidol | 100 mg | 12936 |
Cayman2015 | 10010547 | O-Arachidonoyl Glycidol | 5 mg | 924 |
Cayman2015 | 10010547 | O-Arachidonoyl Glycidol | 50 mg | 7392 |
Cayman2015 | 10010556 | H-89 | 10 mg | 1218 |
Cayman2015 | 10010556 | H-89 | 25 mg | 2898 |
Cayman2015 | 10010556 | H-89 | 5 mg | 644 |
Cayman2015 | 10010556 | H-89 | 50 mg | 5152 |
Cayman2015 | 10010559 | HA-1077 (hydrochloride) | 10 mg | 350 |
Cayman2015 | 10010559 | HA-1077 (hydrochloride) | 100 mg | 1582 |
Cayman2015 | 10010559 | HA-1077 (hydrochloride) | 50 mg | 966 |
Cayman2015 | 10010562 | 16-phenoxy tetranor Prostaglandin F2α methyl amide | 1 mg | 1148 |
Cayman2015 | 10010562 | 16-phenoxy tetranor Prostaglandin F2α methyl amide | 5 mg | 4816 |
Cayman2015 | 10010562 | 16-phenoxy tetranor Prostaglandin F2α methyl amide | 500 μg | 602 |
Cayman2015 | 10010564 | Pyrimidine-4-Carboxylic Acid | 100 mg | 378 |
Cayman2015 | 10010564 | Pyrimidine-4-Carboxylic Acid | 250 mg | 882 |
Cayman2015 | 10010564 | Pyrimidine-4-Carboxylic Acid | 50 mg | 196 |
Cayman2015 | 10010564 | Pyrimidine-4-Carboxylic Acid | 500 mg | 1568 |
Cayman2015 | 10010566 | Albumin (bovine) Acetylated | 1 ea | 364 |
Cayman2015 | 10010567 | Acetyl Lysine Monoclonal Antibody (Clone 7F8) | 1 ea | 4130 |
Cayman2015 | 10010568 | AG-370 | 1 mg | 630 |
Cayman2015 | 10010568 | AG-370 | 10 mg | 5040 |
Cayman2015 | 10010568 | AG-370 | 25 mg | 11032 |
Cayman2015 | 10010568 | AG-370 | 5 mg | 2842 |
Cayman2015 | 10010569 | Acenocoumarol | 10 mg | 630 |
Cayman2015 | 10010569 | Acenocoumarol | 100 mg | 5040 |
Cayman2015 | 10010569 | Acenocoumarol | 25 mg | 1498 |
Cayman2015 | 10010569 | Acenocoumarol | 50 mg | 2842 |
Cayman2015 | 10010571 | Entacapone-d10 | 10 mg | 18260 |
Cayman2015 | 10010571 | Entacapone-d10 | 2.5 mg | 5240 |
Cayman2015 | 10010571 | Entacapone-d10 | 5 mg | 9880 |
Cayman2015 | 10010572 | (R,S)-Lercanidipine-d3 (hydrochloride) | 1 mg | 4620 |
Cayman2015 | 10010572 | (R,S)-Lercanidipine-d3 (hydrochloride) | 10 mg | 36960 |
Cayman2015 | 10010572 | (R,S)-Lercanidipine-d3 (hydrochloride) | 5 mg | 20800 |
Cayman2015 | 10010574 | N-Desmethyltrimebutine (hydrochloride) | 10 mg | 6700 |
Cayman2015 | 10010574 | N-Desmethyltrimebutine (hydrochloride) | 25 mg | 16700 |
Cayman2015 | 10010574 | N-Desmethyltrimebutine (hydrochloride) | 50 mg | 31680 |
Cayman2015 | 10010575 | Desmethyltrimebutine-d3 (hydrochloride) | 10 mg | 19900 |
Cayman2015 | 10010575 | Desmethyltrimebutine-d3 (hydrochloride) | 2.5 mg | 5900 |
Cayman2015 | 10010575 | Desmethyltrimebutine-d3 (hydrochloride) | 5 mg | 10900 |
Cayman2015 | 10010586 | Sildenafil-d8 Citrate | 1 mg | 4660 |
Cayman2015 | 10010586 | Sildenafil-d8 Citrate | 10 mg | 22200 |
Cayman2015 | 10010586 | Sildenafil-d8 Citrate | 5 mg | 11680 |
Cayman2015 | 10010591 | Wortmannin | 1 mg | 560 |
Cayman2015 | 10010591 | Wortmannin | 10 mg | 3360 |
Cayman2015 | 10010591 | Wortmannin | 25 mg | 6300 |
Cayman2015 | 10010591 | Wortmannin | 5 mg | 2240 |
Cayman2015 | 10010592 | AG-1296 | 1 mg | 294 |
Cayman2015 | 10010592 | AG-1296 | 10 mg | 2352 |
Cayman2015 | 10010592 | AG-1296 | 25 mg | 5152 |
Cayman2015 | 10010592 | AG-1296 | 5 mg | 1330 |
Cayman2015 | 10010605 | 17-phenyl trinor Prostaglandin F2α cyclopropyl amide | 1 mg | 826 |
Cayman2015 | 10010605 | 17-phenyl trinor Prostaglandin F2α cyclopropyl amide | 10 mg | 6608 |
Cayman2015 | 10010605 | 17-phenyl trinor Prostaglandin F2α cyclopropyl amide | 5 mg | 3724 |
Cayman2015 | 10010606 | 13,14-dihydro-15-keto Prostaglandin E2-d4 | 100 μg | 4438 |
Cayman2015 | 10010606 | 13,14-dihydro-15-keto Prostaglandin E2-d4 | 25 μg | 1232 |
Cayman2015 | 10010606 | 13,14-dihydro-15-keto Prostaglandin E2-d4 | 50 μg | 2338 |
Cayman2015 | 10010606 | 13,14-dihydro-15-keto Prostaglandin E2-d4 | 500 μg | 19712 |
Cayman2015 | 10010622 | Genipin | 10 mg | 350 |
Cayman2015 | 10010622 | Genipin | 25 mg | 826 |
Cayman2015 | 10010622 | Genipin | 5 mg | 182 |
Cayman2015 | 10010622 | Genipin | 50 mg | 1456 |
Cayman2015 | 10010623 | Linoleic Acid-biotin | 1 mg | 5040 |
Cayman2015 | 10010623 | Linoleic Acid-biotin | 100 μg | 630 |
Cayman2015 | 10010623 | Linoleic Acid-biotin | 500 μg | 2842 |
Cayman2015 | 10010624 | Oleic Acid-biotin | 1 mg | 5040 |
Cayman2015 | 10010624 | Oleic Acid-biotin | 100 μg | 630 |
Cayman2015 | 10010624 | Oleic Acid-biotin | 500 μg | 2842 |
Cayman2015 | 10010630 | Latrunculin A | 100 μg | 1456 |
Cayman2015 | 10010630 | Latrunculin A | 25 μg | 406 |
Cayman2015 | 10010630 | Latrunculin A | 50 μg | 770 |
Cayman2015 | 10010630 | Latrunculin A | 500 μg | 6496 |
Cayman2015 | 10010631 | Latrunculin B | 100 μg | 644 |
Cayman2015 | 10010631 | Latrunculin B | 250 μg | 1512 |
Cayman2015 | 10010631 | Latrunculin B | 50 μg | 336 |
Cayman2015 | 10010631 | Latrunculin B | 500 μg | 2688 |
Cayman2015 | 10010635 | (±)16-HETE | 100 μg | 6048 |
Cayman2015 | 10010635 | (±)16-HETE | 25 μg | 1680 |
Cayman2015 | 10010635 | (±)16-HETE | 50 μg | 3192 |
Cayman2015 | 10010636 | (±)17-HETE | 100 μg | 6048 |
Cayman2015 | 10010636 | (±)17-HETE | 25 μg | 1680 |
Cayman2015 | 10010636 | (±)17-HETE | 50 μg | 3192 |
Cayman2015 | 10010637 | 17(R)-HETE | 100 μg | 6048 |
Cayman2015 | 10010637 | 17(R)-HETE | 25 μg | 1680 |
Cayman2015 | 10010637 | 17(R)-HETE | 50 μg | 3192 |
Cayman2015 | 10010638 | (±)18-HETE | 100 μg | 6048 |
Cayman2015 | 10010638 | (±)18-HETE | 25 μg | 1680 |
Cayman2015 | 10010638 | (±)18-HETE | 50 μg | 3192 |
Cayman2015 | 10010651 | Hydroxymetronidazole-d4 | 10 mg | 19560 |
Cayman2015 | 10010651 | Hydroxymetronidazole-d4 | 5 mg | 10880 |
Cayman2015 | 10010652 | Zolpidem-d6 | 10 mg | 19960 |
Cayman2015 | 10010652 | Zolpidem-d6 | 25 mg | 46900 |
Cayman2015 | 10010652 | Zolpidem-d6 | 50 mg | 89160 |
Cayman2015 | 10010653 | Nisoldipine-d4 | 10 mg | 18260 |
Cayman2015 | 10010653 | Nisoldipine-d4 | 2.5 mg | 5360 |
Cayman2015 | 10010653 | Nisoldipine-d4 | 5 mg | 10140 |
Cayman2015 | 10010654 | Felodipine-d3 | 10 mg | 18720 |
Cayman2015 | 10010654 | Felodipine-d3 | 25 mg | 43960 |
Cayman2015 | 10010654 | Felodipine-d3 | 50 mg | 83560 |
Cayman2015 | 10010660 | Mifepristone-d3 | 1 mg | 3000 |
Cayman2015 | 10010660 | Mifepristone-d3 | 10 mg | 24000 |
Cayman2015 | 10010660 | Mifepristone-d3 | 5 mg | 13500 |
Cayman2015 | 10010661 | L-Ornithine 13C (hydrochloride) | 10 mg | 15960 |
Cayman2015 | 10010661 | L-Ornithine 13C (hydrochloride) | 25 mg | 37900 |
Cayman2015 | 10010661 | L-Ornithine 13C (hydrochloride) | 50 mg | 67200 |
Cayman2015 | 10010662 | Rilmenidine-d4 | 10 mg | 15700 |
Cayman2015 | 10010662 | Rilmenidine-d4 | 25 mg | 36940 |
Cayman2015 | 10010662 | Rilmenidine-d4 | 50 mg | 69920 |
Cayman2015 | 10010663 | Amlodipine-d4 (besylate) | 10 mg | 17800 |
Cayman2015 | 10010663 | Amlodipine-d4 (besylate) | 2.5 mg | 5000 |
Cayman2015 | 10010663 | Amlodipine-d4 (besylate) | 5 mg | 9880 |
Cayman2015 | 10010664 | Ropinirole-d7 (hydrochloride) | 10 mg | 19900 |
Cayman2015 | 10010664 | Ropinirole-d7 (hydrochloride) | 2.5 mg | 5900 |
Cayman2015 | 10010664 | Ropinirole-d7 (hydrochloride) | 5 mg | 10900 |
Cayman2015 | 10010668 | Amiodarone-d4 (hydrochloride) | 10 mg | 14480 |
Cayman2015 | 10010668 | Amiodarone-d4 (hydrochloride) | 2.5 mg | 4260 |
Cayman2015 | 10010668 | Amiodarone-d4 (hydrochloride) | 5 mg | 8040 |
Cayman2015 | 10010669 | Dihydrobupropion-d9 | 10 mg | 24460 |
Cayman2015 | 10010669 | Dihydrobupropion-d9 | 2.5 mg | 7200 |
Cayman2015 | 10010669 | Dihydrobupropion-d9 | 5 mg | 13580 |
Cayman2015 | 10010670 | 7-Aminoclonazepam-d4 | 10 mg | 31460 |
Cayman2015 | 10010670 | 7-Aminoclonazepam-d4 | 2.5 mg | 9240 |
Cayman2015 | 10010670 | 7-Aminoclonazepam-d4 | 5 mg | 17460 |
Cayman2015 | 10010671 | Donepezil-d7 | 10 mg | 19360 |
Cayman2015 | 10010671 | Donepezil-d7 | 2.5 mg | 5700 |
Cayman2015 | 10010671 | Donepezil-d7 | 5 mg | 10740 |
Cayman2015 | 10010673 | Clopidogrel-d3 hydrogen sulfate | 10 mg | 21600 |
Cayman2015 | 10010673 | Clopidogrel-d3 hydrogen sulfate | 2.5 mg | 6360 |
Cayman2015 | 10010673 | Clopidogrel-d3 hydrogen sulfate | 5 mg | 12000 |
Cayman2015 | 10010674 | Hydroxyalprazolam-d5 | 10 mg | 33200 |
Cayman2015 | 10010674 | Hydroxyalprazolam-d5 | 2.5 mg | 9760 |
Cayman2015 | 10010674 | Hydroxyalprazolam-d5 | 5 mg | 18440 |
Cayman2015 | 10010675 | Doxifluridine-d2 | 10 mg | 12474 |
Cayman2015 | 10010675 | Doxifluridine-d2 | 2.5 mg | 3668 |
Cayman2015 | 10010675 | Doxifluridine-d2 | 5 mg | 6916 |
Cayman2015 | 10010676 | Hydrochlorothiazide-d2 15N2 | 10 mg | 29960 |
Cayman2015 | 10010676 | Hydrochlorothiazide-d2 15N2 | 2.5 mg | 8800 |
Cayman2015 | 10010676 | Hydrochlorothiazide-d2 15N2 | 5 mg | 16640 |
Cayman2015 | 10010679 | Bupropion-d9 (hydrochloride) | 10 mg | 17020 |
Cayman2015 | 10010679 | Bupropion-d9 (hydrochloride) | 2.5 mg | 5000 |
Cayman2015 | 10010679 | Bupropion-d9 (hydrochloride) | 5 mg | 9440 |
Cayman2015 | 10010681 | Capecitabine-d11 | 10 mg | 21340 |
Cayman2015 | 10010681 | Capecitabine-d11 | 2.5 mg | 6280 |
Cayman2015 | 10010681 | Capecitabine-d11 | 5 mg | 11840 |
Cayman2015 | 10010685 | Capecitabine-d8 | 10 mg | 21340 |
Cayman2015 | 10010685 | Capecitabine-d8 | 2.5 mg | 6280 |
Cayman2015 | 10010685 | Capecitabine-d8 | 5 mg | 11840 |
Cayman2015 | 10010688 | Ceftiofur-d3 | 10 mg | 29640 |
Cayman2015 | 10010688 | Ceftiofur-d3 | 2.5 mg | 8700 |
Cayman2015 | 10010688 | Ceftiofur-d3 | 5 mg | 16440 |
Cayman2015 | 10010706 | (-)-Deguelin | 10 mg | 1414 |
Cayman2015 | 10010706 | (-)-Deguelin | 25 mg | 3346 |
Cayman2015 | 10010706 | (-)-Deguelin | 5 mg | 742 |
Cayman2015 | 10010706 | (-)-Deguelin | 50 mg | 5936 |
Cayman2015 | 10010712 | CB2 Receptor Polyclonal FITC Antibody | 1 ea | 3780 |
Cayman2015 | 10010721 | S-Glutathionylated Protein Detection Kit | 1 ea | 4200 |
Cayman2015 | 10010723 | 17-phenoxy trinor Prostaglandin F2α isopropyl ester | 1 mg | 714 |
Cayman2015 | 10010723 | 17-phenoxy trinor Prostaglandin F2α isopropyl ester | 10 mg | 5712 |
Cayman2015 | 10010723 | 17-phenoxy trinor Prostaglandin F2α isopropyl ester | 5 mg | 3220 |
Cayman2015 | 10010726 | PSSG Assay Buffer (10X) | 1 ea | 154 |
Cayman2015 | 10010727 | PSSG Blocking Reagent | 1 ea | 266 |
Cayman2015 | 10010728 | PSSG Lysis Buffer | 1 ea | 154 |
Cayman2015 | 10010729 | PSSG Reduction Reagent | 1 ea | 644 |
Cayman2015 | 10010731 | PSSG Labeling Reagent | 1 ea | 266 |
Cayman2015 | 10010732 | PSSG Detection Reagent I (HRP) | 1 ea | 504 |
Cayman2015 | 10010733 | PSSG Detection Reagent II (FITC) | 1 ea | 504 |
Cayman2015 | 10010740 | CAY10550 | 1 mg | 294 |
Cayman2015 | 10010740 | CAY10550 | 10 mg | 2352 |
Cayman2015 | 10010740 | CAY10550 | 25 mg | 5152 |
Cayman2015 | 10010740 | CAY10550 | 5 mg | 1330 |
Cayman2015 | 10010742 | 17-phenoxy trinor Prostaglandin F2α ethyl amide | 1 mg | 980 |
Cayman2015 | 10010742 | 17-phenoxy trinor Prostaglandin F2α ethyl amide | 10 mg | 7840 |
Cayman2015 | 10010742 | 17-phenoxy trinor Prostaglandin F2α ethyl amide | 5 mg | 4410 |
Cayman2015 | 10010743 | Capsaicin (technical grade) | 1000 mg | 2170 |
Cayman2015 | 10010743 | Capsaicin (technical grade) | 250 mg | 602 |
Cayman2015 | 10010743 | Capsaicin (technical grade) | 500 mg | 1148 |
Cayman2015 | 10010743 | Capsaicin (technical grade) | 5000 mg | 9632 |
Cayman2015 | 10010744 | SC-51322 | 1 mg | 210 |
Cayman2015 | 10010744 | SC-51322 | 10 mg | 1680 |
Cayman2015 | 10010744 | SC-51322 | 25 mg | 3682 |
Cayman2015 | 10010744 | SC-51322 | 5 mg | 952 |
Cayman2015 | 10010749 | PIK-90 | 1 mg | 196 |
Cayman2015 | 10010749 | PIK-90 | 10 mg | 966 |
Cayman2015 | 10010749 | PIK-90 | 5 mg | 686 |
Cayman2015 | 10010755 | Glycerol Colorimetric Assay Kit | 96 Well | 2772 |
Cayman2015 | 10010785 | (±)-Lisofylline | 10 mg | 826 |
Cayman2015 | 10010785 | (±)-Lisofylline | 100 mg | 4480 |
Cayman2015 | 10010785 | (±)-Lisofylline | 25 mg | 1330 |
Cayman2015 | 10010785 | (±)-Lisofylline | 50 mg | 2520 |
Cayman2015 | 10010809 | 16-phenoxy tetranor Prostaglandin F2α cyclopropyl methyl amide | 1 mg | 826 |
Cayman2015 | 10010809 | 16-phenoxy tetranor Prostaglandin F2α cyclopropyl methyl amide | 10 mg | 6608 |
Cayman2015 | 10010809 | 16-phenoxy tetranor Prostaglandin F2α cyclopropyl methyl amide | 5 mg | 3724 |
Cayman2015 | 10010810 | 17-phenyl trinor Prostaglandin F2α cyclopropyl methyl amide | 1 mg | 826 |
Cayman2015 | 10010810 | 17-phenyl trinor Prostaglandin F2α cyclopropyl methyl amide | 10 mg | 6608 |
Cayman2015 | 10010810 | 17-phenyl trinor Prostaglandin F2α cyclopropyl methyl amide | 5 mg | 3724 |
Cayman2015 | 10010811 | Lutein | 1 mg | 1050 |
Cayman2015 | 10010811 | Lutein | 10 mg | 7308 |
Cayman2015 | 10010811 | Lutein | 5 mg | 4158 |
Cayman2015 | 10010811 | Lutein | 500 μg | 630 |
Cayman2015 | 10010839 | 17-phenoxy trinor Prostaglandin F2α | 1 mg | 714 |
Cayman2015 | 10010839 | 17-phenoxy trinor Prostaglandin F2α | 10 mg | 5712 |
Cayman2015 | 10010839 | 17-phenoxy trinor Prostaglandin F2α | 5 mg | 3220 |
Cayman2015 | 10010854 | SREBP-1 Transcription Factor Assay Kit | 96 Well | 5740 |
Cayman2015 | 10010893 | Transcription Factor SREBP-1 Positive Control | 1 ea | 910 |
Cayman2015 | 10010894 | Transcription Factor SREBP-1 Primary Antibody | 1 ea | 1092 |
Cayman2015 | 10010895 | Xanthine Oxidase Fluorometric Assay Kit | 96 Well | 1498 |
Cayman2015 | 10010896 | Protein Tyrosine Phosphatase 1B (human recombinant) | 100 μg | 3276 |
Cayman2015 | 10010896 | Protein Tyrosine Phosphatase 1B (human recombinant) | 25 μg | 910 |
Cayman2015 | 10010896 | Protein Tyrosine Phosphatase 1B (human recombinant) | 50 μg | 1736 |
Cayman2015 | 10010907 | PF-622 | 1 mg | 266 |
Cayman2015 | 10010907 | PF-622 | 10 mg | 2128 |
Cayman2015 | 10010907 | PF-622 | 5 mg | 1204 |
Cayman2015 | 10010907 | PF-622 | 50 mg | 9310 |
Cayman2015 | 10010908 | PF-750 | 1 mg | 182 |
Cayman2015 | 10010908 | PF-750 | 10 mg | 1456 |
Cayman2015 | 10010908 | PF-750 | 5 mg | 826 |
Cayman2015 | 10010908 | PF-750 | 50 mg | 6370 |
Cayman2015 | 10010915 | Anti-L-PGDS (human) EIA Strip Plate | 1 ea | 1218 |
Cayman2015 | 10010915 | Anti-L-PGDS (human) EIA Strip Plate | 5 ea | 4564 |
Cayman2015 | 10010916 | L-PGDS (human) EIA Biotinylated Detection Antibody | 100 dtn | 1708 |
Cayman2015 | 10010916 | L-PGDS (human) EIA Biotinylated Detection Antibody | 500 dtn | 6412 |
Cayman2015 | 10010917 | L-PGDS (human) EIA Standard | 1 ea | 924 |
Cayman2015 | 10010947 | β-cyano-L-Alanine | 10 mg | 70 |
Cayman2015 | 10010947 | β-cyano-L-Alanine | 100 mg | 560 |
Cayman2015 | 10010947 | β-cyano-L-Alanine | 250 mg | 1232 |
Cayman2015 | 10010947 | β-cyano-L-Alanine | 50 mg | 322 |
Cayman2015 | 10010948 | DL-Propargyl Glycine (hydrochloride) | 1 mg | 168 |
Cayman2015 | 10010948 | DL-Propargyl Glycine (hydrochloride) | 10 mg | 1344 |
Cayman2015 | 10010948 | DL-Propargyl Glycine (hydrochloride) | 5 mg | 756 |
Cayman2015 | 10010948 | DL-Propargyl Glycine (hydrochloride) | 50 mg | 5880 |
Cayman2015 | 10010960 | Glycerol Standard | 1 ea | 714 |
Cayman2015 | 10010962 | Glycerol Enzyme Mixture | 1 ea | 1428 |
Cayman2015 | 10010965 | KT 5823 | 100 μg | 1414 |
Cayman2015 | 10010965 | KT 5823 | 25 μg | 392 |
Cayman2015 | 10010965 | KT 5823 | 250 μg | 3136 |
Cayman2015 | 10010965 | KT 5823 | 50 μg | 742 |
Cayman2015 | 10010972 | Xanthine Oxidase Assay Buffer (10X) | 1 ea | 154 |
Cayman2015 | 10010973 | Xanthine Oxidase Sample Buffer (10X) | 1 ea | 154 |
Cayman2015 | 10010974 | Xanthine Oxidase Standard | 1 ea | 154 |
Cayman2015 | 10010975 | Xanthine Oxidase Detector | 1 ea | 224 |
Cayman2015 | 10010976 | Xanthine Oxidase Horseradish Peroxidase | 1 ea | 154 |
Cayman2015 | 10010978 | Diphenylphosphine isopropyl ester | 10 mg | 560 |
Cayman2015 | 10010978 | Diphenylphosphine isopropyl ester | 100 mg | 4116 |
Cayman2015 | 10010978 | Diphenylphosphine isopropyl ester | 5 mg | 294 |
Cayman2015 | 10010978 | Diphenylphosphine isopropyl ester | 50 mg | 2352 |
Cayman2015 | 10010991 | SIRT1 FRET-Based Screening Assay Kit | 96 Well | 4200 |
Cayman2015 | 10010992 | W123 | 1 mg | 896 |
Cayman2015 | 10010992 | W123 | 10 mg | 7168 |
Cayman2015 | 10010992 | W123 | 25 mg | 15680 |
Cayman2015 | 10010992 | W123 | 5 mg | 4032 |
Cayman2015 | 10010993 | SIRT1 Direct Assay Buffer (10X) | 1 ea | 154 |
Cayman2015 | 10010994 | SIRT1 (human recombinant) Direct Assay Reagent | 1 ea | 364 |
Cayman2015 | 10010995 | SIRT1 Direct Peptide | 1 ea | 1288 |
Cayman2015 | 10010996 | SIRT1 Direct NAD+ | 1 ea | 154 |
Cayman2015 | 10010997 | SIRT1 Direct Nicotinamide | 1 ea | 154 |
Cayman2015 | 10010998 | SIRT1 Direct Developer | 1 ea | 574 |
Cayman2015 | 10010999 | SIRT1 Direct Fluorophore | 1 ea | 154 |
Cayman2015 | 10011011 | KT 5720 | 100 μg | 1834 |
Cayman2015 | 10011011 | KT 5720 | 250 μg | 4354 |
Cayman2015 | 10011011 | KT 5720 | 50 μg | 966 |
Cayman2015 | 10011011 | KT 5720 | 500 μg | 7728 |
Cayman2015 | 10011018 | Cell-Based Tamoxifen (100 mM) | 1 ea | 574 |
Cayman2015 | 10011020 | SRT 1720 | 1 mg | 406 |
Cayman2015 | 10011020 | SRT 1720 | 10 mg | 2030 |
Cayman2015 | 10011020 | SRT 1720 | 5 mg | 1316 |
Cayman2015 | 10011020 | SRT 1720 | 50 mg | 8120 |
Cayman2015 | 10011032 | QX-314 (bromide) | 100 mg | 910 |
Cayman2015 | 10011032 | QX-314 (bromide) | 25 mg | 350 |
Cayman2015 | 10011032 | QX-314 (bromide) | 50 mg | 490 |
Cayman2015 | 10011038 | Hemopressin | 1 mg | 1148 |
Cayman2015 | 10011040 | 4,5-diphenyl-1,2,3-Thiadiazole | 1000 mg | 700 |
Cayman2015 | 10011040 | 4,5-diphenyl-1,2,3-Thiadiazole | 250 mg | 196 |
Cayman2015 | 10011040 | 4,5-diphenyl-1,2,3-Thiadiazole | 500 mg | 378 |
Cayman2015 | 10011040 | 4,5-diphenyl-1,2,3-Thiadiazole | 5000 mg | 3136 |
Cayman2015 | 10011048 | 2,3-dihydrothieno-Thiadiazole Carboxylate | 10 mg | 154 |
Cayman2015 | 10011048 | 2,3-dihydrothieno-Thiadiazole Carboxylate | 100 mg | 1232 |
Cayman2015 | 10011048 | 2,3-dihydrothieno-Thiadiazole Carboxylate | 50 mg | 700 |
Cayman2015 | 10011049 | 4-phenyl-5-methyl-1,2,3-Thiadiazole | 1 g | 560 |
Cayman2015 | 10011049 | 4-phenyl-5-methyl-1,2,3-Thiadiazole | 250 mg | 154 |
Cayman2015 | 10011049 | 4-phenyl-5-methyl-1,2,3-Thiadiazole | 5 g | 2464 |
Cayman2015 | 10011049 | 4-phenyl-5-methyl-1,2,3-Thiadiazole | 500 mg | 294 |
Cayman2015 | 10011054 | KB2115 | 1 mg | 672 |
Cayman2015 | 10011054 | KB2115 | 10 mg | 4900 |
Cayman2015 | 10011054 | KB2115 | 5 mg | 2800 |
Cayman2015 | 10011054 | KB2115 | 500 μg | 350 |
Cayman2015 | 10011055 | 4-phenyl-1,2,3-Thiadiazole | 1 g | 854 |
Cayman2015 | 10011055 | 4-phenyl-1,2,3-Thiadiazole | 250 mg | 238 |
Cayman2015 | 10011055 | 4-phenyl-1,2,3-Thiadiazole | 5 g | 3808 |
Cayman2015 | 10011055 | 4-phenyl-1,2,3-Thiadiazole | 500 mg | 448 |
Cayman2015 | 10011060 | N-acetyl-D-Mannosamine | 100 mg | 98 |
Cayman2015 | 10011060 | N-acetyl-D-Mannosamine | 1000 mg | 784 |
Cayman2015 | 10011060 | N-acetyl-D-Mannosamine | 250 mg | 238 |
Cayman2015 | 10011060 | N-acetyl-D-Mannosamine | 500 mg | 448 |
Cayman2015 | 10011080 | SIRT1 FRET Assay Buffer (10X) | 1 ea | 154 |
Cayman2015 | 10011081 | SIRT1 (human recombinant) FRET Assay Reagent | 1 ea | 574 |
Cayman2015 | 10011082 | SIRT1 FRET Peptide | 1 ea | 1288 |
Cayman2015 | 10011083 | SIRT1 FRET NAD+ | 1 ea | 154 |
Cayman2015 | 10011084 | SIRT1 FRET Stop Solution | 1 ea | 154 |
Cayman2015 | 10011085 | SIRT1 FRET Developer | 1 ea | 574 |
Cayman2015 | 10011086 | SIRT1 FRET Fluorophore | 1 ea | 154 |
Cayman2015 | 10011094 | 20S Proteasome Positive Control | 1 ea | 924 |
Cayman2015 | 10011095 | 20S Proteasome Substrate (SUC-LLVY-AMC) | 1 ea | 1008 |
Cayman2015 | 10011096 | Cell-Based Assay Epigallocatechin Gallate (EGCG) | 1 ea | 1008 |
Cayman2015 | 10011097 | 20S Proteasome Assay Buffer | 1 ea | 574 |
Cayman2015 | 10011098 | 20S Proteasome Lysis Buffer | 1 ea | 574 |
Cayman2015 | 10011124 | Trimidox (hydrochloride) | 10 mg | 1358 |
Cayman2015 | 10011124 | Trimidox (hydrochloride) | 25 mg | 3220 |
Cayman2015 | 10011124 | Trimidox (hydrochloride) | 5 mg | 714 |
Cayman2015 | 10011124 | Trimidox (hydrochloride) | 50 mg | 5712 |
Cayman2015 | 10011125 | LDL Uptake Cell-Based Assay Kit | 1 ea | 4984 |
Cayman2015 | 10011126 | Clobenpropit (hydrobromide) | 1 mg | 392 |
Cayman2015 | 10011126 | Clobenpropit (hydrobromide) | 10 mg | 3136 |
Cayman2015 | 10011126 | Clobenpropit (hydrobromide) | 25 mg | 6860 |
Cayman2015 | 10011126 | Clobenpropit (hydrobromide) | 5 mg | 1764 |
Cayman2015 | 10011127 | Thioperamide Maleate | 1 mg | 140 |
Cayman2015 | 10011127 | Thioperamide Maleate | 10 mg | 1120 |
Cayman2015 | 10011127 | Thioperamide Maleate | 25 mg | 2450 |
Cayman2015 | 10011127 | Thioperamide Maleate | 5 mg | 630 |
Cayman2015 | 10011131 | BAY-41-8543 | 1 mg | 714 |
Cayman2015 | 10011131 | BAY-41-8543 | 10 mg | 5712 |
Cayman2015 | 10011131 | BAY-41-8543 | 25 mg | 12502 |
Cayman2015 | 10011131 | BAY-41-8543 | 5 mg | 3220 |
Cayman2015 | 10011132 | Rolipram | 10 mg | 588 |
Cayman2015 | 10011132 | Rolipram | 25 mg | 1386 |
Cayman2015 | 10011132 | Rolipram | 5 mg | 308 |
Cayman2015 | 10011133 | Papaverine | 100 mg | 350 |
Cayman2015 | 10011133 | Papaverine | 250 mg | 616 |
Cayman2015 | 10011133 | Papaverine | 500 mg | 882 |
Cayman2015 | 10011135 | BAY-60-7550 | 1 mg | 1050 |
Cayman2015 | 10011135 | BAY-60-7550 | 10 mg | 8400 |
Cayman2015 | 10011135 | BAY-60-7550 | 5 mg | 4732 |
Cayman2015 | 10011141 | MG Phosphate Standard | 1 ea | 266 |
Cayman2015 | 10011142 | MG Blue Solution | 1 ea | 266 |
Cayman2015 | 10011143 | MG Acidic Solution | 1 ea | 266 |
Cayman2015 | 10011144 | 96-Well Solid Plate (low volume) | 1 ea | 434 |
Cayman2015 | 10011178 | Arachidonoyl Ethanolamide-d4 | 1 mg | 2282 |
Cayman2015 | 10011178 | Arachidonoyl Ethanolamide-d4 | 10 mg | 16856 |
Cayman2015 | 10011178 | Arachidonoyl Ethanolamide-d4 | 5 mg | 9632 |
Cayman2015 | 10011178 | Arachidonoyl Ethanolamide-d4 | 500 μg | 1204 |
Cayman2015 | 10011190 | SIRT1 (human recombinant) | 100 U | 4480 |
Cayman2015 | 10011190 | SIRT1 (human recombinant) | 25 U | 1246 |
Cayman2015 | 10011190 | SIRT1 (human recombinant) | 50 U | 2366 |
Cayman2015 | 10011191 | SIRT2 (human recombinant) | 100 μg | 4942 |
Cayman2015 | 10011191 | SIRT2 (human recombinant) | 25 μg | 1372 |
Cayman2015 | 10011191 | SIRT2 (human recombinant) | 50 μg | 2604 |
Cayman2015 | 10011194 | SIRT3 (human recombinant) | 100 μg | 4942 |
Cayman2015 | 10011194 | SIRT3 (human recombinant) | 25 μg | 1372 |
Cayman2015 | 10011194 | SIRT3 (human recombinant) | 50 μg | 2604 |
Cayman2015 | 10011198 | N-heptanoyl-L-Homoserine lactone | 10 mg | 798 |
Cayman2015 | 10011198 | N-heptanoyl-L-Homoserine lactone | 25 mg | 1890 |
Cayman2015 | 10011198 | N-heptanoyl-L-Homoserine lactone | 5 mg | 420 |
Cayman2015 | 10011198 | N-heptanoyl-L-Homoserine lactone | 50 mg | 3360 |
Cayman2015 | 10011199 | N-octanoyl-L-Homoserine lactone | 10 mg | 826 |
Cayman2015 | 10011199 | N-octanoyl-L-Homoserine lactone | 25 mg | 1960 |
Cayman2015 | 10011199 | N-octanoyl-L-Homoserine lactone | 5 mg | 434 |
Cayman2015 | 10011199 | N-octanoyl-L-Homoserine lactone | 50 mg | 3472 |
Cayman2015 | 10011200 | N-tetradecanoyl-L-Homoserine lactone | 10 mg | 798 |
Cayman2015 | 10011200 | N-tetradecanoyl-L-Homoserine lactone | 25 mg | 1890 |
Cayman2015 | 10011200 | N-tetradecanoyl-L-Homoserine lactone | 5 mg | 420 |
Cayman2015 | 10011200 | N-tetradecanoyl-L-Homoserine lactone | 50 mg | 3360 |
Cayman2015 | 10011201 | N-decanoyl-L-Homoserine lactone | 10 mg | 798 |
Cayman2015 | 10011201 | N-decanoyl-L-Homoserine lactone | 25 mg | 1890 |
Cayman2015 | 10011201 | N-decanoyl-L-Homoserine lactone | 5 mg | 420 |
Cayman2015 | 10011201 | N-decanoyl-L-Homoserine lactone | 50 mg | 3360 |
Cayman2015 | 10011203 | N-dodecanoyl-L-Homoserine lactone | 10 mg | 798 |
Cayman2015 | 10011203 | N-dodecanoyl-L-Homoserine lactone | 25 mg | 1890 |
Cayman2015 | 10011203 | N-dodecanoyl-L-Homoserine lactone | 5 mg | 420 |
Cayman2015 | 10011203 | N-dodecanoyl-L-Homoserine lactone | 50 mg | 3360 |
Cayman2015 | 10011204 | N-butyryl-L-Homocysteine thiolactone | 10 mg | 686 |
Cayman2015 | 10011204 | N-butyryl-L-Homocysteine thiolactone | 25 mg | 1638 |
Cayman2015 | 10011204 | N-butyryl-L-Homocysteine thiolactone | 5 mg | 364 |
Cayman2015 | 10011204 | N-butyryl-L-Homocysteine thiolactone | 50 mg | 2912 |
Cayman2015 | 10011206 | N-3-oxo-octanoyl-L-Homoserine lactone | 10 mg | 616 |
Cayman2015 | 10011206 | N-3-oxo-octanoyl-L-Homoserine lactone | 25 mg | 1456 |
Cayman2015 | 10011206 | N-3-oxo-octanoyl-L-Homoserine lactone | 5 mg | 322 |
Cayman2015 | 10011206 | N-3-oxo-octanoyl-L-Homoserine lactone | 50 mg | 2576 |
Cayman2015 | 10011207 | N-(β-ketocaproyl)-L-Homoserine lactone | 10 mg | 616 |
Cayman2015 | 10011207 | N-(β-ketocaproyl)-L-Homoserine lactone | 25 mg | 1456 |
Cayman2015 | 10011207 | N-(β-ketocaproyl)-L-Homoserine lactone | 5 mg | 322 |
Cayman2015 | 10011207 | N-(β-ketocaproyl)-L-Homoserine lactone | 50 mg | 2576 |
Cayman2015 | 10011211 | GW 9578 | 1 mg | 616 |
Cayman2015 | 10011211 | GW 9578 | 10 mg | 4508 |
Cayman2015 | 10011211 | GW 9578 | 5 mg | 2576 |
Cayman2015 | 10011211 | GW 9578 | 500 μg | 322 |
Cayman2015 | 10011213 | WWL70 | 1 mg | 504 |
Cayman2015 | 10011213 | WWL70 | 10 mg | 2688 |
Cayman2015 | 10011213 | WWL70 | 25 mg | 5880 |
Cayman2015 | 10011213 | WWL70 | 5 mg | 1512 |
Cayman2015 | 10011223 | NF-κB (human p50/p65) Combo Transcription Factor Assay Kit | 96 Well | 5740 |
Cayman2015 | 10011229 | LDL-DyLightTM 550 | 1 ea | 2842 |
Cayman2015 | 10011231 | DyLightTM 488-Conjugated Goat Anti-Rabbit IgG Secondary Antibody | 1 ea | 854 |
Cayman2015 | 10011234 | Cell-Based Propidium Iodide Solution | 1 ea | 854 |
Cayman2015 | 10011236 | C-Reactive Protein (human) EIA Kit | 96 Well | 6100 |
Cayman2015 | 10011237 | Protein Phosphatase 2A C subunit (human recombinant; L309 deletion) | 10 μg | 3248 |
Cayman2015 | 10011237 | Protein Phosphatase 2A C subunit (human recombinant; L309 deletion) | 5 μg | 1708 |
Cayman2015 | 10011237 | Protein Phosphatase 2A C subunit (human recombinant; L309 deletion) | 50 μg | 13664 |
Cayman2015 | 10011238 | N-3-oxo-hexadec-11(Z)-enoyl-L-Homoserine lactone | 1 mg | 322 |
Cayman2015 | 10011238 | N-3-oxo-hexadec-11(Z)-enoyl-L-Homoserine lactone | 10 mg | 2576 |
Cayman2015 | 10011238 | N-3-oxo-hexadec-11(Z)-enoyl-L-Homoserine lactone | 25 mg | 5642 |
Cayman2015 | 10011238 | N-3-oxo-hexadec-11(Z)-enoyl-L-Homoserine lactone | 5 mg | 1456 |
Cayman2015 | 10011246 | Janex 1 | 1 mg | 336 |
Cayman2015 | 10011246 | Janex 1 | 10 mg | 2688 |
Cayman2015 | 10011246 | Janex 1 | 25 mg | 5880 |
Cayman2015 | 10011246 | Janex 1 | 5 mg | 1512 |
Cayman2015 | 10011247 | CAY10574 | 1 mg | 266 |
Cayman2015 | 10011247 | CAY10574 | 10 mg | 2128 |
Cayman2015 | 10011247 | CAY10574 | 5 mg | 1204 |
Cayman2015 | 10011247 | CAY10574 | 50 mg | 9310 |
Cayman2015 | 10011248 | CAY10575 | 1 mg | 350 |
Cayman2015 | 10011248 | CAY10575 | 10 mg | 2800 |
Cayman2015 | 10011248 | CAY10575 | 25 mg | 6132 |
Cayman2015 | 10011248 | CAY10575 | 5 mg | 1582 |
Cayman2015 | 10011249 | CAY10576 | 1 mg | 504 |
Cayman2015 | 10011249 | CAY10576 | 10 mg | 4032 |
Cayman2015 | 10011249 | CAY10576 | 5 mg | 2268 |
Cayman2015 | 10011249 | CAY10576 | 50 mg | 17640 |
Cayman2015 | 10011250 | NH125 | 1 mg | 378 |
Cayman2015 | 10011250 | NH125 | 10 mg | 3024 |
Cayman2015 | 10011250 | NH125 | 5 mg | 1708 |
Cayman2015 | 10011250 | NH125 | 50 mg | 13230 |
Cayman2015 | 10011251 | TWS119 | 1 mg | 406 |
Cayman2015 | 10011251 | TWS119 | 10 mg | 1624 |
Cayman2015 | 10011251 | TWS119 | 25 mg | 3556 |
Cayman2015 | 10011251 | TWS119 | 5 mg | 1022 |
Cayman2015 | 10011255 | NSC 210902 | 1 mg | 182 |
Cayman2015 | 10011255 | NSC 210902 | 10 mg | 1456 |
Cayman2015 | 10011255 | NSC 210902 | 5 mg | 826 |
Cayman2015 | 10011255 | NSC 210902 | 50 mg | 6370 |
Cayman2015 | 10011256 | CAY10577 | 1 mg | 182 |
Cayman2015 | 10011256 | CAY10577 | 10 mg | 1456 |
Cayman2015 | 10011256 | CAY10577 | 5 mg | 826 |
Cayman2015 | 10011256 | CAY10577 | 50 mg | 6370 |
Cayman2015 | 10011257 | Transcription Factor NF-κB (human p50) Combo Positive Control | 1 ea | 462 |
Cayman2015 | 10011258 | Transcription Factor NF-κB (human p50) Combo Primary Antibody | 1 ea | 546 |
Cayman2015 | 10011259 | Transcription Factor NF-κB (p65) Combo Primary Antibody | 1 ea | 546 |
Cayman2015 | 10011263 | 15-Lipoxygenase-2 (human recombinant) | 100 μg | 5544 |
Cayman2015 | 10011263 | 15-Lipoxygenase-2 (human recombinant) | 25 μg | 1540 |
Cayman2015 | 10011263 | 15-Lipoxygenase-2 (human recombinant) | 50 μg | 2926 |
Cayman2015 | 10011264 | CAY10578 | 1 mg | 182 |
Cayman2015 | 10011264 | CAY10578 | 10 mg | 1456 |
Cayman2015 | 10011264 | CAY10578 | 25 mg | 3192 |
Cayman2015 | 10011264 | CAY10578 | 5 mg | 826 |
Cayman2015 | 10011269 | Fulvestrant | 1 mg | 210 |
Cayman2015 | 10011269 | Fulvestrant | 10 mg | 1680 |
Cayman2015 | 10011269 | Fulvestrant | 5 mg | 952 |
Cayman2015 | 10011269 | Fulvestrant | 50 mg | 7350 |
Cayman2015 | 10011286 | Chenodeoxycholic Acid | 1 g | 140 |
Cayman2015 | 10011286 | Chenodeoxycholic Acid | 10 g | 1120 |
Cayman2015 | 10011286 | Chenodeoxycholic Acid | 25 g | 2450 |
Cayman2015 | 10011286 | Chenodeoxycholic Acid | 5 g | 630 |
Cayman2015 | 10011288 | Half Volume 96-Well Solid Plate (white) | 1 ea | 168 |
Cayman2015 | 10011288 | Half Volume 96-Well Solid Plate (white) | 5 ea | 630 |
Cayman2015 | 10011296 | (E)-Guggulsterone | 1 mg | 1568 |
Cayman2015 | 10011296 | (E)-Guggulsterone | 10 mg | 12544 |
Cayman2015 | 10011296 | (E)-Guggulsterone | 5 mg | 7056 |
Cayman2015 | 10011297 | 96-Well Solid Plate (black) with lid | 1 ea | 294 |
Cayman2015 | 10011297 | 96-Well Solid Plate (black) with lid | 5 ea | 1106 |
Cayman2015 | 10011298 | Stearic Acid | 1000 mg | 168 |
Cayman2015 | 10011298 | Stearic Acid | 10000 mg | 672 |
Cayman2015 | 10011298 | Stearic Acid | 500 mg | 112 |
Cayman2015 | 10011298 | Stearic Acid | 5000 mg | 448 |
Cayman2015 | 10011300 | NBD-Stearoyl-2-Arachidonoyl-sn-glycerol | 1 mg | 2450 |
Cayman2015 | 10011300 | NBD-Stearoyl-2-Arachidonoyl-sn-glycerol | 10 mg | 18032 |
Cayman2015 | 10011300 | NBD-Stearoyl-2-Arachidonoyl-sn-glycerol | 5 mg | 10304 |
Cayman2015 | 10011300 | NBD-Stearoyl-2-Arachidonoyl-sn-glycerol | 500 μg | 1288 |
Cayman2015 | 10011301 | p38 MAPK Monoclonal Antibody (Clone 9F12) | 1 ea | 3206 |
Cayman2015 | 10011305 | 17(S)-HETE | 100 μg | 6048 |
Cayman2015 | 10011305 | 17(S)-HETE | 25 μg | 1680 |
Cayman2015 | 10011305 | 17(S)-HETE | 50 μg | 3192 |
Cayman2015 | 10011321 | 8-iso Prostaglandin E2-d4 | 100 μg | 6706 |
Cayman2015 | 10011321 | 8-iso Prostaglandin E2-d4 | 25 μg | 1862 |
Cayman2015 | 10011321 | 8-iso Prostaglandin E2-d4 | 50 μg | 3542 |
Cayman2015 | 10011322 | Cysteinyl Leukotriene Express EIA Monoclonal Antibody | 100 dtn | 840 |
Cayman2015 | 10011322 | Cysteinyl Leukotriene Express EIA Monoclonal Antibody | 500 dtn | 3150 |
Cayman2015 | 10011323 | Cysteinyl Leukotriene Express AChE Tracer | 100 dtn | 2590 |
Cayman2015 | 10011323 | Cysteinyl Leukotriene Express AChE Tracer | 500 dtn | 9716 |
Cayman2015 | 10011325 | Immunoassay Buffer A Concentrate (10X) | 10 mL | 224 |
Cayman2015 | 10011332 | Plerixafor (hydrochloride hydrate) | 1 mg | 182 |
Cayman2015 | 10011332 | Plerixafor (hydrochloride hydrate) | 10 mg | 1456 |
Cayman2015 | 10011332 | Plerixafor (hydrochloride hydrate) | 5 mg | 826 |
Cayman2015 | 10011332 | Plerixafor (hydrochloride hydrate) | 50 mg | 6370 |
Cayman2015 | 10011336 | Avenanthramide-C methyl ester | 1 mg | 1148 |
Cayman2015 | 10011336 | Avenanthramide-C methyl ester | 10 mg | 8428 |
Cayman2015 | 10011336 | Avenanthramide-C methyl ester | 5 mg | 4816 |
Cayman2015 | 10011336 | Avenanthramide-C methyl ester | 500 μg | 602 |
Cayman2015 | 10011337 | Diphenylphosphine Acid | 10 mg | 560 |
Cayman2015 | 10011337 | Diphenylphosphine Acid | 100 mg | 4116 |
Cayman2015 | 10011337 | Diphenylphosphine Acid | 5 mg | 294 |
Cayman2015 | 10011337 | Diphenylphosphine Acid | 50 mg | 2352 |
Cayman2015 | 10011343 | Rosiglitazone-d5 Maleate | 10 mg | 19900 |
Cayman2015 | 10011343 | Rosiglitazone-d5 Maleate | 2.5 mg | 5900 |
Cayman2015 | 10011343 | Rosiglitazone-d5 Maleate | 5 mg | 10900 |
Cayman2015 | 10011347 | Glycerophospho-N-Arachidonoyl Ethanolamine | 1 mg | 938 |
Cayman2015 | 10011347 | Glycerophospho-N-Arachidonoyl Ethanolamine | 10 mg | 7504 |
Cayman2015 | 10011347 | Glycerophospho-N-Arachidonoyl Ethanolamine | 5 mg | 4228 |
Cayman2015 | 10011348 | Taprostene (free acid) | 1 mg | 1974 |
Cayman2015 | 10011348 | Taprostene (free acid) | 5 mg | 8288 |
Cayman2015 | 10011348 | Taprostene (free acid) | 500 μg | 1036 |
Cayman2015 | 10011349 | Dimebolin (hydrochloride) | 1 mg | 252 |
Cayman2015 | 10011349 | Dimebolin (hydrochloride) | 10 mg | 1764 |
Cayman2015 | 10011349 | Dimebolin (hydrochloride) | 25 mg | 4410 |
Cayman2015 | 10011349 | Dimebolin (hydrochloride) | 5 mg | 1134 |
Cayman2015 | 10011353 | Protocatechuate Dioxygenase | 100 mg | 3780 |
Cayman2015 | 10011353 | Protocatechuate Dioxygenase | 25 mg | 1050 |
Cayman2015 | 10011353 | Protocatechuate Dioxygenase | 50 mg | 2002 |
Cayman2015 | 10011355 | HRP Stop Solution | 12 mL | 602 |
Cayman2015 | 10011355 | HRP Stop Solution | 30 mL | 1274 |
Cayman2015 | 10011355 | HRP Stop Solution | 60 mL | 2254 |
Cayman2015 | 10011356 | Glycerophospho-N-Palmitoyl Ethanolamine | 1 mg | 938 |
Cayman2015 | 10011356 | Glycerophospho-N-Palmitoyl Ethanolamine | 10 mg | 7504 |
Cayman2015 | 10011356 | Glycerophospho-N-Palmitoyl Ethanolamine | 5 mg | 4228 |
Cayman2015 | 10011357 | Glycerophospho-N-Oleoyl Ethanolamine | 1 mg | 938 |
Cayman2015 | 10011357 | Glycerophospho-N-Oleoyl Ethanolamine | 10 mg | 7504 |
Cayman2015 | 10011357 | Glycerophospho-N-Oleoyl Ethanolamine | 5 mg | 4228 |
Cayman2015 | 10011360 | 14,15-Leukotriene C4 | 100 μg | 5138 |
Cayman2015 | 10011360 | 14,15-Leukotriene C4 | 25 μg | 1428 |
Cayman2015 | 10011360 | 14,15-Leukotriene C4 | 50 μg | 2716 |
Cayman2015 | 10011362 | 14,15-Leukotriene E4 | 100 μg | 5390 |
Cayman2015 | 10011362 | 14,15-Leukotriene E4 | 25 μg | 1498 |
Cayman2015 | 10011362 | 14,15-Leukotriene E4 | 50 μg | 2842 |
Cayman2015 | 10011383 | Hsp40 Polyclonal Antibody | 100 μL | 5820 |
Cayman2015 | 10011383 | Hsp40 Polyclonal Antibody | 25 μL | 2760 |
Cayman2015 | 10011384 | Hsc70 (Hsp73) Polyclonal Antibody | 100 μL | 5280 |
Cayman2015 | 10011384 | Hsc70 (Hsp73) Polyclonal Antibody | 25 μL | 2460 |
Cayman2015 | 10011385 | Bim/BOD (IN) Polyclonal Antibody | 100 μg | 5160 |
Cayman2015 | 10011385 | Bim/BOD (IN) Polyclonal Antibody | 25 μg | 2260 |
Cayman2015 | 10011387 | Cu/Zn SOD (rat) Polyclonal Antibody | 100 μL | 6160 |
Cayman2015 | 10011387 | Cu/Zn SOD (rat) Polyclonal Antibody | 25 μL | 3040 |
Cayman2015 | 10011388 | Cu/Zn SOD (human) Polyclonal Antibody | 100 μL | 6160 |
Cayman2015 | 10011388 | Cu/Zn SOD (human) Polyclonal Antibody | 25 μL | 3040 |
Cayman2015 | 10011389 | Mn SOD (rat) Polyclonal Antibody | 100 μL | 6160 |
Cayman2015 | 10011389 | Mn SOD (rat) Polyclonal Antibody | 25 μL | 3040 |
Cayman2015 | 10011390 | Mn SOD (human) Polyclonal Antibody | 100 μL | 6160 |
Cayman2015 | 10011390 | Mn SOD (human) Polyclonal Antibody | 25 μL | 3040 |
Cayman2015 | 10011421 | Hsp70 Monoclonal Antibody (Clone C92F3A-5) | 200 μg | 6360 |
Cayman2015 | 10011421 | Hsp70 Monoclonal Antibody (Clone C92F3A-5) | 50 μg | 3000 |
Cayman2015 | 10011422 | Hsp70 Monoclonal FITC Antibody (Clone C92) | 200 μg | 6460 |
Cayman2015 | 10011422 | Hsp70 Monoclonal FITC Antibody (Clone C92) | 50 μg | 3140 |
Cayman2015 | 10011423 | Hsp70 (Hsc70) Monoclonal Antibody (Clone N27) | 200 μg | 6400 |
Cayman2015 | 10011423 | Hsp70 (Hsc70) Monoclonal Antibody (Clone N27) | 50 μg | 2980 |
Cayman2015 | 10011424 | GRP94 Monoclonal Antibody (Clone 9G10) | 200 μg | 5260 |
Cayman2015 | 10011424 | GRP94 Monoclonal Antibody (Clone 9G10) | 50 μg | 2440 |
Cayman2015 | 10011425 | Hsp70 (Hsc70) Monoclonal Antibody (Clone BB70) | 200 μg | 6000 |
Cayman2015 | 10011425 | Hsp70 (Hsc70) Monoclonal Antibody (Clone BB70) | 50 μg | 2940 |
Cayman2015 | 10011426 | Hsp90β Monoclonal Antibody (Clone H90-10) | 200 μg | 6160 |
Cayman2015 | 10011426 | Hsp90β Monoclonal Antibody (Clone H90-10) | 50 μg | 2860 |
Cayman2015 | 10011427 | Hsp90α Monoclonal Antibody (Clone K41009) | 100 μg | 6160 |
Cayman2015 | 10011427 | Hsp90α Monoclonal Antibody (Clone K41009) | 25 μg | 2860 |
Cayman2015 | 10011428 | Hsp90 Monoclonal Antibody Complex (Clone 8D3) | 200 μg | 7940 |
Cayman2015 | 10011428 | Hsp90 Monoclonal Antibody Complex (Clone 8D3) | 50 μg | 3600 |
Cayman2015 | 10011429 | Hsp60 Monoclonal Antibody (Clone LK-1) | 200 μg | 4620 |
Cayman2015 | 10011429 | Hsp60 Monoclonal Antibody (Clone LK-1) | 50 μg | 2240 |
Cayman2015 | 10011430 | Hsp60 Monoclonal Antibody (Clone LK-2) | 200 μg | 5420 |
Cayman2015 | 10011430 | Hsp60 Monoclonal Antibody (Clone LK-2) | 50 μg | 2500 |
Cayman2015 | 10011431 | Hsp90 Monoclonal Antibody (Clone AC-16) | 200 μg | 6160 |
Cayman2015 | 10011431 | Hsp90 Monoclonal Antibody (Clone AC-16) | 50 μg | 2860 |
Cayman2015 | 10011432 | CD74 Monoclonal Antibody (Clone PIN1) | 100 μg | 4720 |
Cayman2015 | 10011432 | CD74 Monoclonal Antibody (Clone PIN1) | 25 μg | 2240 |
Cayman2015 | 10011433 | Hsf1 Monoclonal Antibody (Clone 10H8) | 100 μg | 4520 |
Cayman2015 | 10011433 | Hsf1 Monoclonal Antibody (Clone 10H8) | 25 μg | 2040 |
Cayman2015 | 10011434 | Hsf2 Monoclonal Antibody (Clone 3E2) | 100 μg | 4520 |
Cayman2015 | 10011434 | Hsf2 Monoclonal Antibody (Clone 3E2) | 25 μg | 2040 |
Cayman2015 | 10011435 | PSD95 Monoclonal Antibody (Clone 6G6) | 100 μg | 5460 |
Cayman2015 | 10011435 | PSD95 Monoclonal Antibody (Clone 6G6) | 25 μg | 2580 |
Cayman2015 | 10011436 | PSD95 Monoclonal Antibody (Clone 7E3) | 100 μg | 5460 |
Cayman2015 | 10011436 | PSD95 Monoclonal Antibody (Clone 7E3) | 25 μg | 2580 |
Cayman2015 | 10011437 | CaMKII Monoclonal Antibody (Clone 6G9) | 100 μg | 5260 |
Cayman2015 | 10011437 | CaMKII Monoclonal Antibody (Clone 6G9) | 25 μg | 2360 |
Cayman2015 | 10011438 | CaMKII (Phospho-Thr286/Thr287) Monoclonal Antibody (Clone 22B1) | 100 μg | 5460 |
Cayman2015 | 10011438 | CaMKII (Phospho-Thr286/Thr287) Monoclonal Antibody (Clone 22B1) | 25 μg | 2660 |
Cayman2015 | 10011439 | Hsp90α/β Monoclonal Antibody (Clone K41220A) | 100 μg | 6160 |
Cayman2015 | 10011439 | Hsp90α/β Monoclonal Antibody (Clone K41220A) | 25 μg | 2860 |
Cayman2015 | 10011440 | Hsp90β Monoclonal Antibody (Clone K3701) | 100 μg | 6160 |
Cayman2015 | 10011440 | Hsp90β Monoclonal Antibody (Clone K3701) | 25 μg | 2860 |
Cayman2015 | 10011441 | Hsp90α Monoclonal Antibody (Clone D7α) | 100 μg | 6160 |
Cayman2015 | 10011441 | Hsp90α Monoclonal Antibody (Clone D7α) | 25 μg | 2860 |
Cayman2015 | 10011442 | FKBP52 Monoclonal Antibody (Clone Hi52C) | 100 μg | 6160 |
Cayman2015 | 10011442 | FKBP52 Monoclonal Antibody (Clone Hi52C) | 25 μg | 2860 |
Cayman2015 | 10011443 | LAMP1 Monoclonal Antibody (Clone Ly1C6) | 100 μg | 5700 |
Cayman2015 | 10011443 | LAMP1 Monoclonal Antibody (Clone Ly1C6) | 25 μg | 3200 |
Cayman2015 | 10011444 | LAMP2 Monoclonal Antibody (Clone GL2A7) | 100 μg | 5480 |
Cayman2015 | 10011444 | LAMP2 Monoclonal Antibody (Clone GL2A7) | 25 μg | 3060 |
Cayman2015 | 10011446 | DNA/RNA Damage Monoclonal Antibody (Clone 13) | 100 μg | 5460 |
Cayman2015 | 10011446 | DNA/RNA Damage Monoclonal Antibody (Clone 13) | 25 μg | 2560 |
Cayman2015 | 10011453 | Lipoxin A5 | 100 μg | 11284 |
Cayman2015 | 10011453 | Lipoxin A5 | 25 μg | 3136 |
Cayman2015 | 10011453 | Lipoxin A5 | 50 μg | 5964 |
Cayman2015 | 10011454 | Adenosine Receptor A2A Monoclonal Antibody (Clone 7FG-G5-A2) | 1 ea | 2982 |
Cayman2015 | 10011490 | Okadaic Acid | 100 μg | 1358 |
Cayman2015 | 10011490 | Okadaic Acid | 25 μg | 378 |
Cayman2015 | 10011490 | Okadaic Acid | 50 μg | 714 |
Cayman2015 | 10011499 | phytanoyl-Coenzyme A (triethylammonium salt) | 1 mg | 924 |
Cayman2015 | 10011499 | phytanoyl-Coenzyme A (triethylammonium salt) | 10 mg | 7392 |
Cayman2015 | 10011499 | phytanoyl-Coenzyme A (triethylammonium salt) | 25 mg | 16170 |
Cayman2015 | 10011499 | phytanoyl-Coenzyme A (triethylammonium salt) | 5 mg | 4158 |
Cayman2015 | 10011545 | ent-8-iso Prostaglandin F2α | 100 μg | 4942 |
Cayman2015 | 10011545 | ent-8-iso Prostaglandin F2α | 25 μg | 1372 |
Cayman2015 | 10011545 | ent-8-iso Prostaglandin F2α | 50 μg | 2604 |
Cayman2015 | 10011546 | AL 34662 | 1 mg | 126 |
Cayman2015 | 10011546 | AL 34662 | 10 mg | 1008 |
Cayman2015 | 10011546 | AL 34662 | 5 mg | 574 |
Cayman2015 | 10011546 | AL 34662 | 50 mg | 4410 |
Cayman2015 | 10011561 | SC-51089 | 1 mg | 210 |
Cayman2015 | 10011561 | SC-51089 | 10 mg | 1806 |
Cayman2015 | 10011561 | SC-51089 | 25 mg | 3682 |
Cayman2015 | 10011561 | SC-51089 | 5 mg | 952 |
Cayman2015 | 10011562 | L-655,240 | 1 mg | 672 |
Cayman2015 | 10011562 | L-655,240 | 10 mg | 5376 |
Cayman2015 | 10011562 | L-655,240 | 25 mg | 11760 |
Cayman2015 | 10011562 | L-655,240 | 5 mg | 3024 |
Cayman2015 | 10011563 | HDAC Fluorometric Activity Assay Kit | 96 Well | 3920 |
Cayman2015 | 10011564 | HDAC1 Inhibitor Screening Assay Kit | 96 Well | 4200 |
Cayman2015 | 10011565 | L-161,982 | 1 mg | 378 |
Cayman2015 | 10011565 | L-161,982 | 10 mg | 3024 |
Cayman2015 | 10011565 | L-161,982 | 5 mg | 1708 |
Cayman2015 | 10011565 | L-161,982 | 50 mg | 13230 |
Cayman2015 | 10011566 | SIRT3 Direct Fluorescent Screening Assay Kit | 96 Well | 4200 |
Cayman2015 | 10011617 | HDAC1 Positive Control | 1 ea | 462 |
Cayman2015 | 10011618 | HDAC1 (human recombinant) Assay Reagent | 1 ea | 924 |
Cayman2015 | 10011619 | Terbinafine (hydrochloride) | 1 g | 6608 |
Cayman2015 | 10011619 | Terbinafine (hydrochloride) | 100 mg | 826 |
Cayman2015 | 10011619 | Terbinafine (hydrochloride) | 250 mg | 1960 |
Cayman2015 | 10011619 | Terbinafine (hydrochloride) | 500 mg | 3724 |
Cayman2015 | 10011620 | Raloxifene (hydrochloride) | 100 mg | 672 |
Cayman2015 | 10011620 | Raloxifene (hydrochloride) | 250 mg | 1582 |
Cayman2015 | 10011620 | Raloxifene (hydrochloride) | 50 mg | 350 |
Cayman2015 | 10011620 | Raloxifene (hydrochloride) | 500 mg | 2800 |
Cayman2015 | 10011659 | Trolox | 100 mg | 350 |
Cayman2015 | 10011659 | Trolox | 250 mg | 826 |
Cayman2015 | 10011659 | Trolox | 50 mg | 182 |
Cayman2015 | 10011659 | Trolox | 500 mg | 1456 |
Cayman2015 | 10011669 | Soluble Epoxide Hydrolase (human recombinant) | 100 μg | 7714 |
Cayman2015 | 10011669 | Soluble Epoxide Hydrolase (human recombinant) | 25 μg | 2142 |
Cayman2015 | 10011669 | Soluble Epoxide Hydrolase (human recombinant) | 50 μg | 4074 |
Cayman2015 | 10011670 | Soluble Epoxide Hydrolase (mouse recombinant) | 100 μg | 7714 |
Cayman2015 | 10011670 | Soluble Epoxide Hydrolase (mouse recombinant) | 25 μg | 2142 |
Cayman2015 | 10011670 | Soluble Epoxide Hydrolase (mouse recombinant) | 50 μg | 4074 |
Cayman2015 | 10011671 | Soluble Epoxide Hydrolase Inhibitor Screening Assay Kit | 96 Well | 2926 |
Cayman2015 | 10011677 | 15-Lipoxygenase-1 Western Ready Control | 1 ea | 784 |
Cayman2015 | 10011718 | 1-Deoxynojirimycin (hydrochloride) | 1 mg | 322 |
Cayman2015 | 10011718 | 1-Deoxynojirimycin (hydrochloride) | 10 mg | 2576 |
Cayman2015 | 10011718 | 1-Deoxynojirimycin (hydrochloride) | 5 mg | 1456 |
Cayman2015 | 10011718 | 1-Deoxynojirimycin (hydrochloride) | 50 mg | 11270 |
Cayman2015 | 10011720 | ent-8-iso-15(S)-Prostaglandin F2α-d9 | 10 μg | 1806 |
Cayman2015 | 10011720 | ent-8-iso-15(S)-Prostaglandin F2α-d9 | 100 μg | 14448 |
Cayman2015 | 10011720 | ent-8-iso-15(S)-Prostaglandin F2α-d9 | 25 μg | 4284 |
Cayman2015 | 10011720 | ent-8-iso-15(S)-Prostaglandin F2α-d9 | 50 μg | 8134 |
Cayman2015 | 10011721 | ent-8-iso Prostaglandin F2α-d9 | 10 μg | 1806 |
Cayman2015 | 10011721 | ent-8-iso Prostaglandin F2α-d9 | 100 μg | 14448 |
Cayman2015 | 10011721 | ent-8-iso Prostaglandin F2α-d9 | 25 μg | 4284 |
Cayman2015 | 10011721 | ent-8-iso Prostaglandin F2α-d9 | 50 μg | 8134 |
Cayman2015 | 10011724 | Propenyl-L-NIO (hydrochloride) | 10 mg | 1358 |
Cayman2015 | 10011724 | Propenyl-L-NIO (hydrochloride) | 25 mg | 3220 |
Cayman2015 | 10011724 | Propenyl-L-NIO (hydrochloride) | 5 mg | 714 |
Cayman2015 | 10011724 | Propenyl-L-NIO (hydrochloride) | 50 mg | 5712 |
Cayman2015 | 10011725 | Glycerol Cell-Based Assay Kit | 1 ea | 3150 |
Cayman2015 | 10011914 | Deoxynojirimycin Tetrabenzyl Ether | 1 mg | 350 |
Cayman2015 | 10011914 | Deoxynojirimycin Tetrabenzyl Ether | 10 mg | 2800 |
Cayman2015 | 10011914 | Deoxynojirimycin Tetrabenzyl Ether | 5 mg | 1582 |
Cayman2015 | 10011914 | Deoxynojirimycin Tetrabenzyl Ether | 50 mg | 12250 |
Cayman2015 | 10011925 | JNJ-7777120 | 1 mg | 210 |
Cayman2015 | 10011925 | JNJ-7777120 | 10 mg | 1680 |
Cayman2015 | 10011925 | JNJ-7777120 | 5 mg | 952 |
Cayman2015 | 10011925 | JNJ-7777120 | 50 mg | 7350 |
Cayman2015 | 10012088 | Ethyl-L-NIO (hydrochloride) | 10 mg | 1148 |
Cayman2015 | 10012088 | Ethyl-L-NIO (hydrochloride) | 100 mg | 8428 |
Cayman2015 | 10012088 | Ethyl-L-NIO (hydrochloride) | 5 mg | 602 |
Cayman2015 | 10012088 | Ethyl-L-NIO (hydrochloride) | 50 mg | 4816 |
Cayman2015 | 10012201 | Sphingosine Kinase 1 Polyclonal FITC Antibody | 1 ea | 3556 |
Cayman2015 | 10012298 | Ebselen Oxide | 1 mg | 518 |
Cayman2015 | 10012298 | Ebselen Oxide | 10 mg | 4144 |
Cayman2015 | 10012298 | Ebselen Oxide | 25 mg | 9072 |
Cayman2015 | 10012298 | Ebselen Oxide | 5 mg | 2338 |
Cayman2015 | 10012422 | Rabbit Anti-LDL Receptor Primary Antibody | 1 ea | 1428 |
Cayman2015 | 10012424 | CAY10583 | 10 mg | 1274 |
Cayman2015 | 10012424 | CAY10583 | 25 mg | 3024 |
Cayman2015 | 10012424 | CAY10583 | 5 mg | 672 |
Cayman2015 | 10012424 | CAY10583 | 50 mg | 5376 |
Cayman2015 | 10012431 | PD 184161 | 1 mg | 294 |
Cayman2015 | 10012431 | PD 184161 | 10 mg | 2352 |
Cayman2015 | 10012431 | PD 184161 | 25 mg | 5152 |
Cayman2015 | 10012431 | PD 184161 | 5 mg | 1330 |
Cayman2015 | 10012445 | His-Tag Detection EIA Kit | 480 Solid | 9352 |
Cayman2015 | 10012445 | His-Tag Detection EIA Kit | 480 Well | 9352 |
Cayman2015 | 10012445 | His-Tag Detection EIA Kit | 96 Solid | 2492 |
Cayman2015 | 10012445 | His-Tag Detection EIA Kit | 96 Well | 2492 |
Cayman2015 | 10012447 | CG 4305 | 1 mg | 9184 |
Cayman2015 | 10012447 | CG 4305 | 100 μg | 1148 |
Cayman2015 | 10012447 | CG 4305 | 500 μg | 5166 |
Cayman2015 | 10012536 | CAY10592 | 1 mg | 392 |
Cayman2015 | 10012536 | CAY10592 | 10 mg | 3136 |
Cayman2015 | 10012536 | CAY10592 | 5 mg | 1764 |
Cayman2015 | 10012539 | CAY10597 | 1 mg | 798 |
Cayman2015 | 10012539 | CAY10597 | 10 mg | 6384 |
Cayman2015 | 10012539 | CAY10597 | 5 mg | 3598 |
Cayman2015 | 10012540 | SIRT3 Direct Assay Buffer (10X) | 1 ea | 154 |
Cayman2015 | 10012541 | SIRT3 (human recombinant) Direct Assay Reagent | 1 ea | 1078 |
Cayman2015 | 10012542 | SIRT3 Direct Peptide | 1 ea | 1288 |
Cayman2015 | 10012543 | SIRT3 Direct NAD+ | 1 ea | 154 |
Cayman2015 | 10012544 | SIRT3 Direct Nicotinamide | 1 ea | 154 |
Cayman2015 | 10012545 | SIRT3 Direct Developer | 1 ea | 574 |
Cayman2015 | 10012546 | SIRT3 Direct Fluorophore | 1 ea | 154 |
Cayman2015 | 10012553 | CAY10595 | 1 mg | 742 |
Cayman2015 | 10012553 | CAY10595 | 10 mg | 5936 |
Cayman2015 | 10012553 | CAY10595 | 5 mg | 3346 |
Cayman2015 | 10012554 | Resolvin D1 | 10 μg | 1750 |
Cayman2015 | 10012554 | Resolvin D1 | 100 μg | 13832 |
Cayman2015 | 10012554 | Resolvin D1 | 25 μg | 4158 |
Cayman2015 | 10012554 | Resolvin D1 | 50 μg | 7882 |
Cayman2015 | 10012555 | Sodium Hydrogen Sulfide (hydrate) | 1 g | 252 |
Cayman2015 | 10012555 | Sodium Hydrogen Sulfide (hydrate) | 10 g | 2016 |
Cayman2015 | 10012555 | Sodium Hydrogen Sulfide (hydrate) | 25 g | 4410 |
Cayman2015 | 10012555 | Sodium Hydrogen Sulfide (hydrate) | 5 g | 1134 |
Cayman2015 | 10012556 | Phytomonic Acid | 1 mg | 756 |
Cayman2015 | 10012556 | Phytomonic Acid | 10 mg | 6048 |
Cayman2015 | 10012556 | Phytomonic Acid | 5 mg | 3402 |
Cayman2015 | 10012559 | TP Receptor (human) Polyclonal FITC Antibody | 1 ea | 3556 |
Cayman2015 | 10012562 | CAY10566 | 1 mg | 756 |
Cayman2015 | 10012562 | CAY10566 | 10 mg | 6048 |
Cayman2015 | 10012562 | CAY10566 | 25 mg | 13230 |
Cayman2015 | 10012562 | CAY10566 | 5 mg | 3402 |
Cayman2015 | 10012565 | CAY10568 | 10 mg | 406 |
Cayman2015 | 10012565 | CAY10568 | 100 mg | 3248 |
Cayman2015 | 10012565 | CAY10568 | 25 mg | 966 |
Cayman2015 | 10012565 | CAY10568 | 50 mg | 1834 |
Cayman2015 | 10012567 | 7(Z),11(Z)-Heptacosadiene | 1 mg | 588 |
Cayman2015 | 10012567 | 7(Z),11(Z)-Heptacosadiene | 10 mg | 4704 |
Cayman2015 | 10012567 | 7(Z),11(Z)-Heptacosadiene | 5 mg | 2646 |
Cayman2015 | 10012567 | 7(Z),11(Z)-Heptacosadiene | 50 mg | 20580 |
Cayman2015 | 10012577 | Diallyl Trisulfide | 100 mg | 1568 |
Cayman2015 | 10012577 | Diallyl Trisulfide | 25 mg | 434 |
Cayman2015 | 10012577 | Diallyl Trisulfide | 250 mg | 3472 |
Cayman2015 | 10012577 | Diallyl Trisulfide | 50 mg | 826 |
Cayman2015 | 10012582 | Diallyl Disulfide | 1 g | 1008 |
Cayman2015 | 10012582 | Diallyl Disulfide | 100 mg | 252 |
Cayman2015 | 10012582 | Diallyl Disulfide | 500 mg | 630 |
Cayman2015 | 10012583 | cis-ACCP | 1 mg | 308 |
Cayman2015 | 10012583 | cis-ACCP | 10 mg | 2464 |
Cayman2015 | 10012583 | cis-ACCP | 5 mg | 1386 |
Cayman2015 | 10012583 | cis-ACCP | 50 mg | 10780 |
Cayman2015 | 10012588 | A-803467 | 10 mg | 770 |
Cayman2015 | 10012588 | A-803467 | 100 mg | 5684 |
Cayman2015 | 10012588 | A-803467 | 5 mg | 406 |
Cayman2015 | 10012588 | A-803467 | 50 mg | 3248 |
Cayman2015 | 10012591 | CCT018159 | 1 mg | 182 |
Cayman2015 | 10012591 | CCT018159 | 10 mg | 1456 |
Cayman2015 | 10012591 | CCT018159 | 5 mg | 826 |
Cayman2015 | 10012591 | CCT018159 | 50 mg | 6370 |
Cayman2015 | 10012597 | Allopurinol | 100 g | 1260 |
Cayman2015 | 10012597 | Allopurinol | 25 g | 350 |
Cayman2015 | 10012597 | Allopurinol | 50 g | 672 |
Cayman2015 | 10012600 | Myricetin | 10 mg | 294 |
Cayman2015 | 10012600 | Myricetin | 100 mg | 1764 |
Cayman2015 | 10012600 | Myricetin | 25 mg | 658 |
Cayman2015 | 10012600 | Myricetin | 50 mg | 1176 |
Cayman2015 | 10012601 | DNA/RNA Oxidative Damage AChE Tracer | 100 dtn | 2842 |
Cayman2015 | 10012601 | DNA/RNA Oxidative Damage AChE Tracer | 500 dtn | 10654 |
Cayman2015 | 10012602 | DNA/RNA Oxidative Damage EIA Monoclonal Antibody | 100 dtn | 1288 |
Cayman2015 | 10012602 | DNA/RNA Oxidative Damage EIA Monoclonal Antibody | 500 dtn | 5152 |
Cayman2015 | 10012603 | DNA/RNA Oxidative Damage EIA Standard | 1 ea | 714 |
Cayman2015 | 10012609 | Eeyarestatin 1 | 10 mg | 1176 |
Cayman2015 | 10012609 | Eeyarestatin 1 | 25 mg | 2310 |
Cayman2015 | 10012609 | Eeyarestatin 1 | 5 mg | 616 |
Cayman2015 | 10012628 | (S)-MG132 | 1 mg | 168 |
Cayman2015 | 10012628 | (S)-MG132 | 10 mg | 1344 |
Cayman2015 | 10012628 | (S)-MG132 | 5 mg | 756 |
Cayman2015 | 10012628 | (S)-MG132 | 50 mg | 5530 |
Cayman2015 | 10012643 | Steatosis Colorimetric Assay Kit | 1 ea | 2590 |
Cayman2015 | 10012659 | Ki16425 | 1 mg | 406 |
Cayman2015 | 10012659 | Ki16425 | 10 mg | 1624 |
Cayman2015 | 10012659 | Ki16425 | 100 mg | 10150 |
Cayman2015 | 10012659 | Ki16425 | 5 mg | 1120 |
Cayman2015 | 10012670 | Chloroquine Positive Control (25 mM) | 1 ea | 364 |
Cayman2015 | 10012671 | Steatosis Assay Hematoxylin | 1 ea | 294 |
Cayman2015 | 10012672 | N-cis-tetradec-9Z-enoyl-L-Homoserine lactone | 10 mg | 980 |
Cayman2015 | 10012672 | N-cis-tetradec-9Z-enoyl-L-Homoserine lactone | 25 mg | 2338 |
Cayman2015 | 10012672 | N-cis-tetradec-9Z-enoyl-L-Homoserine lactone | 5 mg | 518 |
Cayman2015 | 10012672 | N-cis-tetradec-9Z-enoyl-L-Homoserine lactone | 50 mg | 4144 |
Cayman2015 | 10012673 | N-cis-hexadec-9Z-enoyl-L-Homoserine lactone | 10 mg | 952 |
Cayman2015 | 10012673 | N-cis-hexadec-9Z-enoyl-L-Homoserine lactone | 25 mg | 2268 |
Cayman2015 | 10012673 | N-cis-hexadec-9Z-enoyl-L-Homoserine lactone | 5 mg | 504 |
Cayman2015 | 10012673 | N-cis-hexadec-9Z-enoyl-L-Homoserine lactone | 50 mg | 4032 |
Cayman2015 | 10012674 | N-cis-octadec-9Z-enoyl-L-Homoserine lactone | 10 mg | 952 |
Cayman2015 | 10012674 | N-cis-octadec-9Z-enoyl-L-Homoserine lactone | 25 mg | 2268 |
Cayman2015 | 10012674 | N-cis-octadec-9Z-enoyl-L-Homoserine lactone | 5 mg | 504 |
Cayman2015 | 10012674 | N-cis-octadec-9Z-enoyl-L-Homoserine lactone | 50 mg | 4032 |
Cayman2015 | 10012682 | CAY10585 | 1 mg | 154 |
Cayman2015 | 10012682 | CAY10585 | 10 mg | 1232 |
Cayman2015 | 10012682 | CAY10585 | 25 mg | 2702 |
Cayman2015 | 10012682 | CAY10585 | 5 mg | 700 |
Cayman2015 | 10012694 | CAY10607 | 1 mg | 1372 |
Cayman2015 | 10012694 | CAY10607 | 10 mg | 10976 |
Cayman2015 | 10012694 | CAY10607 | 5 mg | 6174 |
Cayman2015 | 10012698 | NVP-AUY922 | 10 mg | 2800 |
Cayman2015 | 10012698 | NVP-AUY922 | 5 mg | 1750 |
Cayman2015 | 10012699 | JMV3002 | 1 mg | 5264 |
Cayman2015 | 10012699 | JMV3002 | 100 μg | 658 |
Cayman2015 | 10012699 | JMV3002 | 5 mg | 22050 |
Cayman2015 | 10012699 | JMV3002 | 500 μg | 2968 |
Cayman2015 | 10012708 | A-922500 | 1 mg | 420 |
Cayman2015 | 10012708 | A-922500 | 10 mg | 3360 |
Cayman2015 | 10012708 | A-922500 | 25 mg | 7350 |
Cayman2015 | 10012708 | A-922500 | 5 mg | 1890 |
Cayman2015 | 10013 | Prostaglandin A1-biotin | 1 mg | 2912 |
Cayman2015 | 10013 | Prostaglandin A1-biotin | 100 μg | 364 |
Cayman2015 | 10013 | Prostaglandin A1-biotin | 5 mg | 12740 |
Cayman2015 | 10013 | Prostaglandin A1-biotin | 500 μg | 1638 |
Cayman2015 | 10014 | N-Ac-Tyr-Val-Ala-Asp-CMK | 1 mg | 798 |
Cayman2015 | 10014 | N-Ac-Tyr-Val-Ala-Asp-CMK | 10 mg | 5880 |
Cayman2015 | 10014 | N-Ac-Tyr-Val-Ala-Asp-CMK | 5 mg | 3360 |
Cayman2015 | 10014 | N-Ac-Tyr-Val-Ala-Asp-CMK | 500 μg | 420 |
Cayman2015 | 10016 | N-Ac-Tyr-Val-Ala-Asp-CHO | 1 mg | 490 |
Cayman2015 | 10016 | N-Ac-Tyr-Val-Ala-Asp-CHO | 10 mg | 3920 |
Cayman2015 | 10016 | N-Ac-Tyr-Val-Ala-Asp-CHO | 5 mg | 2212 |
Cayman2015 | 10017 | N-Ac-Asp-Glu-Val-Asp-CHO | 1 mg | 980 |
Cayman2015 | 10017 | N-Ac-Asp-Glu-Val-Asp-CHO | 10 mg | 7252 |
Cayman2015 | 10017 | N-Ac-Asp-Glu-Val-Asp-CHO | 5 mg | 4144 |
Cayman2015 | 10017 | N-Ac-Asp-Glu-Val-Asp-CHO | 500 μg | 518 |
Cayman2015 | 10018 | DDMS | 1 mg | 784 |
Cayman2015 | 10018 | DDMS | 10 mg | 6272 |
Cayman2015 | 10018 | DDMS | 5 mg | 3528 |
Cayman2015 | 10020 | Prostaglandin A1 ethyl ester | 1 mg | 756 |
Cayman2015 | 10020 | Prostaglandin A1 ethyl ester | 10 mg | 6048 |
Cayman2015 | 10020 | Prostaglandin A1 ethyl ester | 5 mg | 3402 |
Cayman2015 | 10022 | F16 | 1 mg | 126 |
Cayman2015 | 10022 | F16 | 10 mg | 1008 |
Cayman2015 | 10022 | F16 | 5 mg | 574 |
Cayman2015 | 10022 | F16 | 50 mg | 4410 |
Cayman2015 | 10023 | (S)-AL 8810 | 1 mg | 658 |
Cayman2015 | 10023 | (S)-AL 8810 | 10 mg | 5264 |
Cayman2015 | 10023 | (S)-AL 8810 | 5 mg | 2968 |
Cayman2015 | 10026 | T0070907 | 1 mg | 126 |
Cayman2015 | 10026 | T0070907 | 10 mg | 1008 |
Cayman2015 | 10026 | T0070907 | 5 mg | 574 |
Cayman2015 | 10026 | T0070907 | 50 mg | 4410 |
Cayman2015 | 10028 | Pioglitazone (potassium salt) | 1 mg | 308 |
Cayman2015 | 10028 | Pioglitazone (potassium salt) | 10 mg | 1134 |
Cayman2015 | 10028 | Pioglitazone (potassium salt) | 5 mg | 630 |
Cayman2015 | 10028 | Pioglitazone (potassium salt) | 50 mg | 4466 |
Cayman2015 | 10029 | MK 571 | 1 mg | 350 |
Cayman2015 | 10029 | MK 571 | 10 mg | 1372 |
Cayman2015 | 10029 | MK 571 | 5 mg | 784 |
Cayman2015 | 10029 | MK 571 | 50 mg | 6132 |
Cayman2015 | 10031 | POV-PC | 1 mg | 1008 |
Cayman2015 | 10031 | POV-PC | 10 mg | 8064 |
Cayman2015 | 10031 | POV-PC | 25 mg | 17640 |
Cayman2015 | 10031 | POV-PC | 5 mg | 4536 |
Cayman2015 | 10032 | N-(α-Linolenoyl) Tyrosine | 10 mg | 1512 |
Cayman2015 | 10032 | N-(α-Linolenoyl) Tyrosine | 100 mg | 11172 |
Cayman2015 | 10032 | N-(α-Linolenoyl) Tyrosine | 5 mg | 798 |
Cayman2015 | 10032 | N-(α-Linolenoyl) Tyrosine | 50 mg | 6384 |
Cayman2015 | 10033 | 5(S),6(R)-Lipoxin A4 methyl ester | 100 μg | 11284 |
Cayman2015 | 10033 | 5(S),6(R)-Lipoxin A4 methyl ester | 25 μg | 3136 |
Cayman2015 | 10033 | 5(S),6(R)-Lipoxin A4 methyl ester | 50 μg | 5964 |
Cayman2015 | 10035 | 8-iso Prostaglandin A1 | 1 mg | 1176 |
Cayman2015 | 10035 | 8-iso Prostaglandin A1 | 10 mg | 9408 |
Cayman2015 | 10035 | 8-iso Prostaglandin A1 | 5 mg | 5292 |
Cayman2015 | 10037 | 10-Nitrolinoleate | 1 mg | 4256 |
Cayman2015 | 10037 | 10-Nitrolinoleate | 100 μg | 532 |
Cayman2015 | 10037 | 10-Nitrolinoleate | 500 μg | 2394 |
Cayman2015 | 10038 | TMS | 1 mg | 154 |
Cayman2015 | 10038 | TMS | 10 mg | 1232 |
Cayman2015 | 10038 | TMS | 5 mg | 700 |
Cayman2015 | 10038 | TMS | 50 mg | 5390 |
Cayman2015 | 10039 | FR122047 (hydrate) | 1 mg | 196 |
Cayman2015 | 10039 | FR122047 (hydrate) | 10 mg | 1568 |
Cayman2015 | 10039 | FR122047 (hydrate) | 5 mg | 882 |
Cayman2015 | 10039 | FR122047 (hydrate) | 50 mg | 6860 |
Cayman2015 | 10043 | 15(R)-Iloprost | 1 mg | 2338 |
Cayman2015 | 10043 | 15(R)-Iloprost | 10 mg | 17248 |
Cayman2015 | 10043 | 15(R)-Iloprost | 5 mg | 9856 |
Cayman2015 | 10043 | 15(R)-Iloprost | 500 μg | 1232 |
Cayman2015 | 10044 | PGPC | 1 mg | 476 |
Cayman2015 | 10044 | PGPC | 10 mg | 3528 |
Cayman2015 | 10044 | PGPC | 5 mg | 2016 |
Cayman2015 | 10044 | PGPC | 500 μg | 252 |
Cayman2015 | 10045 | UCM707 | 10 mg | 1736 |
Cayman2015 | 10045 | UCM707 | 25 mg | 4102 |
Cayman2015 | 10045 | UCM707 | 5 mg | 910 |
Cayman2015 | 10045 | UCM707 | 50 mg | 7280 |
Cayman2015 | 10046 | URB597 | 10 mg | 854 |
Cayman2015 | 10046 | URB597 | 100 mg | 6272 |
Cayman2015 | 10046 | URB597 | 5 mg | 448 |
Cayman2015 | 10046 | URB597 | 50 mg | 3584 |
Cayman2015 | 10047 | 8-iso Misoprostol | 1 mg | 910 |
Cayman2015 | 10047 | 8-iso Misoprostol | 10 mg | 7280 |
Cayman2015 | 10047 | 8-iso Misoprostol | 5 mg | 4102 |
Cayman2015 | 10049 | 5(S),6(S)-Lipoxin A4 | 100 μg | 11284 |
Cayman2015 | 10049 | 5(S),6(S)-Lipoxin A4 | 25 μg | 3136 |
Cayman2015 | 10049 | 5(S),6(S)-Lipoxin A4 | 50 μg | 5964 |
Cayman2015 | 10054 | GW 3965 (hydrochloride) | 1 mg | 490 |
Cayman2015 | 10054 | GW 3965 (hydrochloride) | 10 mg | 1960 |
Cayman2015 | 10054 | GW 3965 (hydrochloride) | 5 mg | 1330 |
Cayman2015 | 10057 | BAY-41-2272 | 10 mg | 2268 |
Cayman2015 | 10057 | BAY-41-2272 | 25 mg | 4760 |
Cayman2015 | 10057 | BAY-41-2272 | 5 mg | 1190 |
Cayman2015 | 10057 | BAY-41-2272 | 50 mg | 8932 |
Cayman2015 | 10065 | 15-deoxy-Δ12,14-Prostaglandin A1 | 1 mg | 1638 |
Cayman2015 | 10065 | 15-deoxy-Δ12,14-Prostaglandin A1 | 5 mg | 7644 |
Cayman2015 | 10065 | 15-deoxy-Δ12,14-Prostaglandin A1 | 500 μg | 1092 |
Cayman2015 | 10070 | 15-epi Prostaglandin A1 | 1 mg | 1750 |
Cayman2015 | 10070 | 15-epi Prostaglandin A1 | 100 μg | 350 |
Cayman2015 | 10070 | 15-epi Prostaglandin A1 | 500 μg | 1232 |
Cayman2015 | 10072 | Ursolic Acid | 100 mg | 532 |
Cayman2015 | 10072 | Ursolic Acid | 250 mg | 1330 |
Cayman2015 | 10072 | Ursolic Acid | 50 mg | 322 |
Cayman2015 | 10073 | (+)-Abscisic Acid | 1 mg | 224 |
Cayman2015 | 10073 | (+)-Abscisic Acid | 10 mg | 1792 |
Cayman2015 | 10073 | (+)-Abscisic Acid | 5 mg | 1008 |
Cayman2015 | 10073 | (+)-Abscisic Acid | 50 mg | 7840 |
Cayman2015 | 10075 | CAY10452 | 1 mg | 350 |
Cayman2015 | 10075 | CAY10452 | 10 mg | 1932 |
Cayman2015 | 10075 | CAY10452 | 25 mg | 4116 |
Cayman2015 | 10075 | CAY10452 | 5 mg | 1134 |
Cayman2015 | 10080 | 16,16-dimethyl Prostaglandin A1 | 1 mg | 980 |
Cayman2015 | 10080 | 16,16-dimethyl Prostaglandin A1 | 10 mg | 7840 |
Cayman2015 | 10080 | 16,16-dimethyl Prostaglandin A1 | 5 mg | 4410 |
Cayman2015 | 100830 | Caveolin 1/3 Polyclonal Antiserum | 1 ea | 2618 |
Cayman2015 | 10092 | Adenosine Receptor A2A Blocking Peptide | 1 ea | 1498 |
Cayman2015 | 10096 | SB 242084 (hydrochloride) | 1 mg | 378 |
Cayman2015 | 10096 | SB 242084 (hydrochloride) | 10 mg | 1708 |
Cayman2015 | 10096 | SB 242084 (hydrochloride) | 5 mg | 1232 |
Cayman2015 | 10111 | EA4 | 10 mg | 1946 |
Cayman2015 | 10111 | EA4 | 100 mg | 14308 |
Cayman2015 | 10111 | EA4 | 5 mg | 1022 |
Cayman2015 | 10111 | EA4 | 50 mg | 8176 |
Cayman2015 | 10112 | (±)-Enterolactone | 1 mg | 392 |
Cayman2015 | 10112 | (±)-Enterolactone | 10 mg | 3136 |
Cayman2015 | 10112 | (±)-Enterolactone | 5 mg | 1764 |
Cayman2015 | 10112 | (±)-Enterolactone | 50 mg | 13720 |
Cayman2015 | 10113 | AL 8810 isopropyl ester | 1 mg | 798 |
Cayman2015 | 10113 | AL 8810 isopropyl ester | 10 mg | 6384 |
Cayman2015 | 10113 | AL 8810 isopropyl ester | 5 mg | 3598 |
Cayman2015 | 10115 | N-Oleoyl Dopamine | 10 mg | 938 |
Cayman2015 | 10115 | N-Oleoyl Dopamine | 100 mg | 6860 |
Cayman2015 | 10115 | N-Oleoyl Dopamine | 5 mg | 490 |
Cayman2015 | 10115 | N-Oleoyl Dopamine | 50 mg | 3920 |
Cayman2015 | 10118 | 15(R)-Prostaglandin D2 | 1 mg | 882 |
Cayman2015 | 10118 | 15(R)-Prostaglandin D2 | 10 mg | 7938 |
Cayman2015 | 10118 | 15(R)-Prostaglandin D2 | 5 mg | 4186 |
Cayman2015 | 10120 | CP 24,879 (hydrochloride) | 1 mg | 336 |
Cayman2015 | 10120 | CP 24,879 (hydrochloride) | 10 mg | 2688 |
Cayman2015 | 10120 | CP 24,879 (hydrochloride) | 5 mg | 1512 |
Cayman2015 | 10120 | CP 24,879 (hydrochloride) | 50 mg | 11760 |
Cayman2015 | 10129 | 5-trans Latanoprost (free acid) | 1 mg | 770 |
Cayman2015 | 10129 | 5-trans Latanoprost (free acid) | 10 mg | 6160 |
Cayman2015 | 10129 | 5-trans Latanoprost (free acid) | 5 mg | 3472 |
Cayman2015 | 10133 | MK 886 (sodium salt) | 1 mg | 350 |
Cayman2015 | 10133 | MK 886 (sodium salt) | 10 mg | 1750 |
Cayman2015 | 10133 | MK 886 (sodium salt) | 25 mg | 3934 |
Cayman2015 | 10133 | MK 886 (sodium salt) | 5 mg | 1050 |
Cayman2015 | 10134 | HQL-79 | 1 mg | 420 |
Cayman2015 | 10134 | HQL-79 | 10 mg | 1680 |
Cayman2015 | 10134 | HQL-79 | 5 mg | 1372 |
Cayman2015 | 10134 | HQL-79 | 50 mg | 6300 |
Cayman2015 | 10136 | GPR17 (C-Term) Polyclonal Antibody | 1 ea | 3206 |
Cayman2015 | 10137 | Icilin | 10 mg | 938 |
Cayman2015 | 10137 | Icilin | 100 mg | 6272 |
Cayman2015 | 10137 | Icilin | 5 mg | 560 |
Cayman2015 | 10137 | Icilin | 50 mg | 4312 |
Cayman2015 | 10138 | (±)12-HpETE | 100 μg | 1456 |
Cayman2015 | 10138 | (±)12-HpETE | 25 μg | 406 |
Cayman2015 | 10138 | (±)12-HpETE | 50 μg | 770 |
Cayman2015 | 10138 | (±)12-HpETE | 500 μg | 6496 |
Cayman2015 | 10139 | Prostaglandin F2α-1-glyceryl ester | 1 mg | 840 |
Cayman2015 | 10139 | Prostaglandin F2α-1-glyceryl ester | 5 mg | 3920 |
Cayman2015 | 10139 | Prostaglandin F2α-1-glyceryl ester | 500 μg | 490 |
Cayman2015 | 10140 | Prostaglandin E2-1-glyceryl ester | 1 mg | 1008 |
Cayman2015 | 10140 | Prostaglandin E2-1-glyceryl ester | 10 mg | 8064 |
Cayman2015 | 10140 | Prostaglandin E2-1-glyceryl ester | 5 mg | 4536 |
Cayman2015 | 10141 | 15-deoxy-Δ12,14-Prostaglandin J2-biotin | 100 μg | 2800 |
Cayman2015 | 10141 | 15-deoxy-Δ12,14-Prostaglandin J2-biotin | 50 μg | 1470 |
Cayman2015 | 10141 | 15-deoxy-Δ12,14-Prostaglandin J2-biotin | 500 μg | 11760 |
Cayman2015 | 10143 | Cytochrome P450 1A1 (human) Yeast Reductase | 1 nmol | 4700 |
Cayman2015 | 10144 | Cytochrome P450 1A2 (human) Yeast Reductase | 1 nmol | 4700 |
Cayman2015 | 10146 | Cytochrome P450 3A4 (human) Human Reductase | 1 nmol | 4700 |
Cayman2015 | 10147 | Cytochrome P450 3A5 (human) | 1 nmol | 4700 |
Cayman2015 | 10148 | Cytochrome P450 1B1 (human) Yeast Reductase | 1 nmol | 4700 |
Cayman2015 | 10149 | Cytochrome P450 2B6 (human) Human Reductase | 1 nmol | 4700 |
Cayman2015 | 10150 | Cytochrome P450 2C8 (human) Yeast Reductase | 1 nmol | 4700 |
Cayman2015 | 101500 | CB1 Receptor Polyclonal Antibody | 1 ea | 3206 |
Cayman2015 | 101500 | CB1 Receptor Polyclonal Antibody | 1 Trial | 1386 |
Cayman2015 | 10151 | Cytochrome P450 2C9 (human) Yeast Reductase | 1 nmol | 4700 |
Cayman2015 | 10152 | Cytochrome P450 2C18 (human) Yeast Reductase | 1 nmol | 4700 |
Cayman2015 | 10153 | Cytochrome P450 2D6 (human) Yeast Reductase | 1 nmol | 4700 |
Cayman2015 | 10154 | Cytochrome P450 2E1 (human) Yeast Reductase | 1 nmol | 4700 |
Cayman2015 | 10155 | BM 567 | 1000 μg | 672 |
Cayman2015 | 10155 | BM 567 | 10000 μg | 5376 |
Cayman2015 | 10155 | BM 567 | 5000 μg | 3024 |
Cayman2015 | 101550 | CB2 Receptor Polyclonal Antibody | 1 ea | 3780 |
Cayman2015 | 101550 | CB2 Receptor Polyclonal Antibody | 1 Trial | 1680 |
Cayman2015 | 10156 | BAY-u3405 | 1 mg | 350 |
Cayman2015 | 10156 | BAY-u3405 | 10 mg | 1890 |
Cayman2015 | 10156 | BAY-u3405 | 5 mg | 1092 |
Cayman2015 | 10156 | BAY-u3405 | 50 mg | 8582 |
Cayman2015 | 10157 | APF | 1 mg | 3304 |
Cayman2015 | 10157 | APF | 5 mg | 13888 |
Cayman2015 | 10157 | APF | 500 μg | 1736 |
Cayman2015 | 10158 | N-Arachidonoyl-3-hydroxy-γ-Aminobutyric Acid | 1 mg | 154 |
Cayman2015 | 10158 | N-Arachidonoyl-3-hydroxy-γ-Aminobutyric Acid | 10 mg | 1232 |
Cayman2015 | 10158 | N-Arachidonoyl-3-hydroxy-γ-Aminobutyric Acid | 5 mg | 700 |
Cayman2015 | 10158 | N-Arachidonoyl-3-hydroxy-γ-Aminobutyric Acid | 50 mg | 5390 |
Cayman2015 | 10159 | HPF | 1 mg | 3570 |
Cayman2015 | 10159 | HPF | 5 mg | 15008 |
Cayman2015 | 10159 | HPF | 500 μg | 1890 |
Cayman2015 | 101600 | Fatty Acid Amide Hydrolase Polyclonal Antibody | 1 ea | 3206 |
Cayman2015 | 101600 | Fatty Acid Amide Hydrolase Polyclonal Antibody | 1 Trial | 1386 |
Cayman2015 | 10162 | Treprostinil | 1 mg | 1106 |
Cayman2015 | 10162 | Treprostinil | 10 mg | 8848 |
Cayman2015 | 10162 | Treprostinil | 5 mg | 4984 |
Cayman2015 | 101640 | DP1 Receptor Polyclonal Antibody | 1 ea | 3206 |
Cayman2015 | 10165 | D-erythro-MAPP | 1 mg | 182 |
Cayman2015 | 10165 | D-erythro-MAPP | 10 mg | 1372 |
Cayman2015 | 10165 | D-erythro-MAPP | 5 mg | 784 |
Cayman2015 | 10165 | D-erythro-MAPP | 500 μg | 98 |
Cayman2015 | 10168 | Arachidonoyl p-Nitroaniline | 1 mg | 154 |
Cayman2015 | 10168 | Arachidonoyl p-Nitroaniline | 10 mg | 1232 |
Cayman2015 | 10168 | Arachidonoyl p-Nitroaniline | 5 mg | 700 |
Cayman2015 | 10168 | Arachidonoyl p-Nitroaniline | 50 mg | 5390 |
Cayman2015 | 10169 | 15(S)-HETE Ethanolamide | 100 μg | 6300 |
Cayman2015 | 10169 | 15(S)-HETE Ethanolamide | 25 μg | 1750 |
Cayman2015 | 10169 | 15(S)-HETE Ethanolamide | 50 μg | 3332 |
Cayman2015 | 10170 | BEC | 1 mg | 406 |
Cayman2015 | 10170 | BEC | 10 mg | 3248 |
Cayman2015 | 10170 | BEC | 25 mg | 7112 |
Cayman2015 | 10170 | BEC | 5 mg | 1834 |
Cayman2015 | 101700 | PPARγ Polyclonal Antibody | 1 ea | 3206 |
Cayman2015 | 10171 | OMDM-1 | 1 mg | 140 |
Cayman2015 | 10171 | OMDM-1 | 10 mg | 1120 |
Cayman2015 | 10171 | OMDM-1 | 5 mg | 630 |
Cayman2015 | 10171 | OMDM-1 | 50 mg | 4900 |
Cayman2015 | 101710 | PPARα Polyclonal Antibody | 1 ea | 3206 |
Cayman2015 | 10172 | Lyso-PC | 100 mg | 1918 |
Cayman2015 | 10172 | Lyso-PC | 25 mg | 532 |
Cayman2015 | 10172 | Lyso-PC | 50 mg | 1008 |
Cayman2015 | 10172 | Lyso-PC | 500 mg | 8512 |
Cayman2015 | 101720 | PPARδ Polyclonal Antibody | 1 ea | 3206 |
Cayman2015 | 10173 | 14(15)-EpETE | 100 μg | 1918 |
Cayman2015 | 10173 | 14(15)-EpETE | 25 μg | 532 |
Cayman2015 | 10173 | 14(15)-EpETE | 50 μg | 1008 |
Cayman2015 | 10173 | 14(15)-EpETE | 500 μg | 8512 |
Cayman2015 | 101730 | MCAD Polyclonal Antibody | 1 ea | 2870 |
Cayman2015 | 10174 | 16(17)-EpDPE | 100 μg | 1666 |
Cayman2015 | 10174 | 16(17)-EpDPE | 25 μg | 462 |
Cayman2015 | 10174 | 16(17)-EpDPE | 50 μg | 882 |
Cayman2015 | 10174 | 16(17)-EpDPE | 500 μg | 7392 |
Cayman2015 | 101740 | EP1 Receptor Polyclonal Antibody | 1 ea | 3206 |
Cayman2015 | 101740 | EP1 Receptor Polyclonal Antibody | 1 Trial | 1428 |
Cayman2015 | 10175 | 19(20)-EpDPE | 100 μg | 1666 |
Cayman2015 | 10175 | 19(20)-EpDPE | 25 μg | 462 |
Cayman2015 | 10175 | 19(20)-EpDPE | 50 μg | 882 |
Cayman2015 | 10175 | 19(20)-EpDPE | 500 μg | 7392 |
Cayman2015 | 101750 | EP2 Receptor Polyclonal Antibody | 1 ea | 3066 |
Cayman2015 | 101760 | EP3 Receptor Polyclonal Antibody | 1 ea | 3206 |
Cayman2015 | 101770 | EP4 Receptor (N-Term) Polyclonal Antiserum | 1 ea | 3010 |
Cayman2015 | 101775 | EP4 Receptor (C-Term) Polyclonal Antibody | 1 ea | 3206 |
Cayman2015 | 101780 | EP4 Receptor (N-Term) Blocking Peptide | 200 μg | 1498 |
Cayman2015 | 10179 | OMDM-2 | 1 mg | 196 |
Cayman2015 | 10179 | OMDM-2 | 10 mg | 1568 |
Cayman2015 | 10179 | OMDM-2 | 5 mg | 882 |
Cayman2015 | 10179 | OMDM-2 | 50 mg | 6860 |
Cayman2015 | 10180 | Arachidonoyl Ethanolamide Phosphate | 1 mg | 952 |
Cayman2015 | 10180 | Arachidonoyl Ethanolamide Phosphate | 250 μg | 266 |
Cayman2015 | 10180 | Arachidonoyl Ethanolamide Phosphate | 5 mg | 4256 |
Cayman2015 | 10180 | Arachidonoyl Ethanolamide Phosphate | 500 μg | 504 |
Cayman2015 | 101802 | FP Receptor Polyclonal Antibody | 1 ea | 3206 |
Cayman2015 | 10185 | 4-oxo-2-Nonenal | 1 mg | 1204 |
Cayman2015 | 10185 | 4-oxo-2-Nonenal | 10 mg | 8820 |
Cayman2015 | 10185 | 4-oxo-2-Nonenal | 5 mg | 5040 |
Cayman2015 | 10185 | 4-oxo-2-Nonenal | 500 μg | 630 |
Cayman2015 | 10186 | COX Inhibitor Pack | 1 ea | 7112 |
Cayman2015 | 10188 | trans-trismethoxy Resveratrol | 100 mg | 728 |
Cayman2015 | 10188 | trans-trismethoxy Resveratrol | 250 mg | 1526 |
Cayman2015 | 10188 | trans-trismethoxy Resveratrol | 50 mg | 406 |
Cayman2015 | 10188 | trans-trismethoxy Resveratrol | 500 mg | 2842 |
Cayman2015 | 101882 | TP Receptor (mouse) Polyclonal Antibody | 1 ea | 3206 |
Cayman2015 | 10189540 | Nitrotyrosine Polyclonal Antibody | 1 ea | 3374 |
Cayman2015 | 10190 | 2,4-Dichlorophenoxy Acetic Acid | 100 g | 294 |
Cayman2015 | 10190 | 2,4-Dichlorophenoxy Acetic Acid | 250 g | 700 |
Cayman2015 | 10190 | 2,4-Dichlorophenoxy Acetic Acid | 50 g | 154 |
Cayman2015 | 10192 | Prostaglandin D2 serinol amide | 1 mg | 770 |
Cayman2015 | 10192 | Prostaglandin D2 serinol amide | 10 mg | 6930 |
Cayman2015 | 10192 | Prostaglandin D2 serinol amide | 5 mg | 3654 |
Cayman2015 | 10193 | Prostaglandin E2 serinol amide | 1 mg | 686 |
Cayman2015 | 10193 | Prostaglandin E2 serinol amide | 10 mg | 5096 |
Cayman2015 | 10193 | Prostaglandin E2 serinol amide | 5 mg | 2912 |
Cayman2015 | 10193 | Prostaglandin E2 serinol amide | 500 μg | 364 |
Cayman2015 | 10194 | Prostaglandin F2α serinol amide | 1 mg | 798 |
Cayman2015 | 10194 | Prostaglandin F2α serinol amide | 10 mg | 6384 |
Cayman2015 | 10194 | Prostaglandin F2α serinol amide | 5 mg | 3598 |
Cayman2015 | 10195 | 13-epi-12-oxo Phytodienoic Acid | 1 mg | 5376 |
Cayman2015 | 10195 | 13-epi-12-oxo Phytodienoic Acid | 100 μg | 672 |
Cayman2015 | 10195 | 13-epi-12-oxo Phytodienoic Acid | 500 μg | 3024 |
Cayman2015 | 10196 | Rabbit Anti-Mouse IgA Polyclonal FITC | 1 ea | 1148 |
Cayman2015 | 10197 | Glutathione S-Transferase Polyclonal FITC Antibody | 1 ea | 3486 |
Cayman2015 | 10202 | Hsp90α (human recombinant) | 100 μg | 2618 |
Cayman2015 | 10202 | Hsp90α (human recombinant) | 25 μg | 728 |
Cayman2015 | 10202 | Hsp90α (human recombinant) | 50 μg | 1386 |
Cayman2015 | 10203 | AM2201 N-(4-hydroxypentyl) metabolite | 1 mg | 5460 |
Cayman2015 | 10203 | AM2201 N-(4-hydroxypentyl) metabolite | 100 μg | 910 |
Cayman2015 | 10203 | AM2201 N-(4-hydroxypentyl) metabolite | 500 μg | 3416 |
Cayman2015 | 10208 | CD34 Monoclonal FITC Antibody (Clone ICO-115) | 1 ea | 3346 |
Cayman2015 | 10209 | Prostaglandin E Synthase (cytosolic, FL) Polyclonal Antibody | 1 ea | 2828 |
Cayman2015 | 10210 | Prostaglandin A2 | 1 mg | 350 |
Cayman2015 | 10210 | Prostaglandin A2 | 10 mg | 2450 |
Cayman2015 | 10210 | Prostaglandin A2 | 5 mg | 1484 |
Cayman2015 | 10212 | Monoacylglycerol Lipase (FL) Polyclonal Antibody | 1 ea | 2982 |
Cayman2015 | 10214 | Nrf2 (C-Term) Polyclonal Antibody | 1 ea | 3206 |
Cayman2015 | 10215 | IDFP | 1 mg | 1204 |
Cayman2015 | 10215 | IDFP | 10 mg | 8820 |
Cayman2015 | 10215 | IDFP | 5 mg | 5040 |
Cayman2015 | 10215 | IDFP | 500 μg | 630 |
Cayman2015 | 10217 | 24(R)-hydroxy Cholesterol | 1 mg | 630 |
Cayman2015 | 10217 | 24(R)-hydroxy Cholesterol | 10 mg | 5670 |
Cayman2015 | 10217 | 24(R)-hydroxy Cholesterol | 5 mg | 2996 |
Cayman2015 | 10218 | PCSK9 Monoclonal Antibody (Clone 16) | 1 ea | 2828 |
Cayman2015 | 10221 | Phosphothreonine (Ascites) Monoclonal Antibody (Clone 18F6) | 100 μL | 5260 |
Cayman2015 | 10222 | Phosphotyrosine (Ascites) Monoclonal Antibody (Clone 13F9) | 100 μL | 5260 |
Cayman2015 | 10224 | GPR55 Polyclonal Antibody | 1 ea | 3206 |
Cayman2015 | 10225 | GPR55 Blocking Peptide | 1 ea | 1498 |
Cayman2015 | 10228 | TAF 10 Peptide | 1 ea | 1428 |
Cayman2015 | 10229 | β-Amyloid (1-8, A2V) Peptide | 1 ea | 854 |
Cayman2015 | 10231 | CD3 Monoclonal FITC Antibody (Clone RIV9) | 1 ea | 3346 |
Cayman2015 | 10232 | CD5 Monoclonal FITC Antibody (Clone CRIS1) | 1 ea | 3206 |
Cayman2015 | 10233 | FABP3 Monoclonal Antibody (Clone CC68) | 1 ea | 2982 |
Cayman2015 | 10235 | 8-iso Prostaglandin A2 | 1 mg | 1106 |
Cayman2015 | 10235 | 8-iso Prostaglandin A2 | 5 mg | 5012 |
Cayman2015 | 10235 | 8-iso Prostaglandin A2 | 500 μg | 686 |
Cayman2015 | 10239 | IP6K2 Monoclonal Antibody (Clone 4F10) | 1 ea | 3206 |
Cayman2015 | 10240 | PCSK9 Polyclonal Antibody | 1 ea | 3556 |
Cayman2015 | 10241 | β-Amyloid (1-8) Peptide | 1 ea | 854 |
Cayman2015 | 10242 | 11β-Hydroxysteroid Dehydrogenase (Type 2) Blocking Peptide | 1 ea | 1498 |
Cayman2015 | 10245 | LSD1 (human recombinant) | 100 U | 5138 |
Cayman2015 | 10245 | LSD1 (human recombinant) | 25 U | 1428 |
Cayman2015 | 10245 | LSD1 (human recombinant) | 50 U | 2716 |
Cayman2015 | 10247 | Prostaglandin I Synthase Monoclonal Antibody (Clone 3C8) | 1 ea | 3206 |
Cayman2015 | 10249 | Deoxy-5-fluorocytidine-d2 | 10 mg | 12488 |
Cayman2015 | 10249 | Deoxy-5-fluorocytidine-d2 | 2.5 mg | 3668 |
Cayman2015 | 10249 | Deoxy-5-fluorocytidine-d2 | 5 mg | 6916 |
Cayman2015 | 10250 | Programmed Cell Death Protein 4 (C-Term) Polyclonal Antibody | 1 ea | 3206 |
Cayman2015 | 10253 | Doxifluridine | 10 mg | 350 |
Cayman2015 | 10253 | Doxifluridine | 100 mg | 1372 |
Cayman2015 | 10253 | Doxifluridine | 25 mg | 658 |
Cayman2015 | 10253 | Doxifluridine | 50 mg | 784 |
Cayman2015 | 10260 | 13,14-dihydro-15-keto Prostaglandin A2 | 1 mg | 952 |
Cayman2015 | 10260 | 13,14-dihydro-15-keto Prostaglandin A2 | 10 mg | 7616 |
Cayman2015 | 10260 | 13,14-dihydro-15-keto Prostaglandin A2 | 5 mg | 4284 |
Cayman2015 | 10261 | Histone H2A (Xenopus recombinant) | 1 mg | 5950 |
Cayman2015 | 10261 | Histone H2A (Xenopus recombinant) | 100 μg | 1372 |
Cayman2015 | 10261 | Histone H2A (Xenopus recombinant) | 250 μg | 3220 |
Cayman2015 | 10261 | Histone H2A (Xenopus recombinant) | 50 μg | 770 |
Cayman2015 | 10262 | Histone H2B (Xenopus recombinant) | 1 mg | 4900 |
Cayman2015 | 10262 | Histone H2B (Xenopus recombinant) | 100 μg | 672 |
Cayman2015 | 10262 | Histone H2B (Xenopus recombinant) | 250 μg | 1582 |
Cayman2015 | 10262 | Histone H2B (Xenopus recombinant) | 50 μg | 350 |
Cayman2015 | 10263 | Histone H3 (human recombinant) | 1 mg | 4900 |
Cayman2015 | 10263 | Histone H3 (human recombinant) | 100 μg | 672 |
Cayman2015 | 10263 | Histone H3 (human recombinant) | 250 μg | 1582 |
Cayman2015 | 10263 | Histone H3 (human recombinant) | 50 μg | 350 |
Cayman2015 | 10264 | Histone H4 (human recombinant) | 1 mg | 4900 |
Cayman2015 | 10264 | Histone H4 (human recombinant) | 100 μg | 672 |
Cayman2015 | 10264 | Histone H4 (human recombinant) | 250 μg | 1582 |
Cayman2015 | 10264 | Histone H4 (human recombinant) | 50 μg | 350 |
Cayman2015 | 10265 | 15-deoxy-Δ12,14-Prostaglandin A2 | 1 mg | 1568 |
Cayman2015 | 10265 | 15-deoxy-Δ12,14-Prostaglandin A2 | 5 mg | 6608 |
Cayman2015 | 10265 | 15-deoxy-Δ12,14-Prostaglandin A2 | 500 μg | 826 |
Cayman2015 | 10266 | JWH 007 | 10 mg | 1484 |
Cayman2015 | 10266 | JWH 007 | 25 mg | 3528 |
Cayman2015 | 10266 | JWH 007 | 5 mg | 784 |
Cayman2015 | 10270 | 15(R)-15-methyl Prostaglandin A2 | 1 mg | 602 |
Cayman2015 | 10270 | 15(R)-15-methyl Prostaglandin A2 | 10 mg | 4816 |
Cayman2015 | 10270 | 15(R)-15-methyl Prostaglandin A2 | 5 mg | 2716 |
Cayman2015 | 10271 | EUK 118 | 10 mg | 672 |
Cayman2015 | 10271 | EUK 118 | 100 mg | 4900 |
Cayman2015 | 10271 | EUK 118 | 5 mg | 350 |
Cayman2015 | 10271 | EUK 118 | 50 mg | 2800 |
Cayman2015 | 10272 | Prostratin | 1 mg | 1232 |
Cayman2015 | 10272 | Prostratin | 100 μg | 154 |
Cayman2015 | 10272 | Prostratin | 250 μg | 364 |
Cayman2015 | 10272 | Prostratin | 500 μg | 700 |
Cayman2015 | 10273 | FABP3 Blocking Peptide | 1 ea | 1498 |
Cayman2015 | 10277 | ATB-337 | 1 mg | 392 |
Cayman2015 | 10277 | ATB-337 | 10 mg | 3136 |
Cayman2015 | 10277 | ATB-337 | 5 mg | 1764 |
Cayman2015 | 10277 | ATB-337 | 50 mg | 13720 |
Cayman2015 | 10279 | PAF Acetylhydrolase (human recombinant) | 100 μg | 5292 |
Cayman2015 | 10279 | PAF Acetylhydrolase (human recombinant) | 25 μg | 1890 |
Cayman2015 | 10279 | PAF Acetylhydrolase (human recombinant) | 50 μg | 2646 |
Cayman2015 | 10280 | 16,16-dimethyl Prostaglandin A2 | 1 mg | 1036 |
Cayman2015 | 10280 | 16,16-dimethyl Prostaglandin A2 | 10 mg | 8288 |
Cayman2015 | 10280 | 16,16-dimethyl Prostaglandin A2 | 5 mg | 4662 |
Cayman2015 | 10285 | 16-phenoxy tetranor Prostaglandin A2 | 1 mg | 672 |
Cayman2015 | 10285 | 16-phenoxy tetranor Prostaglandin A2 | 10 mg | 5376 |
Cayman2015 | 10285 | 16-phenoxy tetranor Prostaglandin A2 | 5 mg | 3024 |
Cayman2015 | 10288 | 17-phenyl trinor Prostaglandin A2 | 1 mg | 672 |
Cayman2015 | 10288 | 17-phenyl trinor Prostaglandin A2 | 10 mg | 5376 |
Cayman2015 | 10288 | 17-phenyl trinor Prostaglandin A2 | 5 mg | 3024 |
Cayman2015 | 10290 | 17-phenyl trinor-13,14-dihydro Prostaglandin A2 | 1 mg | 826 |
Cayman2015 | 10290 | 17-phenyl trinor-13,14-dihydro Prostaglandin A2 | 10 mg | 6608 |
Cayman2015 | 10290 | 17-phenyl trinor-13,14-dihydro Prostaglandin A2 | 5 mg | 3724 |
Cayman2015 | 10295 | 19(R)-hydroxy Prostaglandin A2 | 100 μg | 1386 |
Cayman2015 | 10295 | 19(R)-hydroxy Prostaglandin A2 | 50 μg | 728 |
Cayman2015 | 10295 | 19(R)-hydroxy Prostaglandin A2 | 500 μg | 5824 |
Cayman2015 | 10303 | NAPE-PLD Blocking Peptide (aa 159-172) | 1 ea | 1498 |
Cayman2015 | 10304 | NAPE-PLD Blocking Peptide (aa 6-20) | 1 ea | 1498 |
Cayman2015 | 10305 | NAPE-PLD Polyclonal Antibody (aa 159-172) | 1 ea | 2982 |
Cayman2015 | 10306 | NAPE-PLD Polyclonal Antibody (aa 6-20) | 1 ea | 2982 |
Cayman2015 | 10310 | Prostaglandin A3 | 100 μg | 3360 |
Cayman2015 | 10310 | Prostaglandin A3 | 25 μg | 1106 |
Cayman2015 | 10310 | Prostaglandin A3 | 50 μg | 1820 |
Cayman2015 | 10311 | (R)-(-)-Mellein | 10 mg | 1064 |
Cayman2015 | 10311 | (R)-(-)-Mellein | 100 mg | 7840 |
Cayman2015 | 10311 | (R)-(-)-Mellein | 5 mg | 560 |
Cayman2015 | 10311 | (R)-(-)-Mellein | 50 mg | 4480 |
Cayman2015 | 10312 | 8,12-iso-iPF2α-VI-1,5-lactone | 100 μg | 4732 |
Cayman2015 | 10312 | 8,12-iso-iPF2α-VI-1,5-lactone | 25 μg | 1316 |
Cayman2015 | 10312 | 8,12-iso-iPF2α-VI-1,5-lactone | 50 μg | 2506 |
Cayman2015 | 10315 | SIRT6 (human recombinant) | 100 μg | 4942 |
Cayman2015 | 10315 | SIRT6 (human recombinant) | 25 μg | 1372 |
Cayman2015 | 10315 | SIRT6 (human recombinant) | 50 μg | 2604 |
Cayman2015 | 10316 | SIRT7 (human recombinant) | 100 μg | 4942 |
Cayman2015 | 10316 | SIRT7 (human recombinant) | 25 μg | 1372 |
Cayman2015 | 10316 | SIRT7 (human recombinant) | 50 μg | 2604 |
Cayman2015 | 10317 | SIRT4 (human recombinant) | 100 μg | 4480 |
Cayman2015 | 10317 | SIRT4 (human recombinant) | 25 μg | 1246 |
Cayman2015 | 10317 | SIRT4 (human recombinant) | 50 μg | 2366 |
Cayman2015 | 10318 | SIRT5 (human recombinant) | 100 μg | 4942 |
Cayman2015 | 10318 | SIRT5 (human recombinant) | 25 μg | 1372 |
Cayman2015 | 10318 | SIRT5 (human recombinant) | 50 μg | 2604 |
Cayman2015 | 10319 | SET8 (human recombinant) | 100 μg | 4634 |
Cayman2015 | 10319 | SET8 (human recombinant) | 25 μg | 1288 |
Cayman2015 | 10319 | SET8 (human recombinant) | 50 μg | 2450 |
Cayman2015 | 10320 | SET7/9 (human recombinant) | 100 μg | 1652 |
Cayman2015 | 10320 | SET7/9 (human recombinant) | 50 μg | 868 |
Cayman2015 | 10320 | SET7/9 (human recombinant) | 500 μg | 6944 |
Cayman2015 | 10322 | TIM4 Monoclonal Antibody | 1 ea | 3206 |
Cayman2015 | 10325 | Chemokine-Like Receptor 1 Polyclonal Antibody | 1 ea | 3206 |
Cayman2015 | 10326 | Chemokine-Like Receptor 1 Blocking Peptide | 1 ea | 1498 |
Cayman2015 | 10329 | Cystathionine γ-Lyase (human recombinant) | 100 μg | 4984 |
Cayman2015 | 10329 | Cystathionine γ-Lyase (human recombinant) | 25 μg | 1386 |
Cayman2015 | 10329 | Cystathionine γ-Lyase (human recombinant) | 50 μg | 2632 |
Cayman2015 | 10335 | JMJD2D (human recombinant) | 100 μg | 4536 |
Cayman2015 | 10335 | JMJD2D (human recombinant) | 25 μg | 1260 |
Cayman2015 | 10335 | JMJD2D (human recombinant) | 50 μg | 2394 |
Cayman2015 | 10336 | JMJD2A (human recombinant) | 100 μg | 4634 |
Cayman2015 | 10336 | JMJD2A (human recombinant) | 25 μg | 1288 |
Cayman2015 | 10336 | JMJD2A (human recombinant) | 50 μg | 2450 |
Cayman2015 | 10337 | AdPLA2 Polyclonal Antibody | 1 ea | 3780 |
Cayman2015 | 10338 | AdPLA2 Blocking Peptide | 1 ea | 1498 |
Cayman2015 | 10339 | CD25 Monoclonal PE Antibody (Clone 143-13) | 1 ea | 3346 |
Cayman2015 | 10340 | Griffithsin | 100 μg | 4634 |
Cayman2015 | 10340 | Griffithsin | 25 μg | 1288 |
Cayman2015 | 10340 | Griffithsin | 50 μg | 2450 |
Cayman2015 | 10341 | 12-Lipoxygenase (plaet-type, mouse recombinant) | 10 μg | 1876 |
Cayman2015 | 10341 | 12-Lipoxygenase (plaet-type, mouse recombinant) | 25 μg | 4228 |
Cayman2015 | 10341 | 12-Lipoxygenase (plaet-type, mouse recombinant) | 50 μg | 7504 |
Cayman2015 | 10342 | Hsp90β (human recombinant) | 100 μg | 3332 |
Cayman2015 | 10342 | Hsp90β (human recombinant) | 25 μg | 924 |
Cayman2015 | 10342 | Hsp90β (human recombinant) | 50 μg | 1750 |
Cayman2015 | 10343 | IgG1 Isotype Control FITC Monoclonal Antibody (Clone MOPC-21) | 100 test | 1610 |
Cayman2015 | 10345 | GPR17 (C-Term) Blocking Peptide | 1 ea | 1498 |
Cayman2015 | 10347 | HIF-1α Monoclonal Antibody (Clone H1α67) | 1 ea | 3206 |
Cayman2015 | 10348 | Sphingosine Kinase 1 (human recombinant) | 10 μg | 1848 |
Cayman2015 | 10348 | Sphingosine Kinase 1 (human recombinant) | 25 μg | 4396 |
Cayman2015 | 10348 | Sphingosine Kinase 1 (human recombinant) | 50 μg | 8316 |
Cayman2015 | 10349 | Cytokeratin Monoclonal FITC Antibody (Clone C-11) | 1 ea | 3416 |
Cayman2015 | 10350 | PRMT1 (human recombinant) | 100 μg | 3332 |
Cayman2015 | 10350 | PRMT1 (human recombinant) | 25 μg | 924 |
Cayman2015 | 10350 | PRMT1 (human recombinant) | 50 μg | 1750 |
Cayman2015 | 10352 | Formaldehyde Dehydrogenase (P. putida recombinant) | 100 μg | 4984 |
Cayman2015 | 10352 | Formaldehyde Dehydrogenase (P. putida recombinant) | 25 μg | 1386 |
Cayman2015 | 10352 | Formaldehyde Dehydrogenase (P. putida recombinant) | 50 μg | 2632 |
Cayman2015 | 10353 | G9a (human recombinant) | 100 μg | 8568 |
Cayman2015 | 10353 | G9a (human recombinant) | 25 μg | 2380 |
Cayman2015 | 10353 | G9a (human recombinant) | 50 μg | 4522 |
Cayman2015 | 10354 | Dot1L (human recombinant) | 100 μg | 7308 |
Cayman2015 | 10354 | Dot1L (human recombinant) | 25 μg | 2030 |
Cayman2015 | 10354 | Dot1L (human recombinant) | 50 μg | 3864 |
Cayman2015 | 10380 | Histone H4 Peptide Substrate (15-24) | 1 ea | 854 |
Cayman2015 | 10380 | Histone H4 Peptide Substrate (15-24) | 5 ea | 3416 |
Cayman2015 | 10381 | Adropin Polyclonal Antibody | 1 ea | 3206 |
Cayman2015 | 10382 | JMJD2A Polyclonal Antibody | 1 ea | 3010 |
Cayman2015 | 10383 | JMJD2D Polyclonal Antibody | 1 ea | 3206 |
Cayman2015 | 10384 | Prostaglandin E2 isopropyl ester | 1 mg | 630 |
Cayman2015 | 10384 | Prostaglandin E2 isopropyl ester | 10 mg | 5040 |
Cayman2015 | 10384 | Prostaglandin E2 isopropyl ester | 5 mg | 2842 |
Cayman2015 | 10385 | 1'-Hydroxymidazolam | 10 mg | 5320 |
Cayman2015 | 10385 | 1'-Hydroxymidazolam | 25 mg | 12600 |
Cayman2015 | 10385 | 1'-Hydroxymidazolam | 5 mg | 2800 |
Cayman2015 | 10386 | 1'-Hydroxymidazolam β-D-Glucuronide | 1 mg | 4900 |
Cayman2015 | 10386 | 1'-Hydroxymidazolam β-D-Glucuronide | 10 mg | 39200 |
Cayman2015 | 10386 | 1'-Hydroxymidazolam β-D-Glucuronide | 5 mg | 22060 |
Cayman2015 | 10387 | Naringenin-4'-O-β-D-Glucuronide | 1 mg | 17980 |
Cayman2015 | 10387 | Naringenin-4'-O-β-D-Glucuronide | 100 μg | 2500 |
Cayman2015 | 10387 | Naringenin-4'-O-β-D-Glucuronide | 500 μg | 9980 |
Cayman2015 | 10388 | Naringenin-7-O-β-D-Glucuronide | 1 mg | 2500 |
Cayman2015 | 10388 | Naringenin-7-O-β-D-Glucuronide | 10 mg | 17980 |
Cayman2015 | 10388 | Naringenin-7-O-β-D-Glucuronide | 5 mg | 9980 |
Cayman2015 | 10393 | Butylone (hydrochloride) | 10 mg | 1638 |
Cayman2015 | 10393 | Butylone (hydrochloride) | 5 mg | 910 |
Cayman2015 | 10393 | Butylone (hydrochloride) | 50 mg | 6146 |
Cayman2015 | 10395 | 2C-E (hydrochloride) | 10 mg | 952 |
Cayman2015 | 10395 | 2C-E (hydrochloride) | 5 mg | 616 |
Cayman2015 | 10395 | 2C-E (hydrochloride) | 50 mg | 3696 |
Cayman2015 | 10397 | 3-amino Benzamide | 1 g | 532 |
Cayman2015 | 10397 | 3-amino Benzamide | 5 g | 2520 |
Cayman2015 | 10397 | 3-amino Benzamide | 500 mg | 280 |
Cayman2015 | 10398 | TG003 | 1 mg | 252 |
Cayman2015 | 10398 | TG003 | 10 mg | 2016 |
Cayman2015 | 10398 | TG003 | 25 mg | 4410 |
Cayman2015 | 10398 | TG003 | 5 mg | 1134 |
Cayman2015 | 10437 | 3',4'-methylenedioxy-α-Pyrrolidinobutiophenone (hydrochloride) | 10 mg | 1302 |
Cayman2015 | 10437 | 3',4'-methylenedioxy-α-Pyrrolidinobutiophenone (hydrochloride) | 5 mg | 686 |
Cayman2015 | 10437 | 3',4'-methylenedioxy-α-Pyrrolidinobutiophenone (hydrochloride) | 50 mg | 3850 |
Cayman2015 | 10439 | 3',4'-methylenedioxy-α-Pyrrolidinopropiophenone (hydrochloride) | 10 mg | 1638 |
Cayman2015 | 10439 | 3',4'-methylenedioxy-α-Pyrrolidinopropiophenone (hydrochloride) | 5 mg | 910 |
Cayman2015 | 10439 | 3',4'-methylenedioxy-α-Pyrrolidinopropiophenone (hydrochloride) | 50 mg | 6146 |
Cayman2015 | 10443 | SB 939 | 1 mg | 490 |
Cayman2015 | 10443 | SB 939 | 10 mg | 2940 |
Cayman2015 | 10443 | SB 939 | 25 mg | 6734 |
Cayman2015 | 10443 | SB 939 | 5 mg | 1596 |
Cayman2015 | 10444 | PCI 34051 | 10 mg | 1568 |
Cayman2015 | 10444 | PCI 34051 | 100 mg | 11564 |
Cayman2015 | 10444 | PCI 34051 | 5 mg | 826 |
Cayman2015 | 10444 | PCI 34051 | 50 mg | 6608 |
Cayman2015 | 10445 | α-Pyrrolidinopropiophenone (hydrochloride) | 10 mg | 1638 |
Cayman2015 | 10445 | α-Pyrrolidinopropiophenone (hydrochloride) | 5 mg | 910 |
Cayman2015 | 10445 | α-Pyrrolidinopropiophenone (hydrochloride) | 50 mg | 6146 |
Cayman2015 | 10446 | 4'-methyl-α-Pyrrolidinopropiophenone (hydrochloride) | 10 mg | 1638 |
Cayman2015 | 10446 | 4'-methyl-α-Pyrrolidinopropiophenone (hydrochloride) | 5 mg | 910 |
Cayman2015 | 10446 | 4'-methyl-α-Pyrrolidinopropiophenone (hydrochloride) | 50 mg | 6146 |
Cayman2015 | 10448 | 4'-methyl-α-Pyrrolidinohexanophenone (hydrochloride) | 10 mg | 1638 |
Cayman2015 | 10448 | 4'-methyl-α-Pyrrolidinohexanophenone (hydrochloride) | 5 mg | 910 |
Cayman2015 | 10448 | 4'-methyl-α-Pyrrolidinohexanophenone (hydrochloride) | 50 mg | 6146 |
Cayman2015 | 10449 | 4'-methoxy-α-Pyrrolidinopropiophenone (tosylate) | 10 mg | 1638 |
Cayman2015 | 10449 | 4'-methoxy-α-Pyrrolidinopropiophenone (tosylate) | 5 mg | 910 |
Cayman2015 | 10449 | 4'-methoxy-α-Pyrrolidinopropiophenone (tosylate) | 50 mg | 6146 |
Cayman2015 | 10458 | Dihomo-γ-Linolenic Acid-d6 | 1 mg | 1750 |
Cayman2015 | 10458 | Dihomo-γ-Linolenic Acid-d6 | 100 μg | 350 |
Cayman2015 | 10458 | Dihomo-γ-Linolenic Acid-d6 | 5 mg | 2982 |
Cayman2015 | 10458 | Dihomo-γ-Linolenic Acid-d6 | 500 μg | 966 |
Cayman2015 | 10459 | PKC 412 | 1 mg | 1120 |
Cayman2015 | 10459 | PKC 412 | 10 mg | 6720 |
Cayman2015 | 10459 | PKC 412 | 25 mg | 13440 |
Cayman2015 | 10459 | PKC 412 | 5 mg | 4480 |
Cayman2015 | 10460 | Doramapimod | 1 mg | 238 |
Cayman2015 | 10460 | Doramapimod | 10 mg | 1904 |
Cayman2015 | 10460 | Doramapimod | 25 mg | 4172 |
Cayman2015 | 10460 | Doramapimod | 5 mg | 1078 |
Cayman2015 | 10461 | Paclitaxel | 100 mg | 2450 |
Cayman2015 | 10461 | Paclitaxel | 25 mg | 1232 |
Cayman2015 | 10461 | Paclitaxel | 5 mg | 350 |
Cayman2015 | 10461 | Paclitaxel | 50 mg | 1932 |
Cayman2015 | 10462 | 11(12)-EpETE | 100 μg | 1918 |
Cayman2015 | 10462 | 11(12)-EpETE | 25 μg | 532 |
Cayman2015 | 10462 | 11(12)-EpETE | 50 μg | 1008 |
Cayman2015 | 10462 | 11(12)-EpETE | 500 μg | 8512 |
Cayman2015 | 10467 | 5,6-DiHETE | 100 μg | 3836 |
Cayman2015 | 10467 | 5,6-DiHETE | 25 μg | 1064 |
Cayman2015 | 10467 | 5,6-DiHETE | 50 μg | 2016 |
Cayman2015 | 10470 | 8(9)-EpETE | 100 μg | 1918 |
Cayman2015 | 10470 | 8(9)-EpETE | 25 μg | 532 |
Cayman2015 | 10470 | 8(9)-EpETE | 50 μg | 1008 |
Cayman2015 | 10470 | 8(9)-EpETE | 500 μg | 8512 |
Cayman2015 | 10477 | EP2 Receptor Polyclonal PE Antibody | 1 ea | 4130 |
Cayman2015 | 10478 | Cytokeratin Monoclonal PE Antibody (Clone C-11) | 1 ea | 3416 |
Cayman2015 | 10479 | EP4 Receptor (C-Term) Polyclonal PE Antibody | 1 ea | 3542 |
Cayman2015 | 10483 | Erlotinib | 1 g | 1064 |
Cayman2015 | 10483 | Erlotinib | 250 mg | 294 |
Cayman2015 | 10483 | Erlotinib | 5 g | 4704 |
Cayman2015 | 10483 | Erlotinib | 500 mg | 560 |
Cayman2015 | 10486 | JWH 007-d9 | 1 mg | 1736 |
Cayman2015 | 10486 | JWH 007-d9 | 500 μg | 910 |
Cayman2015 | 10487 | Capecitabine | 1 g | 1008 |
Cayman2015 | 10487 | Capecitabine | 5 g | 4256 |
Cayman2015 | 10487 | Capecitabine | 500 mg | 532 |
Cayman2015 | 10488 | Bupropion (hydrochloride) | 10 mg | 490 |
Cayman2015 | 10488 | Bupropion (hydrochloride) | 5 mg | 350 |
Cayman2015 | 10488 | Bupropion (hydrochloride) | 50 mg | 882 |
Cayman2015 | 10489 | Candesartan cilexetil | 1 g | 1596 |
Cayman2015 | 10489 | Candesartan cilexetil | 10 g | 11760 |
Cayman2015 | 10489 | Candesartan cilexetil | 5 g | 6720 |
Cayman2015 | 10489 | Candesartan cilexetil | 500 mg | 840 |
Cayman2015 | 10490 | (S)-AM1241 | 1 mg | 700 |
Cayman2015 | 10490 | (S)-AM1241 | 10 mg | 5600 |
Cayman2015 | 10490 | (S)-AM1241 | 25 mg | 12250 |
Cayman2015 | 10490 | (S)-AM1241 | 5 mg | 3150 |
Cayman2015 | 10491 | (R)-AM1241 | 1 mg | 700 |
Cayman2015 | 10491 | (R)-AM1241 | 10 mg | 5600 |
Cayman2015 | 10491 | (R)-AM1241 | 25 mg | 12250 |
Cayman2015 | 10491 | (R)-AM1241 | 5 mg | 3150 |
Cayman2015 | 10493 | Atorvastatin (calcium salt) | 10 mg | 322 |
Cayman2015 | 10493 | Atorvastatin (calcium salt) | 25 mg | 756 |
Cayman2015 | 10493 | Atorvastatin (calcium salt) | 5 mg | 168 |
Cayman2015 | 10493 | Atorvastatin (calcium salt) | 50 mg | 1344 |
Cayman2015 | 10495 | 4-iodo-SAHA | 100 mg | 1918 |
Cayman2015 | 10495 | 4-iodo-SAHA | 250 mg | 4536 |
Cayman2015 | 10495 | 4-iodo-SAHA | 50 mg | 1008 |
Cayman2015 | 10495 | 4-iodo-SAHA | 500 mg | 8064 |
Cayman2015 | 10496 | Sulforaphane | 10 mg | 882 |
Cayman2015 | 10496 | Sulforaphane | 25 mg | 2086 |
Cayman2015 | 10496 | Sulforaphane | 5 mg | 462 |
Cayman2015 | 10497 | CAY10632 | 100 μg | 4942 |
Cayman2015 | 10497 | CAY10632 | 25 μg | 1372 |
Cayman2015 | 10497 | CAY10632 | 50 μg | 2604 |
Cayman2015 | 10500 | PAD4 (human recombinant) | 100 μg | 3836 |
Cayman2015 | 10500 | PAD4 (human recombinant) | 250 μg | 9072 |
Cayman2015 | 10500 | PAD4 (human recombinant) | 50 μg | 2016 |
Cayman2015 | 10501 | Prostaglandin Screening Library I (96-Well) | 100 μL | 21322 |
Cayman2015 | 10501 | Prostaglandin Screening Library I (96-Well) | 200 μL | 38374 |
Cayman2015 | 10501 | Prostaglandin Screening Library I (96-Well) | 50 μL | 13510 |
Cayman2015 | 10502 | Prostaglandin Screening Library II (96-Well) | 100 μL | 21322 |
Cayman2015 | 10502 | Prostaglandin Screening Library II (96-Well) | 200 μL | 38374 |
Cayman2015 | 10502 | Prostaglandin Screening Library II (96-Well) | 50 μL | 13510 |
Cayman2015 | 10503 | Prostaglandin Screening Library III (96-Well) | 100 μL | 21322 |
Cayman2015 | 10503 | Prostaglandin Screening Library III (96-Well) | 200 μL | 38374 |
Cayman2015 | 10503 | Prostaglandin Screening Library III (96-Well) | 50 μL | 13510 |
Cayman2015 | 10504 | Fatty Acid Screening Library (96-Well) | 100 μL | 30702 |
Cayman2015 | 10504 | Fatty Acid Screening Library (96-Well) | 200 μL | 54572 |
Cayman2015 | 10504 | Fatty Acid Screening Library (96-Well) | 50 μL | 17052 |
Cayman2015 | 10505 | Kinase Screening Library (96-Well) | 100 μL | 13510 |
Cayman2015 | 10506 | Bio-active Lipid I Screening Library (96-Well) | 100 μL | 135002 |
Cayman2015 | 10506 | Bio-active Lipid I Screening Library (96-Well) | 500 μL | 404992 |
Cayman2015 | 10507 | Bio-active Lipid II Screening Library (96-Well) | 100 μL | 51156 |
Cayman2015 | 10510 | JWH 210-d9 | 1 mg | 1736 |
Cayman2015 | 10510 | JWH 210-d9 | 500 μg | 910 |
Cayman2015 | 10511 | JWH 081-d9 | 1 mg | 1736 |
Cayman2015 | 10511 | JWH 081-d9 | 500 μg | 910 |
Cayman2015 | 10512 | JWH 122-d9 | 1 mg | 1736 |
Cayman2015 | 10512 | JWH 122-d9 | 500 μg | 910 |
Cayman2015 | 10513 | RCS-4-d9 | 1 mg | 938 |
Cayman2015 | 10513 | RCS-4-d9 | 5 mg | 3920 |
Cayman2015 | 10513 | RCS-4-d9 | 500 μg | 490 |
Cayman2015 | 10514 | JWH 398-d9 | 1 mg | 1736 |
Cayman2015 | 10514 | JWH 398-d9 | 500 μg | 910 |
Cayman2015 | 10515 | 3,4-DHMA (trifluoroacetate salt) | 10 mg | 938 |
Cayman2015 | 10515 | 3,4-DHMA (trifluoroacetate salt) | 5 mg | 490 |
Cayman2015 | 10515 | 3,4-DHMA (trifluoroacetate salt) | 50 mg | 3920 |
Cayman2015 | 10517 | Naphyrone (hydrochloride) | 1 mg | 686 |
Cayman2015 | 10517 | Naphyrone (hydrochloride) | 10 mg | 3430 |
Cayman2015 | 10517 | Naphyrone (hydrochloride) | 5 mg | 1890 |
Cayman2015 | 10518 | 3,4-Methylenedioxy Pyrovalerone metabolite 1 (hydrochloride) | 1 mg | 1330 |
Cayman2015 | 10518 | 3,4-Methylenedioxy Pyrovalerone metabolite 1 (hydrochloride) | 10 mg | 4900 |
Cayman2015 | 10518 | 3,4-Methylenedioxy Pyrovalerone metabolite 1 (hydrochloride) | 5 mg | 3150 |
Cayman2015 | 10521 | JWH 018 N-(5-chloropentyl) analog | 1 mg | 910 |
Cayman2015 | 10521 | JWH 018 N-(5-chloropentyl) analog | 10 mg | 7280 |
Cayman2015 | 10521 | JWH 018 N-(5-chloropentyl) analog | 5 mg | 4102 |
Cayman2015 | 10522 | Thapsigargin | 1 mg | 825 |
Cayman2015 | 10522 | Thapsigargin | 5 mg | 3300 |
Cayman2015 | 10523 | Sirtinol | 1 mg | 350 |
Cayman2015 | 10523 | Sirtinol | 10 mg | 1582 |
Cayman2015 | 10523 | Sirtinol | 5 mg | 966 |
Cayman2015 | 10524 | Paprotrain | 1 mg | 1470 |
Cayman2015 | 10525 | PK 11195 | 10 mg | 735 |
Cayman2015 | 10525 | PK 11195 | 50 mg | 3300 |
Cayman2015 | 10527 | Necrostatin-5 | 25 mg | 2370 |
Cayman2015 | 10527 | Necrostatin-5 | 5 mg | 525 |
Cayman2015 | 10528 | Necrostatin-7 | 25 mg | 4875 |
Cayman2015 | 10528 | Necrostatin-7 | 5 mg | 1230 |
Cayman2015 | 10529 | Methedrone (hydrochloride) | 10 mg | 1302 |
Cayman2015 | 10529 | Methedrone (hydrochloride) | 5 mg | 686 |
Cayman2015 | 10529 | Methedrone (hydrochloride) | 50 mg | 5488 |
Cayman2015 | 10530 | Histone H3 Trimethyl Lys9 Peptide | 1 mg | 2142 |
Cayman2015 | 10532 | BayCysLT2 | 1 mg | 602 |
Cayman2015 | 10532 | BayCysLT2 | 10 mg | 4816 |
Cayman2015 | 10532 | BayCysLT2 | 25 mg | 10542 |
Cayman2015 | 10532 | BayCysLT2 | 5 mg | 2716 |
Cayman2015 | 10534 | (R)-Bromoenol lactone-d7 | 1 mg | 3248 |
Cayman2015 | 10534 | (R)-Bromoenol lactone-d7 | 100 μg | 406 |
Cayman2015 | 10534 | (R)-Bromoenol lactone-d7 | 500 μg | 1834 |
Cayman2015 | 10535 | (S)-Bromoenol lactone-d7 | 1 mg | 3248 |
Cayman2015 | 10535 | (S)-Bromoenol lactone-d7 | 100 μg | 406 |
Cayman2015 | 10535 | (S)-Bromoenol lactone-d7 | 500 μg | 1834 |
Cayman2015 | 10538 | Arachidonic Acid Alkyne | 1 mg | 11970 |
Cayman2015 | 10538 | Arachidonic Acid Alkyne | 100 μg | 1330 |
Cayman2015 | 10538 | Arachidonic Acid Alkyne | 500 μg | 6314 |
Cayman2015 | 10539 | Tetratriaconta-16(Z),19(Z),22(Z),25(Z),28(Z),31(Z)-hexaenoic Acid | 100 μg | 4942 |
Cayman2015 | 10539 | Tetratriaconta-16(Z),19(Z),22(Z),25(Z),28(Z),31(Z)-hexaenoic Acid | 25 μg | 1372 |
Cayman2015 | 10539 | Tetratriaconta-16(Z),19(Z),22(Z),25(Z),28(Z),31(Z)-hexaenoic Acid | 50 μg | 2604 |
Cayman2015 | 10546 | 7(S),17(S)-dihydroxy-8(E),10(Z),13(Z),15(E),19(Z)-Docosapentaenoic Acid | 100 μg | 1820 |
Cayman2015 | 10546 | 7(S),17(S)-dihydroxy-8(E),10(Z),13(Z),15(E),19(Z)-Docosapentaenoic Acid | 25 μg | 504 |
Cayman2015 | 10546 | 7(S),17(S)-dihydroxy-8(E),10(Z),13(Z),15(E),19(Z)-Docosapentaenoic Acid | 50 μg | 952 |
Cayman2015 | 10547 | 4-pentynoyl-Coenzyme A (trifluoroacetate salt) | 1 mg | 1596 |
Cayman2015 | 10547 | 4-pentynoyl-Coenzyme A (trifluoroacetate salt) | 10 mg | 11760 |
Cayman2015 | 10547 | 4-pentynoyl-Coenzyme A (trifluoroacetate salt) | 5 mg | 6720 |
Cayman2015 | 10547 | 4-pentynoyl-Coenzyme A (trifluoroacetate salt) | 500 μg | 840 |
Cayman2015 | 10549 | C646 | 1 mg | 435 |
Cayman2015 | 10549 | C646 | 10 mg | 2085 |
Cayman2015 | 10549 | C646 | 5 mg | 1260 |
Cayman2015 | 10550 | 4-biphenylthio Carboxamide | 1 g | 3136 |
Cayman2015 | 10550 | 4-biphenylthio Carboxamide | 100 mg | 392 |
Cayman2015 | 10550 | 4-biphenylthio Carboxamide | 250 mg | 938 |
Cayman2015 | 10550 | 4-biphenylthio Carboxamide | 500 mg | 1764 |
Cayman2015 | 10551 | Pyrazine-2-thio Carboxamide | 1 g | 1792 |
Cayman2015 | 10551 | Pyrazine-2-thio Carboxamide | 100 mg | 224 |
Cayman2015 | 10551 | Pyrazine-2-thio Carboxamide | 250 mg | 532 |
Cayman2015 | 10551 | Pyrazine-2-thio Carboxamide | 500 mg | 1008 |
Cayman2015 | 10552 | 4-methoxythio Benzamide | 1 g | 420 |
Cayman2015 | 10552 | 4-methoxythio Benzamide | 5 g | 1792 |
Cayman2015 | 10552 | 4-methoxythio Benzamide | 500 mg | 224 |
Cayman2015 | 10553 | 3-methoxythio Benzamide | 1 g | 392 |
Cayman2015 | 10553 | 3-methoxythio Benzamide | 5 g | 1246 |
Cayman2015 | 10553 | 3-methoxythio Benzamide | 500 mg | 210 |
Cayman2015 | 10554 | NG-amino-L-Arginine (hydrochloride) | 10 mg | 1092 |
Cayman2015 | 10554 | NG-amino-L-Arginine (hydrochloride) | 25 mg | 2590 |
Cayman2015 | 10554 | NG-amino-L-Arginine (hydrochloride) | 5 mg | 574 |
Cayman2015 | 10554 | NG-amino-L-Arginine (hydrochloride) | 50 mg | 4592 |
Cayman2015 | 10556 | 7-hydroxycoumarinyl-γ-Linolenate | 10 mg | 742 |
Cayman2015 | 10556 | 7-hydroxycoumarinyl-γ-Linolenate | 25 mg | 1764 |
Cayman2015 | 10556 | 7-hydroxycoumarinyl-γ-Linolenate | 5 mg | 392 |
Cayman2015 | 10556 | 7-hydroxycoumarinyl-γ-Linolenate | 50 mg | 3136 |
Cayman2015 | 10557 | 9-Nitrooleate-d17 | 1 mg | 8092 |
Cayman2015 | 10557 | 9-Nitrooleate-d17 | 100 μg | 1092 |
Cayman2015 | 10557 | 9-Nitrooleate-d17 | 50 μg | 686 |
Cayman2015 | 10557 | 9-Nitrooleate-d17 | 500 μg | 4592 |
Cayman2015 | 10558 | 10-Nitrooleate-d17 | 1 mg | 8092 |
Cayman2015 | 10558 | 10-Nitrooleate-d17 | 100 μg | 1092 |
Cayman2015 | 10558 | 10-Nitrooleate-d17 | 50 μg | 686 |
Cayman2015 | 10558 | 10-Nitrooleate-d17 | 500 μg | 4592 |
Cayman2015 | 10559 | Tubastatin A (trifluoroacetate salt) | 1 mg | 350 |
Cayman2015 | 10559 | Tubastatin A (trifluoroacetate salt) | 10 mg | 1582 |
Cayman2015 | 10559 | Tubastatin A (trifluoroacetate salt) | 5 mg | 1050 |
Cayman2015 | 10562 | CAY10631 | 1 mg | 1596 |
Cayman2015 | 10562 | CAY10631 | 10 mg | 11760 |
Cayman2015 | 10562 | CAY10631 | 5 mg | 6720 |
Cayman2015 | 10562 | CAY10631 | 500 μg | 840 |
Cayman2015 | 10563 | MDA 19 | 1 mg | 350 |
Cayman2015 | 10563 | MDA 19 | 10 mg | 2100 |
Cayman2015 | 10563 | MDA 19 | 5 mg | 1484 |
Cayman2015 | 10563 | MDA 19 | 50 mg | 7882 |
Cayman2015 | 10565 | NVP-BEZ235 | 100 mg | 1820 |
Cayman2015 | 10565 | NVP-BEZ235 | 25 mg | 504 |
Cayman2015 | 10565 | NVP-BEZ235 | 250 mg | 4032 |
Cayman2015 | 10565 | NVP-BEZ235 | 50 mg | 952 |
Cayman2015 | 10566 | Garcinol | 1 mg | 168 |
Cayman2015 | 10566 | Garcinol | 10 mg | 1106 |
Cayman2015 | 10566 | Garcinol | 25 mg | 2660 |
Cayman2015 | 10566 | Garcinol | 5 mg | 686 |
Cayman2015 | 10567 | AM694 | 10 mg | 1484 |
Cayman2015 | 10567 | AM694 | 25 mg | 3528 |
Cayman2015 | 10567 | AM694 | 5 mg | 784 |
Cayman2015 | 10568 | Cytokeratin Monoclonal APC Antibody (Clone C-11) | 1 ea | 4130 |
Cayman2015 | 10569 | Ellagic Acid | 1 g | 1176 |
Cayman2015 | 10569 | Ellagic Acid | 100 mg | 196 |
Cayman2015 | 10569 | Ellagic Acid | 500 mg | 784 |
Cayman2015 | 10570 | Heneicosapentaenoic Acid-d6 | 100 μg | 3276 |
Cayman2015 | 10570 | Heneicosapentaenoic Acid-d6 | 25 μg | 910 |
Cayman2015 | 10570 | Heneicosapentaenoic Acid-d6 | 50 μg | 1736 |
Cayman2015 | 10572 | Scriptaid | 1 mg | 490 |
Cayman2015 | 10572 | Scriptaid | 10 mg | 2702 |
Cayman2015 | 10572 | Scriptaid | 5 mg | 1596 |
Cayman2015 | 10574 | Suberohydroxamic Acid | 1 g | 2352 |
Cayman2015 | 10574 | Suberohydroxamic Acid | 100 mg | 294 |
Cayman2015 | 10574 | Suberohydroxamic Acid | 250 mg | 700 |
Cayman2015 | 10574 | Suberohydroxamic Acid | 500 mg | 1330 |
Cayman2015 | 10575 | Apicidin | 1 mg | 588 |
Cayman2015 | 10575 | Apicidin | 10 mg | 4704 |
Cayman2015 | 10575 | Apicidin | 5 mg | 2646 |
Cayman2015 | 10576 | HC Toxin | 1 mg | 1960 |
Cayman2015 | 10576 | HC Toxin | 500 μg | 952 |
Cayman2015 | 10578 | JWH 251 | 10 mg | 1484 |
Cayman2015 | 10578 | JWH 251 | 25 mg | 3528 |
Cayman2015 | 10578 | JWH 251 | 5 mg | 784 |
Cayman2015 | 10579 | JWH 081 | 10 mg | 1246 |
Cayman2015 | 10579 | JWH 081 | 25 mg | 3094 |
Cayman2015 | 10579 | JWH 081 | 5 mg | 686 |
Cayman2015 | 10580 | HAMI3379 | 1 mg | 602 |
Cayman2015 | 10580 | HAMI3379 | 10 mg | 4816 |
Cayman2015 | 10580 | HAMI3379 | 25 mg | 10542 |
Cayman2015 | 10580 | HAMI3379 | 5 mg | 2716 |
Cayman2015 | 10581 | Prostaglandin E2-d9 | 100 μg | 1358 |
Cayman2015 | 10581 | Prostaglandin E2-d9 | 250 μg | 3220 |
Cayman2015 | 10581 | Prostaglandin E2-d9 | 50 μg | 714 |
Cayman2015 | 10581 | Prostaglandin E2-d9 | 500 μg | 5712 |
Cayman2015 | 10582 | UNC0321 (trifluoroacetate salt) | 1 mg | 532 |
Cayman2015 | 10582 | UNC0321 (trifluoroacetate salt) | 10 mg | 2352 |
Cayman2015 | 10582 | UNC0321 (trifluoroacetate salt) | 5 mg | 1512 |
Cayman2015 | 10582 | UNC0321 (trifluoroacetate salt) | 50 mg | 10920 |
Cayman2015 | 10584 | (-)-Neplanocin A | 1 mg | 5880 |
Cayman2015 | 10584 | (-)-Neplanocin A | 5 mg | 24192 |
Cayman2015 | 10584 | (-)-Neplanocin A | 500 μg | 3094 |
Cayman2015 | 10591 | JWH 122 | 10 mg | 1246 |
Cayman2015 | 10591 | JWH 122 | 25 mg | 3094 |
Cayman2015 | 10591 | JWH 122 | 5 mg | 686 |
Cayman2015 | 10599 | Cl-Amidine (trifluoroacetate salt) | 1 mg | 868 |
Cayman2015 | 10599 | Cl-Amidine (trifluoroacetate salt) | 10 mg | 6650 |
Cayman2015 | 10599 | Cl-Amidine (trifluoroacetate salt) | 5 mg | 3906 |
Cayman2015 | 10600 | GABAA Receptor δ-subunit (N-Term) Polyclonal Antibody | 1 ea | 6500 |
Cayman2015 | 10601 | GluR1 (Phospho-Ser845) Polyclonal Antibody | 1 ea | 6500 |
Cayman2015 | 10602 | GluR1 (Phospho-Ser831) Polyclonal Antibody | 1 ea | 6500 |
Cayman2015 | 10603 | DARPP-32 (Phospho-Thr34) Polyclonal Antibody | 1 ea | 6300 |
Cayman2015 | 10604 | Tyrosine Hydroxylase Polyclonal Antibody | 1 ea | 6500 |
Cayman2015 | 10605 | Synapsin I Polyclonal Antibody (neat serum) | 1 ea | 5500 |
Cayman2015 | 10606 | Synapsin I Polyclonal Antibody | 1 ea | 6500 |
Cayman2015 | 10607 | NMDA Receptor NR1 Subunit Monoclonal Antibody | 1 ea | 6500 |
Cayman2015 | 10608 | NMDA Receptor NR2A Subunit Polyclonal Antibody | 1 ea | 6300 |
Cayman2015 | 10609 | NMDA Receptor NR2B Subunit Polyclonal Antibody | 1 ea | 6500 |
Cayman2015 | 10610 | F-Amidine (trifluoroacetate salt) | 1 mg | 2800 |
Cayman2015 | 10610 | F-Amidine (trifluoroacetate salt) | 100 μg | 350 |
Cayman2015 | 10610 | F-Amidine (trifluoroacetate salt) | 250 μg | 826 |
Cayman2015 | 10610 | F-Amidine (trifluoroacetate salt) | 500 μg | 1582 |
Cayman2015 | 10617 | IU1 | 10 mg | 798 |
Cayman2015 | 10617 | IU1 | 100 mg | 5880 |
Cayman2015 | 10617 | IU1 | 5 mg | 420 |
Cayman2015 | 10617 | IU1 | 50 mg | 3360 |
Cayman2015 | 10621 | Olaparib | 10 mg | 770 |
Cayman2015 | 10621 | Olaparib | 100 mg | 4368 |
Cayman2015 | 10621 | Olaparib | 25 mg | 1638 |
Cayman2015 | 10621 | Olaparib | 5 mg | 546 |
Cayman2015 | 10624 | 3,4-Methylenedioxy Pyrovalerone | 10 mg | 1638 |
Cayman2015 | 10624 | 3,4-Methylenedioxy Pyrovalerone | 5 mg | 910 |
Cayman2015 | 10624 | 3,4-Methylenedioxy Pyrovalerone | 50 mg | 6146 |
Cayman2015 | 10625 | StemRegenin 1 | 1 mg | 588 |
Cayman2015 | 10625 | StemRegenin 1 | 10 mg | 2058 |
Cayman2015 | 10625 | StemRegenin 1 | 5 mg | 1330 |
Cayman2015 | 10626 | AS-1269574 | 1 mg | 350 |
Cayman2015 | 10626 | AS-1269574 | 10 mg | 1330 |
Cayman2015 | 10626 | AS-1269574 | 25 mg | 2940 |
Cayman2015 | 10626 | AS-1269574 | 5 mg | 1050 |
Cayman2015 | 10627 | 4-hydroxy Nonenal Glutathione (trifluoroacetate salt) | 1 mg | 742 |
Cayman2015 | 10627 | 4-hydroxy Nonenal Glutathione (trifluoroacetate salt) | 10 mg | 5936 |
Cayman2015 | 10627 | 4-hydroxy Nonenal Glutathione (trifluoroacetate salt) | 25 mg | 12992 |
Cayman2015 | 10627 | 4-hydroxy Nonenal Glutathione (trifluoroacetate salt) | 5 mg | 3346 |
Cayman2015 | 10628 | EED (human recombinant) | 100 μg | 7714 |
Cayman2015 | 10628 | EED (human recombinant) | 25 μg | 2142 |
Cayman2015 | 10628 | EED (human recombinant) | 50 μg | 4074 |
Cayman2015 | 10631 | Ampkinone | 1 mg | 630 |
Cayman2015 | 10631 | Ampkinone | 10 mg | 4410 |
Cayman2015 | 10631 | Ampkinone | 5 mg | 2520 |
Cayman2015 | 10633 | JWH 073 2-hydroxyindole metabolite | 1 mg | 1330 |
Cayman2015 | 10633 | JWH 073 2-hydroxyindole metabolite | 10 mg | 4900 |
Cayman2015 | 10633 | JWH 073 2-hydroxyindole metabolite | 5 mg | 3150 |
Cayman2015 | 10636 | RCS-8 | 1 mg | 630 |
Cayman2015 | 10636 | RCS-8 | 10 mg | 1960 |
Cayman2015 | 10636 | RCS-8 | 5 mg | 1330 |
Cayman2015 | 10639 | MDA 77 | 1 mg | 350 |
Cayman2015 | 10639 | MDA 77 | 10 mg | 2100 |
Cayman2015 | 10639 | MDA 77 | 5 mg | 1484 |
Cayman2015 | 10639 | MDA 77 | 50 mg | 7882 |
Cayman2015 | 10640 | KM 233 | 1 mg | 700 |
Cayman2015 | 10640 | KM 233 | 10 mg | 5600 |
Cayman2015 | 10640 | KM 233 | 25 mg | 12250 |
Cayman2015 | 10640 | KM 233 | 5 mg | 3150 |
Cayman2015 | 10641 | JGB1741 | 1 mg | 714 |
Cayman2015 | 10641 | JGB1741 | 10 mg | 5712 |
Cayman2015 | 10641 | JGB1741 | 25 mg | 12502 |
Cayman2015 | 10641 | JGB1741 | 5 mg | 3220 |
Cayman2015 | 10642 | CAY10640 | 1 mg | 588 |
Cayman2015 | 10642 | CAY10640 | 10 mg | 3752 |
Cayman2015 | 10642 | CAY10640 | 5 mg | 2352 |
Cayman2015 | 10643 | JWH 182 | 1 mg | 490 |
Cayman2015 | 10643 | JWH 182 | 10 mg | 3500 |
Cayman2015 | 10643 | JWH 182 | 25 mg | 6930 |
Cayman2015 | 10643 | JWH 182 | 5 mg | 1960 |
Cayman2015 | 10644 | JWH 210 | 1 mg | 490 |
Cayman2015 | 10644 | JWH 210 | 10 mg | 2030 |
Cayman2015 | 10644 | JWH 210 | 25 mg | 4550 |
Cayman2015 | 10644 | JWH 210 | 5 mg | 1330 |
Cayman2015 | 10645 | RCS-4 | 1 mg | 490 |
Cayman2015 | 10645 | RCS-4 | 10 mg | 3920 |
Cayman2015 | 10645 | RCS-4 | 5 mg | 2142 |
Cayman2015 | 10649 | Niclosamide | 100 g | 1568 |
Cayman2015 | 10649 | Niclosamide | 25 g | 434 |
Cayman2015 | 10649 | Niclosamide | 250 g | 3472 |
Cayman2015 | 10649 | Niclosamide | 50 g | 826 |
Cayman2015 | 10653 | ent-Corey PG-Lactone Diol | 1 mg | 8512 |
Cayman2015 | 10653 | ent-Corey PG-Lactone Diol | 100 μg | 1064 |
Cayman2015 | 10653 | ent-Corey PG-Lactone Diol | 500 μg | 4788 |
Cayman2015 | 10658 | MLL1 (human recombinant) | 100 μg | 5026 |
Cayman2015 | 10658 | MLL1 (human recombinant) | 250 μg | 11886 |
Cayman2015 | 10658 | MLL1 (human recombinant) | 50 μg | 2646 |
Cayman2015 | 10660 | JWH 015-d7 | 1 mg | 1736 |
Cayman2015 | 10660 | JWH 015-d7 | 500 μg | 910 |
Cayman2015 | 10661 | JWH 250-d5 | 1 mg | 1708 |
Cayman2015 | 10661 | JWH 250-d5 | 5 mg | 6846 |
Cayman2015 | 10661 | JWH 250-d5 | 500 μg | 896 |
Cayman2015 | 10664 | Hormone-Sensitive Lipase (human recombinant) | 100 μg | 4984 |
Cayman2015 | 10664 | Hormone-Sensitive Lipase (human recombinant) | 25 μg | 1386 |
Cayman2015 | 10664 | Hormone-Sensitive Lipase (human recombinant) | 50 μg | 2632 |
Cayman2015 | 10670 | Heneicosapentaenoic Acid | 1 mg | 686 |
Cayman2015 | 10670 | Heneicosapentaenoic Acid | 10 mg | 5488 |
Cayman2015 | 10670 | Heneicosapentaenoic Acid | 25 mg | 10976 |
Cayman2015 | 10670 | Heneicosapentaenoic Acid | 5 mg | 3094 |
Cayman2015 | 10671 | coumarin-SAHA | 1 mg | 392 |
Cayman2015 | 10671 | coumarin-SAHA | 10 mg | 1512 |
Cayman2015 | 10671 | coumarin-SAHA | 25 mg | 2842 |
Cayman2015 | 10671 | coumarin-SAHA | 5 mg | 1008 |
Cayman2015 | 10674 | URB937 | 10 mg | 854 |
Cayman2015 | 10674 | URB937 | 100 mg | 6272 |
Cayman2015 | 10674 | URB937 | 5 mg | 448 |
Cayman2015 | 10674 | URB937 | 50 mg | 3584 |
Cayman2015 | 10675 | SAHA-BPyne | 100 μg | 2184 |
Cayman2015 | 10675 | SAHA-BPyne | 50 μg | 1148 |
Cayman2015 | 10675 | SAHA-BPyne | 500 μg | 9184 |
Cayman2015 | 10676 | I-BET762 | 1 mg | 350 |
Cayman2015 | 10676 | I-BET762 | 10 mg | 2450 |
Cayman2015 | 10676 | I-BET762 | 25 mg | 5684 |
Cayman2015 | 10676 | I-BET762 | 5 mg | 1316 |
Cayman2015 | 10679 | 3,4-Methylenedioxy Pyrovalerone-d8 (hydrochloride) | 1 mg | 910 |
Cayman2015 | 10679 | 3,4-Methylenedioxy Pyrovalerone-d8 (hydrochloride) | 10 mg | 3500 |
Cayman2015 | 10679 | 3,4-Methylenedioxy Pyrovalerone-d8 (hydrochloride) | 5 mg | 1820 |
Cayman2015 | 10680 | JWH 098 | 1 mg | 490 |
Cayman2015 | 10680 | JWH 098 | 10 mg | 2030 |
Cayman2015 | 10680 | JWH 098 | 25 mg | 4550 |
Cayman2015 | 10680 | JWH 098 | 5 mg | 1330 |
Cayman2015 | 10681 | C-16 Ceramide | 1 mg | 140 |
Cayman2015 | 10681 | C-16 Ceramide | 10 mg | 1120 |
Cayman2015 | 10681 | C-16 Ceramide | 25 mg | 2450 |
Cayman2015 | 10681 | C-16 Ceramide | 5 mg | 630 |
Cayman2015 | 10682 | JWH 200-d5 (exempt preparation) | 1 mg | 1708 |
Cayman2015 | 10682 | JWH 200-d5 (exempt preparation) | 5 mg | 6846 |
Cayman2015 | 10682 | JWH 200-d5 (exempt preparation) | 500 μg | 896 |
Cayman2015 | 10683 | SR 16584 | 1 mg | 364 |
Cayman2015 | 10683 | SR 16584 | 10 mg | 2240 |
Cayman2015 | 10683 | SR 16584 | 5 mg | 1638 |
Cayman2015 | 10683 | SR 16584 | 50 mg | 9786 |
Cayman2015 | 10684 | 3,4-Methylenedioxy Pyrovalerone (hydrochloride) | 10 mg | 1638 |
Cayman2015 | 10684 | 3,4-Methylenedioxy Pyrovalerone (hydrochloride) | 5 mg | 910 |
Cayman2015 | 10684 | 3,4-Methylenedioxy Pyrovalerone (hydrochloride) | 50 mg | 6146 |
Cayman2015 | 10685 | 9-oxo-10(E),12(E)-Octadecadienoic Acid | 1 mg | 1302 |
Cayman2015 | 10685 | 9-oxo-10(E),12(E)-Octadecadienoic Acid | 5 mg | 5488 |
Cayman2015 | 10685 | 9-oxo-10(E),12(E)-Octadecadienoic Acid | 500 μg | 686 |
Cayman2015 | 10686 | (±)-CP 47,497-C8-homolog-d7 (exempt preparation) | 1 mg | 9240 |
Cayman2015 | 10686 | (±)-CP 47,497-C8-homolog-d7 (exempt preparation) | 100 μg | 1540 |
Cayman2015 | 10686 | (±)-CP 47,497-C8-homolog-d7 (exempt preparation) | 500 μg | 6160 |
Cayman2015 | 10687 | (±)-CP 47,497-d11 (exempt preparation) | 1 mg | 9240 |
Cayman2015 | 10687 | (±)-CP 47,497-d11 (exempt preparation) | 100 μg | 1540 |
Cayman2015 | 10687 | (±)-CP 47,497-d11 (exempt preparation) | 500 μg | 6160 |
Cayman2015 | 10690 | JWH 018 N-(2-methylbutyl) isomer | 10 mg | 1484 |
Cayman2015 | 10690 | JWH 018 N-(2-methylbutyl) isomer | 25 mg | 3528 |
Cayman2015 | 10690 | JWH 018 N-(2-methylbutyl) isomer | 5 mg | 784 |
Cayman2015 | 10691 | JWH 018 N-(3-methylbutyl) isomer | 10 mg | 1484 |
Cayman2015 | 10691 | JWH 018 N-(3-methylbutyl) isomer | 25 mg | 3528 |
Cayman2015 | 10691 | JWH 018 N-(3-methylbutyl) isomer | 5 mg | 784 |
Cayman2015 | 10696 | dinor-12-oxo Phytodienoic Acid-d5 | 100 μg | 2982 |
Cayman2015 | 10696 | dinor-12-oxo Phytodienoic Acid-d5 | 50 μg | 1568 |
Cayman2015 | 10696 | dinor-12-oxo Phytodienoic Acid-d5 | 500 μg | 12544 |
Cayman2015 | 10697 | JWH 018 6-methoxyindole analog | 1 mg | 910 |
Cayman2015 | 10697 | JWH 018 6-methoxyindole analog | 10 mg | 7280 |
Cayman2015 | 10697 | JWH 018 6-methoxyindole analog | 5 mg | 4102 |
Cayman2015 | 10699 | HTS 01037 | 1 mg | 224 |
Cayman2015 | 10699 | HTS 01037 | 10 mg | 1792 |
Cayman2015 | 10699 | HTS 01037 | 25 mg | 3920 |
Cayman2015 | 10699 | HTS 01037 | 5 mg | 1008 |
Cayman2015 | 10703 | (±)-CP 55,940-d11 | 1 mg | 9240 |
Cayman2015 | 10703 | (±)-CP 55,940-d11 | 100 μg | 1540 |
Cayman2015 | 10703 | (±)-CP 55,940-d11 | 500 μg | 6160 |
Cayman2015 | 10704 | (±)13-HpODE | 1 mg | 10780 |
Cayman2015 | 10704 | (±)13-HpODE | 100 μg | 1470 |
Cayman2015 | 10704 | (±)13-HpODE | 50 μg | 770 |
Cayman2015 | 10704 | (±)13-HpODE | 500 μg | 6160 |
Cayman2015 | 10705 | (±)9-HpODE | 1 mg | 10780 |
Cayman2015 | 10705 | (±)9-HpODE | 100 μg | 1470 |
Cayman2015 | 10705 | (±)9-HpODE | 50 μg | 770 |
Cayman2015 | 10705 | (±)9-HpODE | 500 μg | 6160 |
Cayman2015 | 10706 | AM2201-d5 | 1 mg | 2002 |
Cayman2015 | 10706 | AM2201-d5 | 500 μg | 1050 |
Cayman2015 | 10707 | AM2201 | 10 mg | 1330 |
Cayman2015 | 10707 | AM2201 | 100 mg | 7980 |
Cayman2015 | 10707 | AM2201 | 25 mg | 2660 |
Cayman2015 | 10707 | AM2201 | 50 mg | 4984 |
Cayman2015 | 10710 | dinor-12-oxo Phytodienoic Acid | 1 mg | 12544 |
Cayman2015 | 10710 | dinor-12-oxo Phytodienoic Acid | 100 μg | 1568 |
Cayman2015 | 10710 | dinor-12-oxo Phytodienoic Acid | 5 mg | 54880 |
Cayman2015 | 10710 | dinor-12-oxo Phytodienoic Acid | 500 μg | 7056 |
Cayman2015 | 10711 | JWH 018 2-hydroxyindole metabolite-d9 | 1 mg | 5572 |
Cayman2015 | 10711 | JWH 018 2-hydroxyindole metabolite-d9 | 100 μg | 1330 |
Cayman2015 | 10711 | JWH 018 2-hydroxyindole metabolite-d9 | 500 μg | 4102 |
Cayman2015 | 10712 | JWH 018 4-hydroxyindole metabolite-d9 | 1 mg | 5572 |
Cayman2015 | 10712 | JWH 018 4-hydroxyindole metabolite-d9 | 100 μg | 1330 |
Cayman2015 | 10712 | JWH 018 4-hydroxyindole metabolite-d9 | 500 μg | 4102 |
Cayman2015 | 10713 | JWH 018 5-hydroxyindole metabolite-d9 | 1 mg | 5572 |
Cayman2015 | 10713 | JWH 018 5-hydroxyindole metabolite-d9 | 100 μg | 1330 |
Cayman2015 | 10713 | JWH 018 5-hydroxyindole metabolite-d9 | 500 μg | 4102 |
Cayman2015 | 10714 | JWH 018 6-hydroxyindole metabolite-d9 | 1 mg | 5572 |
Cayman2015 | 10714 | JWH 018 6-hydroxyindole metabolite-d9 | 100 μg | 1330 |
Cayman2015 | 10714 | JWH 018 6-hydroxyindole metabolite-d9 | 500 μg | 4102 |
Cayman2015 | 10715 | JWH 018 7-hydroxyindole metabolite-d9 | 1 mg | 9310 |
Cayman2015 | 10715 | JWH 018 7-hydroxyindole metabolite-d9 | 100 μg | 1330 |
Cayman2015 | 10715 | JWH 018 7-hydroxyindole metabolite-d9 | 500 μg | 5320 |
Cayman2015 | 10716 | JWH 073 2-hydroxyindole metabolite-d7 | 1 mg | 5572 |
Cayman2015 | 10716 | JWH 073 2-hydroxyindole metabolite-d7 | 100 μg | 1330 |
Cayman2015 | 10716 | JWH 073 2-hydroxyindole metabolite-d7 | 500 μg | 4102 |
Cayman2015 | 10717 | JWH 073 4-hydroxyindole metabolite-d7 | 1 mg | 5572 |
Cayman2015 | 10717 | JWH 073 4-hydroxyindole metabolite-d7 | 100 μg | 1330 |
Cayman2015 | 10717 | JWH 073 4-hydroxyindole metabolite-d7 | 500 μg | 4102 |
Cayman2015 | 10718 | JWH 073 5-hydroxyindole metabolite-d7 | 1 mg | 5572 |
Cayman2015 | 10718 | JWH 073 5-hydroxyindole metabolite-d7 | 100 μg | 1330 |
Cayman2015 | 10718 | JWH 073 5-hydroxyindole metabolite-d7 | 500 μg | 4102 |
Cayman2015 | 10719 | JWH 073 6-hydroxyindole metabolite-d7 | 1 mg | 5572 |
Cayman2015 | 10719 | JWH 073 6-hydroxyindole metabolite-d7 | 100 μg | 1330 |
我们公司zui大优势是强大的采购,
1:基本什么都能进口,血清,抗体,耗材,还有部分限制进口的,
2: 货品全,现经营过700多个品牌,基本所有生物试剂耗材都可以进口,特别是冷偏的产品那就更有优势,
3:提供加急服务,一般1-2周到货,超过时限加急费全免
4:价格公道,绝大部分价格有优势,当然不能保证100%产品都是,因为意味着没有服务.
5:良好的信誉,大部分客户我们提供货到付款服务,客户包括清华,北大 交大 复旦,中山等100多所大学,ROCHE,阿斯利康,国药 ,fisher等500多家公司
6:我们还是santa,Advanced Biotechnologies Inc;Athens Research & Technology, bangs, BBInternational, crystalchem, dianova, FD Neurotechnologies, Inc. FormuMax Scientific, Inc; Genebridege; Glycotope Biotechnology GmbH; iduron; Innovative Research of America; Ludger ; neuroprobe; omicronbio; Polysciences; prospecbi; QA-BIO;quickzyme;RESEARCH DIETS, INC;sterlitech;sysy;TriLink BioTechnologies, Inc;worthington-biochem;zyagen;......几十家国外公司授权代理
7:我们还从事invitrogen,qiagen; abcam ;sigma;neb; roche;merck; rnd; BD; GE; pierce; BioLegend....等*批发